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Abstract 
The triterpenes are one of the largest and most structurally diverse classes of plant 
specialised metabolites, with important commercial, agronomical and medical 
potential. However the structural complexity and low abundance of these 
compounds in nature presents significant challenges for exploiting this diversity. In 
recent years, advances in our understanding of triterpene biosynthesis in various 
plant species have greatly facilitated the ability to produce these compounds in 
other hosts. Plant-based host systems hold great promise because they may 
provide substrates, cofactors and subcellular compartmentalisation mechanisms 
facilitating engineering production of complex triterpenoids. Agroinfiltration is a rapid 
and scalable process that enables transient expression of biosynthetic genes in 
amenable plants such as Nicotiana benthamiana. This technique holds great 
promise for selective production and modification of triterpenes, but studies in this 
area have been limited. 
In this PhD thesis, transient expression is used to produce and oxidise triterpenes in 
N. benthamiana. Triterpene yields are improved through expression of rate-limiting 
genes in the mevalonate pathway (Chapter 3). An enzymatic ‘toolkit’ is established 
from a collection of previously characterised triterpene biosynthetic genes, allowing 
production of milligram quantities of a diverse array of simple and oxidised 
triterpenes in N. benthamiana. Furthermore, combinatorial biosynthesis is utilised to 
engineer production of novel oxidised triterpenes in planta (Chapter 4). A set of 
oxidised derivatives of β-amyrin are purified and evaluated for antiproliferative and 
anti-inflammatory activity in human cell lines, yielding insights into structural 
features underlying these activities in humans (Chapter 5). Finally, N. benthamiana 
is used for functional screening of cytochrome P450s implicated in the biosynthesis 
of agronomically important antifungal triterpene glycosides (avenacins) in oat, 
leading to identification of new P450s required for disease resistance (Chapter 6). 
This work highlights the utility of N. benthamiana as triterpene engineering platform 
and provides a basis for future studies exploring triterpene structure-activity 
relationships. 
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1.1 – Plant specialised metabolism 
Plants have adapted to the constraints of a sessile lifestyle through chemical 
innovation. They produce a huge range of specialised metabolites that are likely to 
have important ecological functions. For humans, these specialized metabolites are 
an important source of therapeutics such as painkillers, anti-cancer and anti-
parasitic compounds [1-3]. Because of the chemical complexity of these 
compounds, plants are still the primary source. Unfortunately, many of the source 
species are difficult to cultivate, slow-growing and provide only low yields of the 
desired product. These factors create significant supply issues and high market 
prices for many of the most highly valued chemicals such as taxol, vincristine and 
artemisinin. Alternative production methods such as plant cell or hairy root cultures 
have seen only limited success and have often proven difficult to scale [4]. 
Knowledge of the enzymes responsible for biosynthesis of metabolites of interest 
offers the possibility of engineering production in more tractable species. Recent 
advances in sequencing technologies are now rapidly making this possibility a 
reality. Consequently we are entering a new epoch in production of high-value 
compounds from plants in heterologous hosts [5-7]. Furthermore, as the number of 
characterised pathways increases, this presents the exciting opportunity to tap into 
the diversity in plant specialised metabolism to engineer new compounds. Success 
in this endeavour will require not only the elucidation of the relevant pathways, but 
also the development of suitable host systems for their production. 
In the present PhD thesis, Nicotiana benthamiana is explored as a host system for 
the production and purification of triterpenes, a therapeutically and commercially 
important class of plant specialised metabolites. This introductory chapter focuses 
on the background to this work. The importance of triterpenes for both plants and 
humans is first discussed. Current understanding of the biosynthesis of triterpenoids 
is also described with a key focus on scaffold generation and oxidation by 
cytochrome P450s. This chapter further considers how to address the demand for 
structurally diverse triterpenes through discovery of new enzymes, combinatorial 
biosynthesis and engineering enzyme function. 
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1.2 – Terpenoids: functions in nature and human uses 
Terpenoids (or isoprenoids) are the most diverse class of plant secondary metabolic 
products, with in excess of 46,000 different plant terpenoids reported [8]. They form 
a hugely structurally diverse class of natural products built from condensation of 
basic units of 5-carbon isoprene diphosphate precursors [9]. The classes of 
terpenoids found in plants include monoterpenes (C-10), sesquiterpenes (C-15), 
diterpenes (C-20), triterpenes (C-30) and tetraterpenes (C-40 - commonly called 
carotenoids). Terpenes are associated with a diverse array of essential biological 
functions. Small linear terpenoids serve as membrane-anchoring tails for proteins as 
well as components of the respiratory and photosynthetic electron transport chains 
[9, 10]. Others such as sterols have essential structural roles in regulating 
membrane fluidity, while carotenoids function as photosynthetic accessory pigments 
[9]. Terpenoids also have key plant developmental roles as they are necessary for 
biosynthesis of phytohormones, including brassinosteroids, gibberellins, 
strigolactones, cytokinins and abscisic acid [9, 11]. 
In addition to these primary functions, terpenoid biosynthesis in plants has been 
recruited towards specialised functions in defence, survival and communication. For 
example, bitter terpenoids may serve as general antifeedant agents against a range 
of pests and herbivores [12, 13]. Others display highly specific physiological 
interactions with target organisms, such as the potent insecticidal limonoid 
triterpene azadiractin [14] and phytoecdysteroids, which mimic insect moulting 
hormones [15]. Some terpenoids may serve to confer a competitive advantage 
against other plants. The diterpene momilactone B is a known allelopathic agent 
that is produced in the roots of rice and that inhibits the growth of Echinochloa weed 
species [16]. Low molecular-weight terpenoids are also volatile and fulfil a number 
of communicative roles between plants and animals [17-19]. Hence, beyond their 
roles in primary metabolism, terpenes serve vital roles in mediating interactions 
between plants and their environments and ensuring survival (Figure 1-1). 
For humans, terpenoids have great economic value. Plant essential oils associated 
with strong flavours and aromas are rich in terpenoids such as menthol, limonene, 
pinene and geraniol (Figure 1-1). These are widely used as fragrances and 
flavourings as well as in cleaning agents and cosmetics [20]. Natural rubber is a 
terpenoid polymer of huge industrial importance, and is used in the manufacture of 
over 40,000 products [21]. Furthermore, the hydrocarbon nature of many common 
terpenes makes them a potential future source of renewable biofuels [22, 23]. Other 
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terpenes are important medicines. Examples include the sesquiterpene artemisinin, 
an important anti-malarial therapeutic agent for which extensive efforts to engineer 
production in microbial hosts have been undertaken to meet global demand [24]. 
The diterpene taxol is also a widely used chemotherapeutic agent because of its 
ability to stabilise microtubules and disrupt mitosis in mammalian cells [3]. (Figure 
1-1).  
 
Figure 1-1: Examples of terpenes found in the plant kingdom and their functions. The name 
and class of molecules are given in black. Known functions of the compounds in nature are 
given in green, and uses by humans in blue.  
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1.3 – Triterpenes: Importance and bioactivity. 
The triterpenes are C-30 members of the terpenoid family.  Simple triterpenoids are 
amongst the oldest known biomolecules and have been isolated from sediments as 
old as 2.7 billion years [25]. The sterols are the best known examples of the 
triterpenes.  Sterols are essential in eukaryotes, regulating membrane fluidity and 
serving as steroid hormone precursors. In plants, as well as serving these essential 
functions, triterpenes have diversified to fulfil more specialised roles. The term 
triterpene encompasses all C-30 terpenoids but is often used to refer to the 
structurally diverse, non-steroidal class of compounds usually associated with 
specialised roles.  This thesis will focus on these non-steroidal C-30 compounds, 
which are hereafter referred to as triterpenes. 
Triterpenes are likely to have a number of different functions in planta. Simple 
triterpenes are lipophilic molecules and are known to accumulate in the waxy cuticle 
covering the surface of aerial organs of plants [26], where they may have a 
structural role in maintaining the flexibility of the cuticle [27]. Other simple 
triterpenes have roles in growth and development. For example in the model 
legume Lotus japonicus, the pentacyclic triterpene lupeol plays a role in suppressing 
nodulation [28] (Figure 1-2) In oat, accumulation of elevated levels of β-amyrin in 
mutants results in altered cell specification and short super-hairy roots [29] (Figure 
1-2). Similarly, altered expression of the genes for thalianol and marneral 
biosynthesis result in significant morphological effects in Arabidopsis thaliana [30-
32].  The molecular mechanisms underlying these various phenomena are currently 
poorly understood and it remains to be seen whether these examples are indicative 
of a more widespread role for triterpenes in plant development. 
In several cases triterpenes have been shown to have roles in plant defence, 
particularly triterpene glycosides (also known as saponins). Many triterpene 
glycosides are known to have allelopathic, antifungal, insecticidal, piscicidal or 
molluscicidal activity [33-37]. Such compounds may have potential as 
environmentally-sustainable pest-control agents. For example, the ability of 
triterpene glycosides to kill snails at low concentrations has applications for 
controlling parasite-carrying snails in regions where synthetic alternatives would be 
too expensive [37]. Even in modern agriculture, oats are often sown in rotation to 
control fungal disease outbreaks in wheat. The roots of oats produce anti-fungal 
triterpenes, avenacins, which have been implicated in the control of soil-borne 
diseases such as take-all [38]. 
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Figure 1-2: Functions of triterpenoids. Top panel: The simple triterpenes β-amyrin, 
marneral and lupeol have been shown to influence development in Avena strigosa, 
Arabidopsis thaliana and Lotus japonicus, respectively. Triterpene glycosides (saponins) 
such as the avenacins often show detergent-like properties, allowing them to insert into cell 
membranes and complex with sterols, leading to the formation of pores and subsequent cell 
lysis (Figure adapted from Moses et al. [39]) Bottom panel: Triterpenes and saponins have 
a number of important biological activities in humans. Synthetic derivatives of these have 
allowed for their therapeutic activities to be improved. 
Plants
Humans
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Triterpene glycosides are frequently amphipathic due to the coupling of the 
hydrophobic backbone to the highly polar sugar moieties. Thus many saponins have 
surfactant activity.  Indeed, the name saponin derives from ‘sapo’, the Latin for 
soap. Extracts of saponin-rich plant species have traditionally been used as natural 
soaps [36]. The bioactivity of saponins is often linked with this property. For 
example, numerous studies have shown that saponins can complex with membrane 
sterols, resulting in the formation of pores and channels that permeabilise cell 
membranes (reviewed extensively by Augustin et al [35]) (Figure 1-2).  Many 
saponins are haemolytic and also toxic to a range of human cell lines [40]. Removal 
of one or more sugars can abolish this activity [41]. Indeed, a number of specialised 
fungal pathogens of plants are capable of detoxifying saponins by enzymatic 
removal of sugars [42, 43]. 
Many traditional medicines have triterpenes and saponins amongst their active 
constituents. Panax (ginseng) species collectively accumulate >150 structurally 
diverse ginsenosides [44]. Both the saponins and their aglycones are reported to 
have a wide variety of beneficial properties including anti-cancer, 
immunostimulatory and anti-inflammatory activities [44-46]. Likewise, glycyrrhizin is 
a triterpene saponin produced by liquorice and used as a sweetening agent. The 
aglycone of glycyrrhizin, glycyrrhetinic acid, is known to interact with glucocorticoid 
signalling and has been associated with the anti-inflammatory activity of liquorice 
[47]. Many other species are also known to produce triterpenes with potent anti-
inflammatory activity [48].  
Beyond ‘traditional’ uses, there is growing interest in development of triterpenes as 
new therapeutic agents. For example, the pentacyclic triterpene celastrol was 
recently identified as an effective anti-obesity agent in mice due to its ability to 
restore leptin sensitivity [49]. Other triterpenes with cytoprotective functions have 
been considered as possible adjuvants in cancer therapy to help negate the toxicity 
of traditional chemotherapies [50]. Saponins also show promise for use as vaccine 
adjuvants [51-53]. One such saponin from Quillaja saponaria, QS-21, is a complex 
molecule featuring both glycosyl and acyl substituents. QS-21 has been the subject 
of extensive efforts to understand its mode-of-action, enhance stability and lessen 
side effects. These studies have led to the development of a semi-synthetic 
‘minimal’ adjuvant with reduced toxicity, good immunogenicity and better synthetic 
accessibility [54-56] (Figure 1-2).  
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Other triterpenes have also been the subject of extensive synthetic efforts to 
improve their therapeutic profiles. Bardoxolone (or CDDO) is a synthetic triterpene 
derived from oleanolic acid. This molecule was generated using an organic 
chemistry-based approach that aimed to enhance the natural anti-inflammatory 
action of oleanolic acid. Bardoxolone is a remarkably potent inducer of the anti-
inflammatory cytoprotective Keap1-Nrf2 pathway, and is several thousand-fold more 
effective at inhibiting production of the pro-inflammatory mediator nitric oxide than 
the parent compound [57, 58] (Figure 1-2).  
QS-21 and Bardoxolone serve as excellent examples of the potential of 
triterpenoids for human health. The synthetic development of triterpenes as 
therapeutic agents using conventional chemistry depends on access to supply of 
the relevant scaffold and availability of functional groups for modification on this 
scaffold at key positions. Poor availability of triterpene scaffolds, stereochemical 
complexity and the problems of selective chemical oxidation have restricted such 
approaches.  Hence the vast majority of triterpene structural diversity remains 
unexploited. This underscores the need to understand triterpene biosynthesis in 
nature and identify the enzymes responsible for scaffold formation and oxidation. 
1.4 – Triterpenoid biosynthesis in plants 
Two distinct pathways exist in nature for the biosynthesis of terpenoids. The first of 
these is the mevalonate (MVA) pathway, which uses acetyl-CoA as a starting 
molecule and is found in most eukaryotes, archaea and some bacteria [59]. In 
contrast, most bacteria have an alternative (MEP or DOXP) pathway, which utilises 
pyruvate and D-glyceraldehyde-3-phosphate. Despite the significant differences in 
their biochemistry, both pathways culminate in the production of the same 5-carbon 
isomers, namely isopentenyl diphosphate (IPP) and dimethylallyl diphosphate 
(DMAPP). These are the basic building blocks for all terpenes [11, 60]. 
Condensation of a single unit of IPP and DMAPP yields the C-10 molecule geranyl 
diphosphate (GPP). Incorporation of additional units of IPP yields successively 
longer chains, including C-15 farnesyl diphosphate (FPP) and C-20 geranylgeranyl 
diphosphate (GGPP) (Figure 1-3).  
 
Plants are unusual in possessing both the MVA and MEP pathways, a feature that 
is believed to be a consequence of endosymbiotic acquisition of the cyanobacterial-
like ancestor to modern-day chloroplasts [60]. Concordantly, the two pathways are 
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spatially separated; the MEP pathway operates within plastids, while the MVA 
pathway operates mostly within the cytosol, but also the endoplasmic reticulum (ER) 
and peroxisomes [11, 60]. The presence of two pathways underlines the importance 
of terpenoid biosynthesis in the plant kingdom and may enable optimal use of the 
carbon resources available for growth and defence [11]. The maintenance of both of 
these pathways throughout evolution suggests that they are functionally non-
redundant and it follows that they produce clearly distinct types of terpene end 
products. GPP and GGPP are synthesised in the plastids, and give rise to the 
monoterpenes (GPP), diterpenes and carotenoids (GGPP). In contrast, FPP is 
synthesised from the MVA pathway in the cytosol and is used for biosynthesis of 
sesquiterpene and triterpenes. GGPP may also be formed in the cytosol for protein 
prenylation [11] (Figure 1-3). 
Transformation of these linear substrates into cyclic derivatives is an important 
mechanism underlying the enormous diversity seen in the terpenes [61, 62]. 
Monoterpenes, sesquiterpenes and diterpenes are derived directly from 
diphosphorylated substrates. In contrast, for triterpene biosynthesis, two molecules 
of FPP first undergo head-to-head condensation to form the C-30 hydrocarbon 
squalene with loss of the diphosphate groups [63]. In bacteria, squalene may be 
cyclised directly by the action of squalene-hopene cyclases [64]. In eukaryotes 
however, squalene is generally further oxidised prior to cyclisation by squalene 
epoxidase (SQE) to form 2,3-oxidosqualene (OS). This epoxide gives rise to the 
characteristic C-3 oxygen functionality seen in sterols and triterpenes. 
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Figure 1-3: The MVA and MEP pathways. The MEP pathway is in the plastids while the 
MVA pathway is based primarily in the cytosol. In A. thaliana, HMGR is localised to the 
endoplasmic reticulum (pink bubble), while AACT and PMK are believed to be peroxisomal 
(blue bubbles)[11]. Trafficking of IPP and DMAPP occurs between compartments (double-
headed arrows). Compound abbreviations: MVA Pathway: CoA, Coenzyme A; HMG, 3-
hydroxy-3-methylglutaryl-CoA; MVA, mevalonate; MVAP, Mevalonate-5-phosphate; MVAPP,  
Mevalonate-5-diphosphate. MEP pathway: GA-3P, D-glyceraldehyde-3-phosphate; DXP,  
1-deoxy-D-xylulose 5–phosphate; MEP, 2-C-Methyl-D-erythritol 4-phosphate; CDP-ME, 4-
(Cytidine 5’-diphospho)-2-C-methyl-D-erythritol; CDP-ME2P, 2-Phospho-4-(cytidine 5'-
diphospho)-2-C-methyl-D-erythritol; ME-2,4-cPP, 2-C-Methyl-D-erythritol ,2,4-
cyclodiphosphate; HMBPP, 4-Hydroxy-3-methylbut-2-enyl-diphosphate; Downstream: IPP, 
isopentenyl diphosphate, DMAPP – dimethylallyl diphosphate, GPP – geranyl diphosphate, 
FPP – farnesyl diphosphate; GGPP, geranylgeranyl diphosphate. Enzyme abbreviations: 
MVA Pathway: AACT, Acetyl-CoA C-acetyltransferase; HMGS, HMG-CoA synthase; 
HMGR, HMG-CoA reductase; MK, MVA kinase; PMK, Phospho-MVA kinase; MPDC,  
Diphospho-MVA kinase. MEP pathway: DXS, DXP synthase; DXR, DXP reductoisomerase; 
MCT, MEP cytidylyltransferase; CMK. CDP-ME kinase; MDS, ME-2,4cPP synthase; HDS, 
HMBPP synthase; HDR, HMBPP reductase; Downstream: IPPI, IPP isomerase; GPPS, 
GPP synthase; FPPS, FPP synthase; GGPPS,  GGPP synthase; SQS, Squalene synthase; 
SQE, Squalene epoxidase; OSC, Oxidosqualene cyclase. 
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1.4.1– Oxidosqualene cyclisation generates diversity in triterpene scaffolds 
Oxidosqualene cyclases (OSCs) are the enzymes that cyclize OS to triterpenes. 
Triterpene cyclisation is initiated through protonation of the terminal OS epoxide by 
a conserved aspartic acid residue within the motif DCTAEA [65]. Protonation opens 
the epoxide and leads to the formation of cationic carbon species [62]. Double 
bonds within the substrate are brought into proximity to the cation by conformational 
reorganisation within the active site of the OSC. This leads to a cascade of 
nucleophilic attacks that result in ring formation. These cyclised intermediates may 
undergo further ring expansions and methyl- and hydride shifts to yield the final 
product [66, 67]. The degree of cyclisation can vary greatly and may result in the 
formation of anything from mono- to pentacyclic products [62, 68]. In some cases, 
rings may be reopened once formed, leading to the production of seco- triterpenes 
[69]. Termination of the reaction often occurs by deprotonation resulting in the 
formation of a characteristic double bond, but can also arise through water capture 
[68]. The latter results in the formation of triterpene diols such as dammarenediol-II, 
a commercially important scaffold found in the ginsenosides (Figure 1-4).  
These diverse mechanisms can give rise to in excess of 100 different cyclic 
products [66, 68]. However only two such products, cycloartenol and lanosterol, are 
required for sterol production in eukaryotes. The former is produced exclusively by 
plants. Formation of sterols occurs through a highly specific cyclisation route 
involving the formation of a 6,6,6,5 tetracyclic protosteryl cation intermediate. This 
intermediate adopts a chair-boat-chair (C,B,C) conformation in the A, B and C rings 
respectively (Figure 1-4). Several of the major pentacyclic triterpene scaffolds found 
in the plant kingdom (such as β-amyrin and lupeol), are also formed through a 
6,6,6,5 tetracyclic cationic intermediate known as the dammarenyl cation. In 
contrast to the protosteryl cation, however, the dammarenyl cation adopts a chair-
chair-chair (C,C,C) conformation and undergoes further ring expansion and 
generation to form the final pentacyclic products [62, 68, 70] (Figure 1-4). The 
protosteryl and dammarenyl cations provide a useful mechanistic distinction 
between the biosynthesis of sterols and common triterpenes. It must be noted 
however that other common ‘triterpene’ scaffolds which function in specialised 
metabolism (ie cucurbitadienol) are also formed through the protosteryl cation [62]. 
Finally, given the mechanistic flexibility of OS cyclisation, it follows that OSCs are 
often multifunctional and produce a variety of products. An extreme example of this 
is the A. thaliana  OSC baruol synthase BARS1, which makes a total of 23 different 
cyclization products [71].  
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Figure 1-4: Cyclisation of oxidosqualene to form sterols and triterpenes. The substrate 
adopts different conformations in the active site of the OSC prior to cyclisation. Two common 
conformations include the chair-boat-chair (C-B-C) and chair-chair-chair (C-C-C). 
Protonation results in a series of electrophilic attacks which generates cationic intermediates 
including the tetracylic protosteryl- and dammarenyl cations, respectively. The subsequent 
rearrangements of these intermediates define the final products. The protosteryl cation gives 
rise to the sterols including lanosterol and cycloartenol but can also form other products 
including parkeol and cucurbitadienol which may serve as scaffolds for specialised 
metabolites. The dammarenyl cation can give rise to tetracyclic products or undergo further 
ring expansion to form pentacylic triterpenes including β-amyrin and lupeol.  
 
It is particularly remarkable that despite the extensive diversity available in OS 
cyclisation, the majority of the saponins characterised from plants are based on only 
a very limited repertoire of eleven scaffolds [72]. This would imply that the vast 
majority of scaffolds are largely unrepresented in plant extracts and that a valuable 
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source of bioactive compounds may be unutilised. Significant structural diversity has 
been found in the products of OSCs even from well-studied species such as A. 
thaliana [62]. However many of these are present only at very low levels in planta. 
Therefore identification of the OSCs that synthesise these diverse products and 
their expression in heterologous systems represents an important strategy for 
accessing this metabolic diversity. 
1.4.2 – Oxidation allows further diversification of triterpenes 
Oxidation of the scaffold is an integral feature of triterpene biosynthesis and is 
critical for generating structural diversity [73]. Oxidation imparts significant effects on 
the polarity, solubility and reactivity of the backbone. Importantly, it further allows 
functionalisation of chemically-inert C-H bonds within the triterpene scaffold, so 
enabling further tailoring, frequently by glycosylation or acylation. Enzymatic 
oxidation of triterpene scaffolds can also facilitate fundamental structural changes 
such as bond cleavage [74, 75] and bridge formation [76]. A good example of this is 
seen in the limonoid triterpenes, which can undergo such extensive oxidation that 
they barely resemble their tetracyclic precursors [14].  
The principle enzymes responsible for triterpene oxidation are the cytochrome 
P450s (P450s). These enzymes catalyse the regio- and stereoselective oxidation of 
their substrates. P450s are monoxygenases, splitting molecular oxygen to 
incorporate one atom into the substrate while reducing the other to form water [77]. 
In a large number of cases this results in formation of a hydroxylated product: 
RH + O2 + 2e
- + 2H+  ROH + H2O 
This process is catalysed by a central iron atom that is part of a haem cofactor 
within the P450 active site. The mechanism requires electrons donated from 
NADPH via a partner CYP450 reductase (CPR) enzyme [78]. P450s can catalyse a 
remarkable range of unusual reactions [79, 80]. In triterpenes, the most common 
modifications involve hydroxylation, although subsequent rounds of additional 
oxidation can also occur to give carbonyl or carboxylic acid moieties (Table 1-1). 
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Figure 1-5: Activity of various triterpene oxidases on the β-amyrin scaffold. The numbering 
on β-amyrin (left) indicates the carbons which are oxidised by P450s. For simplicity, only the 
activity upon β-amyrin is shown, except in the cases where an oxidised form of β-amyrin is 
needed for full activity. 
 
P450s are one of the largest and diverse enzyme superfamilies, representing 
approximately 1% of the genome of higher plants [73, 81]. P450s show a great deal 
of flexibility in primary sequence, which underlies the catalytic diversity and 
substrate tolerance of these enzymes. P450 categorisation is based on sequence 
similarity to other P450s. At the broadest level, P450s are grouped into clans. 
P450s within each clan are believed to derive from a single ancestral gene. There 
are a total of eleven clans in land plants, ten of which are present in angiosperms 
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[81]. Clans are further divided into families and subfamilies; P450s are assigned to 
these based on values of approximately 40 and 55 percent amino acid sequence 
identity to their nearest neighbours [82]. There is significant variation in the number 
of families within a single clan. For example, in angiosperms, clans CYP51, CYP74, 
CYP97, CYP710, CYP711 and CYP727 each contain only a single family. By 
contrast, the CYP71, CYP72, CYP85 and CYP86 clans contain multiple families 
[81]. P450s within the single-family clans are often functionally associated with 
primary metabolism such as sterol or hormone biosynthesis. By contrast, P450s 
from multi-family clans are more commonly associated with specialised plant 
metabolic pathways [73]. Accordingly, most triterpene-oxidising P450s are found 
within the latter group [83] (Table 1-1). However despite these generalisations, 
members of clans normally associated with primary metabolic functions may still be 
recruited towards roles in specialised metabolism. For example, the CYP51 clan is 
found across all biological kingdoms and its members have ancient conserved 
functions in 14α demethylation of sterols [84]. In grasses however, the CYP51H 
subfamily has arisen from the wider plant CYP51G sterol demethylases and has 
been recruited to secondary metabolic role. In oats, CYP51H10 is a multifunctional 
triterpene (β-amyrin) oxidase required for the biosynthesis of avenacins [85, 86]. 
Examples such as this underscore the importance of experimental verification of 
P450 function. 
Great progress in identifying triterpene-oxidising P450s has been made in recent 
years and the number continues to grow steadily. The most common substrate for 
these enzymes is the ubiquitous pentacyclic triterpene β-amyrin. Collectively these 
P450s oxidise eleven carbons around this scaffold (Figure 1-5 and Table 1-1).  
Oxidases for other less common but commercially-important triterpene scaffolds are 
also becoming known. These include the dammarenediol-II oxidases CYP716A47 
and CYP716A53v2, which give rise to two of the major branches of bioactive 
ginsenosides in species of ginseng [44, 87, 88] (Figure 1-6A). Similarly, a number 
of P450s have recently emerged which are functional on cucurbitadienol [89, 90], a 
tetracyclic triterpene widely distributed throughout the cucurbitaceae and 
responsible for bitterness in these species [91] (Figure 1-6B). 
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Figure 1-6: Oxidases of non-β-amyrin triterpene scaffolds. A) Dammarenediol-II is a 
tetracyclic triterpene which can be oxidised to protopanaxadiol (PPD) and protopanaxatriol 
(PPT) in ginseng species through the action of CYP716A47 and CYP716A53v2.  B) 
Cucurbitadienol is a tetracyclic triterpene scaffold widely distributed in the cucurbitaceae. 
P450s have been identified which oxidise this scaffold in cucumber (CYP88L2 and 
CYP81Q58) as well as Siratia grosvenorii (CYP87D20).  
 
1.4.3 – Clustering aids identification of new triterpene oxidases 
In recent years, it has become apparent that the genes for many plant specialised 
metabolic pathways are organised into biosynthetic gene clusters [83]. Triterpenes 
appear to be no exception to this, and a number of OSCs have been found with 
nearby P450s (and other tailoring enzymes) which are coregulated and functionally 
compatible when expressed in heterologous hosts. Examples of this kind have been 
found in the genome of diverse plant species including Arabidopsis thaliana [30, 32, 
74, 92], Lotus japonicus [93], cucumber [89, 92] and oat [94] (Figure 1-7). As a 
result, this has huge implications for the discovery of new triterpene biosynthetic 
enzymes, allowing new pathways to be elucidated through genome mining or 
sequencing bacterial artificial chromosomes. Recently, analysis of the genomic 
region within 50kb of terpene synthases highlighted a frequent non-random physical 
‘pairing’ of OSCs with P450 enzymes in the genomes of flowering plants [92]. This 
study also revealed common families of P450s which pair with OSCs (Figure 1-7B). 
For example, in dicots, members of the CYP716 family were commonly found 
proximal to OSCs [92]. This fits remarkably well with the list of triterpene oxidases 
B)
A)
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characterised to date, with CYP716 members shown to oxidise a variety of 
triterpene backbones (Table 1-1). Further members of this family (and others) can 
therefore be expected to be characterised in future. Knowledge of common families 
of triterpene oxidases may also prove useful for species for which genomic 
sequence data is not available, allowing identification of candidates from 
transcriptomic data [95].  
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Figure 1-7: Clustering of OSCs and P450s. A) Examples of triterpene oxidases which are 
known to be clustered with oxidosqualene cyclases. OSCs are named in blue and P450s are 
named in red. The approximate distance between the relevant OSC and the P450s are 
given in kb below the P450 name. B) Summary of common OSC-P450 pairs found from a 
recent analysis of five monocot and twelve dicot species [92]. The P450 clans are indicated 
in red boxes, while the individual families are given in green boxes. Numbers in brackets 
indicate the numbers of each pair found within the analysis. Yellow indicates the most 
abundant pairings. Figure adapted from Boutanaev et al [92]. 
 
B)
A)
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Clan Gene Substrate Modification Genbank ID Ref 
CYP51 AsCYP51H10 β-amyrin 
C12,13β-
epoxidation,    
C-16β 
hydroxylation 
ABG88961 [85, 86] 
CYP71 AtCYP71A16 Marnerol 
C-23 
hydroxylation 
NM_123623 [30, 74] 
 
LjCYP71D353 Dihydrolupeol* 
C-20 
hydroxylation         
C-28 oxidation 
(3 step) * 
KF460438 [93] 
 
AtCYP705A1 Arabidiol 
C-15-16 
cleavage 
NM_117621 [74, 75] 
 
AtCYP705A5 
7β-
hydroxythalianol 
C-15-16 
desaturation* 
NM_124173 [32] 
 
CsCYP81Q58 
19-hydroxy- 
cucurbitadienol 
C-25 
hydroxylation 
KM655856 [89, 92] 
 
GmCYP93E1 
β-amyrin/ 
Sophoradiol 
C-24 oxidation 
(3-step) 
AF135485 [96] 
 
MtCYP93E2 β-amyrin 
C-24 
hydroxylation 
DQ335790 [97] 
 
GuCYP93E3 β-amyrin 
C-24 
hydroxylation 
AB437320 [98] 
 
AhCYP93E4 β-amyrin 
C-24 oxidation 
(3-step) 
KF906535 [99] 
 
CaCYP93E5 β-amyrin 
C-24 oxidation 
(3-step) 
KF906536 [99] 
 
GgCYP93E6 β-amyrin 
C-24 oxidation 
(3-step) 
KF906537 [99] 
 
LcCYP93E7 β-amyrin 
C-24 
hydroxylation 
KF906538 [99] 
 
PsCYP93E8 β-amyrin 
C-24 oxidation 
(3-step) 
KF906539 [99] 
  PvCYP93E9 β-amyrin 
C-24 oxidation 
(3-step) 
KF906540 [99] 
 
Table 1-1: P450s involved in triterpene biosynthesis. * denotes putative identity. ** denotes 
where other products were also observed with unconfirmed identity. Initials preceding gene 
name are species as follows: Aa - Artemesia annua, Ah - Arachis hypogaea, As - Avena 
strigosa, At - Arabidopsis thaliana, Bf -  Bupleurum falcatum, Bv - Barbarea vulgaris, Ca -  
Cicer arietinum, Cq – Chenopodium quinoa, Cr - Catharanthus roseus, Cs - Cucumis 
sativus, Gg - Glycyrrhiza glabra, Gm - Glycine max, Gu - Glycyrrhiza uralensis, Lc - Lens 
culinaris, Lj - Lotus japonicus, Md - Malus domestica, Ml - Maesa lanceolata, Mt - Medicago 
truncatula, Pg -  Panax ginseng, Ps -  Pisum sativum, Pv - Phaseolus vulgaris, Sg -  Siratia 
grosvenorii, Vv - Vitis vinifera. 
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Clan Gene Substrate Modification Genbank ID Ref 
CYP72 GuCYP72A154 
β-amyrin/                    
11-oxo-β-amyrin 
C-30 
hydroxylation/        
C-30 oxidation                
(3-step)** 
AB558153 [100] 
 
MtCYP72A61v2 
24-hydroxy-                
β-amyrin 
C-22β 
hydroxylation 
AB558145 [101] 
 
MtCYP72A63 β-amyrin 
C-30 oxidation 
(3-step) 
AB558146 
[100, 
101] 
 
MtCYP72A67 Oleanolic acid 
C-2β 
hydroxylation 
AB558149 [102] 
  MtCYP72A68v2 Oleanolic acid 
C-23 oxidation 
(3-step) 
AB558150 [101] 
CYP85 AtCYP708A2 Thalianol 
C-7β 
hydroxylation 
NM_180822 [32, 74] 
 
AtCYP716A1 Tirucalladienol Hydroxylation* NM_123002 [92] 
 
MtCYP716A12 
α/β-amyrin/ 
Lupeol 
C-28 oxidation 
(3-step) 
FN995113 [97] 
 
AaCYP716A14v2 
α/β/δ-amyrin/ 
lupeol 
C-3 oxidation                      
(to ketone) 
KF309251 [95] 
 
VvCYP716A15 
α/β-amyrin/ 
Lupeol 
C-28 oxidation 
(3-step) 
AB619802 [97] 
 
VvCYP716A17 β-amyrin 
C-28 oxidation 
(3-step) 
AB619803 [97] 
 
PgCYP716A47 
Dammarenediol-
II 
C-12β 
hydroxylation 
JN604536 [103] 
 
PgCYP716A52v2 β-amyrin 
C-28 oxidation 
(3-step) 
JX036032 [87] 
 
PgCYP716A53v2 Protopanaxadiol 
C-6α 
hydroxylation 
JX036031 [88] 
  MlCYP716A75 β-amyrin 
C-28 oxidation 
(3-step) 
KF318733 [76] 
 
Table 1-1 (continued): P450s involved in triterpene biosynthesis. * denotes putative 
identity. ** denotes where other products were also observed with unconfirmed identity. 
Initials preceding gene name are species as follows: Aa - Artemesia annua, Ah - Arachis 
hypogaea, As - Avena strigosa, At - Arabidopsis thaliana, Bf -  Bupleurum falcatum, Bv - 
Barbarea vulgaris, Ca -  Cicer arietinum, Cq – Chenopodium quinoa, Cr - Catharanthus 
roseus, Cs - Cucumis sativus, Gg - Glycyrrhiza glabra, Gm - Glycine max, Gu - Glycyrrhiza 
uralensis, Lc - Lens culinaris, Lj - Lotus japonicus, Md - Malus domestica, Ml - Maesa 
lanceolata, Mt - Medicago truncatula, Pg -  Panax ginseng, Ps -  Pisum sativum, Pv - 
Phaseolus vulgaris, Sg -  Siratia grosvenorii, Vv - Vitis vinifera. 
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Clan Gene Substrate Modification Genbank ID Ref 
CYP85 CqCYP716A78 β-amyrin 
C-28 
oxidation  
(3-step) 
KX343075 [104] 
 CqCYP716A79 β-amyrin 
C-28 
oxidation  
(3-step) 
KX343076 [104] 
 
BvCYP716A80 
α/β-amyrin/ 
Lupeol 
C-28 
oxidation                   
(3-step)** 
KP795926 [105] 
 
BvCYP716A81 
α/β-amyrin/ 
Lupeol 
C-28 
oxidation                   
(3-step)** 
KP795925 [105] 
 
MdCYP716A175 
α/β-amyrin/ 
Lupeol/ 
Germanicol 
C-28 
oxidation                   
(3-step)** 
EB148173 [106] 
 
CrCYP716AL1 β-amyrin 
C-28 
oxidation  
(3-step) 
JN565975 [107] 
 
BfCYP716Y1 α/β-amyrin 
C-16α 
hydroxylation 
KC963423 [108] 
 
MlCYP87D16 β-amyrin 
C-16α 
hydroxylation 
KF318734 [76] 
 
SgCYP87D18 Cucurbitadienol 
C-11 
oxidation  
(2-step) 
AEM42986 [90] 
 
GuCYP88D6 β-amyrin 
C-11 
oxidation  
(2-step) 
AB433179 [98] 
 
CsCYP88L2 Cucurbitadienol 
C-19 
hydroxylation 
KM655860 [89] 
 
Table 1-1 (continued): P450s involved in triterpene biosynthesis. * denotes putative 
identity. ** denotes where other products were also observed with unconfirmed identity. 
Initials preceding gene name are species as follows: Aa - Artemesia annua, Ah - Arachis 
hypogaea, As - Avena strigosa, At - Arabidopsis thaliana, Bf -  Bupleurum falcatum, Bv - 
Barbarea vulgaris, Ca -  Cicer arietinum, Cq – Chenopodium quinoa, Cr - Catharanthus 
roseus, Cs - Cucumis sativus, Gg - Glycyrrhiza glabra, Gm - Glycine max, Gu - Glycyrrhiza 
uralensis, Lc - Lens culinaris, Lj - Lotus japonicus, Md - Malus domestica, Ml - Maesa 
lanceolata, Mt - Medicago truncatula, Pg -  Panax ginseng, Ps -  Pisum sativum, Pv - 
Phaseolus vulgaris, Sg -  Siratia grosvenorii, Vv - Vitis vinifera. 
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1.5 – Engineering diversity in triterpene biosynthesis 
Characterisation of the genes and enzymes in triterpene biosynthesis permits 
reproduction of these pathways in heterologous hosts. At the same time, given the 
difficulties in chemical synthesis of the triterpenes, there is particular interest in how 
these enzymes can be employed to access novel products. Integrating enzymes 
from different pathways into a common host is a powerful means to achieve this 
goal. This ‘combinatorial’ biosynthesis is becoming an increasingly popular 
approach for producing an array of both extant and new-to-nature terpenes in 
different hosts. 
1.5.1 – Combinatorial biosynthesis 
For triterpenes, combinatorial biosynthesis has been demonstrated through the 
combination of common scaffolds such as β-amyrin with tailoring enzymes including 
P450s and glycosyltransferases. Selectively oxidised forms of β-amyrin can be 
predictably produced by the combined action of pairs of β-amyrin oxidases [101]. 
Taking this a step further, triterpene glycosides have also been produced by 
combining OSCs, P450s and glycosyltransferases [108]. In this latter example, the 
C-3 glucoside of echinocystic acid was made in yeast through a combination of 
enzymes from four different plant species (Figure 1-8). As the repertoire of 
triterpene biosynthetic enzymes continues to expand, the assembly of a diverse 
collection of enzymes offers significant potential for the bespoke biosynthesis of 
triterpenes of interest. The success of this approach will be bolstered by the fact that 
numerous triterpene oxidases are known with overlapping functions, but with 
differences in efficiency or activity towards individual substrates [99, 100]. Thus 
several routes may be possible towards the same product and the exact choice of 
enzymes may be tailored for optimising yields.  
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Figure 1-8: Combinatorial biosynthesis of triterpenoids. Combining enzymes from different 
organisms which work on a common scaffold (i.e. β-amyrin), can allow for predictable design 
of triterpenoids Abbreviations: bAS – β-amyrin synthase, Glc – Glucoside. 
 
Combinatorial biosynthesis relies on the ‘promiscuity’ of enzymes in specialised 
metabolism. As a result, enzymes may be active towards substrates which differ 
from that encountered in their native host pathway. Hence, scaffolds for which few 
native tailoring enzymes are known may still be functionalised by enzymes from 
other pathways. For example, members of the CYP716 family have been shown to 
have activity towards a range of pentacyclic backbones (Figure 1-9A) [95, 97, 108]. 
In these examples, the activity of the P450s on other scaffolds was identical to that 
on β-amyrin, due to the similarities between the scaffolds. However other studies 
have hinted that some triterpene oxidases might have activity towards markedly 
different substrates. For example the A. thaliana CYP716A1 has been shown to be 
capable of oxidising both the tetracyclic triterpene tirucalladienol [92] as well as the 
pentacyclic triterpenes lupeol and α- and β-amyrin [109] (Figure 1-9B). 
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Figure 1-9: β-amyrin oxidases which are also functional on other pentacyclic scaffolds. A) A 
number of triterpene oxidases have been found to be capable of oxidising a range of 
pentacyclic scaffolds in addition to β-amyrin (see Figure 1-5). These scaffolds are 
structurally similar and the activity of the P450 is retained in each case. B) Triterpene 
oxidases may also be active on structurally dissimilar scaffolds. The CYP716A1 enzyme 
acts as a C-28 oxidise towards a number of pentacyclic scaffolds (β-amyrin only shown). 
The enzyme also oxidises tirucalladienol, which lacks an equivalent methyl group at the 
same position, thus the regiospecific oxidations will differ depending on substrate. 
 
 
 
B)
A)
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At present, a systematic approach to combinatorial biosynthesis of triterpenes is 
lacking, however it is reasonable to assume that a high success rate will be found. 
Some excellent recent examples have showcased how effective a systematic 
combinatorial biosynthesis approach can be for generating diterpene diversity [110-
112]. In one study, the A. thaliana CYP701A3 was shown to oxidise an array of 15 
out of 22 diverse diterpene scaffolds, with different regioselectivity depending on the 
type of substrate [113]. Remarkably, this enzyme normally operates as an ent-
kaurene oxidase (KO) in the biosynthesis of essential gibberellins. This suggests 
that even enzymes from primary metabolism might be successfully recruited for 
combinatorial biosynthesis. The obvious triterpene counterpart would be sterol 
oxidases, although the success of such an approach remains to be seen. 
Alternatively, P450s are also known to operate in the biosynthesis of sterol-derived 
specialised metabolites such as the steroidal glycoalkaloids and might also be 
applied for triterpene biosynthesis [114].  
1.5.2 – Protein engineering augments combinatorial biosynthesis 
Enzymes such as terpene cyclases and P450s show a high degree of functional 
plasticity and changes to the active site of these enzymes can have a dramatic 
effect on both product and substrate specificity. This provides further opportunity to 
engineer triterpene diversity. For example, mutant cyclases producing ‘new-to-
nature’ diterpenes [115] have been successfully integrated into a combinatorial 
biosynthesis approach [111] (Figure 1-10A). Alternatively, while combinatorial 
biosynthesis is possible thanks to the promiscuity of enzymes in specialised 
metabolism, generally the activity of such enzymes towards novel substrates is not 
optimal. This can result in poor product yields and non-specific reactions which 
would impede creation of a multistep pathway. Hence protein engineering efforts 
can also be used to enhance the specific product yield following the initial 
combinatorial screen. This principle has likewise been demonstrated for diterpene 
P450s, allowing for substantially improved yields of specific products [110] (Figure 
1-10B). In nature, enzymes catalysing sequential steps in a metabolic pathway may 
also interact physically. Such protein complexes or ‘metabolons’ are expected to 
efficiently channel products through the pathway and have recently been 
demonstrated for cyanogenic glycoside production in Sorghum [116]. Assembly of 
synthetic metabolons could present a complementary strategy to the above 
approaches [117]. 
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Figure 1-10: Using mutant enzymes in combinatorial biosynthesis A) Mutant terpene 
cyclases may serve as a source of novel scaffolds for combinatorial biosynthesis. In the 
example here, an A. thaliana ent-copalyl diphosphate synthase (AtCPS) H263A mutant 
produces the new-to-nature diterpene 8β-hydroxy-ent-CPP. Both wild-type and mutant 
products can be further cyclised by the Salvia sclarea sclareol synthase (SsSS). NB: while 
the SsSS enzyme is active on ent-CPP as shown, the specific ent-CPP synthase used in the 
study by Jia et al was ZmCPS2/An2 from Zea mays [111]. B) Mutagenesis can be used to 
enhance the product specificity and activity of enzymes following combinatorial biosynthesis. 
In this example, the specificity and activity of the Pinus taeda abietadiene oxidase (PtAO) 
towards the non-native diterpene substrate miltiradiene could be improved through 
modelling and targeted mutagenesis. The type and combination of mutations allowed for 
different product specificities. 
 
1.6 – Triterpene production in heterologous hosts 
A common method of accessing existing and novel plant metabolites is through 
expression of their biosynthetic enzymes in heterologous host systems. The 
metabolic engineering of biological host systems for production of valuable natural 
products is frequently referred to as ‘synthetic’ biology. A core principle of synthetic 
biology is the application of engineering principles to biological systems including a 
‘design, build, test’ approach to optimise production [118, 119]. Ultimately, synthetic 
biology approaches aim to establish a series of well-defined, standardised biological 
‘parts’ which can be integrated to achieve high level production of the desired 
molecule. The potential of synthetic biology to deliver high-value specialised 
metabolites is highlighted by numerous examples such as the flagship semi-
synthetic production of the antimalarial sesquiterpene lactone, artemisinin (Figure 
1-11). This project saw the development of a yeast-based platform for artemisinin 
production by transfer of the biosynthetic genes from the native producing plant 
Artemisia annua. Successful utilisation of this microbial host required the 
overexpression of the entire MVA pathway to increase precursor supply, as well as 
optimisation of enzyme stoichiometry and expression of relevant coenzymes to 
Chapter 1 – General Introduction 
 
27 
 
avoid build-up of toxic intermediates, thereby improving productivity and host cell 
viability [24]. The final strains were capable of producing 25 g per L of artemisinic 
acid, which can be subsequently photochemically converted to artemisinin [6, 24]. 
More recently, engineering of other highly complex specialised metabolic pathways 
from plants into heterologous hosts has been achieved. These include engineering 
yeast to produce the monoterpene indole alkaloid strictosidine (Figure 1-11), a 
precursor for anticancer drugs normally derived from the Madagascan periwinkle 
Catharanthus roseus [5]. Yeast has also been engineered for production of opioids, 
an important class of alkaloid painkillers normally only attainable from poppy 
(Figure 1-11) [7]. These efforts required incorporation of in excess of ten enzymes 
to catalyse the necessary chemical transformations to the desired metabolites from 
common precursors. Additionally enzymes from animals, plants and yeast, mutant 
and fusion enzyme variants and host gene knockouts were all employed to improve 
the titre of the final products. These endeavours showcase the enormous potential 
of synthetic biology to deliver complex natural products which may be limiting in 
nature. 
 
Figure 1-11: Synthetic biology for engineering plant specialised metabolites. The structures 
of some important plant specialised metabolites which have been engineered in 
heterologous hosts are shown. The native host producing species is listed below each 
product. 
 
Choosing an appropriate host producer is a key factor in successful production of 
the desired compound. Suitable hosts should be well-characterised, fast-growing 
and amenable to genetic manipulation. Bacteria such as Escherichia coli are 
common platforms for hosting a variety of biosynthetic pathways, particularly from 
other bacterial species. However these lack cellular compartmentalisation and post-
translational processing capability which can impede reconstruction of pathways 
from eukaryotic systems. For instance, P450s normally localise to the endoplasmic 
reticulum (ER) and consequently often function poorly in E. coli. Hence eukaryotic 
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systems such as yeast have become the preferred production hosts for high-value 
plant terpenoids such as artemisinin [24].  
For triterpenoids, yeast is also the platform most-used for validating the function of 
OSCs and their associated P450s. Furthermore, this host has shown promise for 
the production of simple synthetic triterpene glycosides [108]. However an open 
question is whether yeast will prove to be suitable for the production of more 
complex triterpenes such as saponins. Saponins frequently feature uncommon 
sugars and acyl moieties [72] which are not products of endogenous yeast 
metabolism and would require further development of yeast strains. Furthermore, 
the inherent antimicrobial activity of many saponins may also impose difficulties on 
efficient production. These factors warrant the parallel exploration of the potential of 
other host organisms. 
1.6.1 – Nicotiana benthamiana is an emerging host for producing plant 
specialised metabolites 
As photosynthetic organisms, plants have excellent potential for the 
environmentally-sustainable production of high-value products. Furthermore, plants 
share common pathways, codon usage, subcellular compartments and enzyme 
cofactors, thereby facilitating transfer of metabolic pathways from one plant species 
to another. Indeed tobacco-based systems have also proven to be viable platforms 
for artemisinin production [120, 121]. 
N. benthamiana is a fast-growing, wild relative of tobacco which has grown in 
popularity in recent years as a heterologous expression host for numerous plant 
metabolites. One of the major reasons for this is due to the amenability of this 
species to transient gene expression through agroinfiltration. This technique 
involves infiltration of Agrobacterium tumefaciens into the interstitial spaces of N. 
benthamiana leaves. The bacteria then transfer a section of DNA (T-DNA) carrying 
the gene(s) of interest from a binary vector to the plant cell where they are 
translated. If these genes encode biosynthetic enzymes, this technique can be used 
for production of specialised metabolites. To-date, transient expression in N. 
benthamiana has been used to produce a range of molecules derived from other 
plant species including seco-iridoids [122], glucosinolates [123, 124] and 
cyanogenic glucosides [125]. A range of terpenes have likewise been successfully 
produced in this system, including monoterpenes [126, 127], diterpenes [112, 128-
130], sesquiterpenes [131-134] and triterpenes [85, 93, 95, 105]. 
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1.6.2 – Realising N. benthamiana as a (tri)terpene production platform 
In order to enhance the capacity of N. benthamiana for terpene production, a 
number of strategies can be employed to augment the yield of the desired product. 
In the first instance, agroinfiltration can be used to manipulate the host plant’s 
metabolism to overcome metabolic bottlenecks and loss of intermediates to other 
pathways. Such strategies include expression of yield-boosting enzymes [128, 132] 
and silencing of competing pathways [131]. Targeting certain proteins to non-native 
subcellular compartments such as mitochondria or chloroplasts might also be 
employed to increase yields [127, 129, 131, 132] (Figure 1-12).  
Molecular techniques such as Golden Gate cloning facilitate generation of single 
vectors containing multiple genes [135]. This allows for entire biosynthetic pathways 
to be expressed from a single strain of A. tumefaciens. Furthermore, vector 
construction can incorporate suites of well-characterised promoters, terminators, 
localisation signals and UTRs [136]. Hence fine-tuned control over individual 
enzymes in a pathway is possible and may be utilised for optimising production 
(Figure 1-12). In parallel to optimisation of the molecular components, the 
agroinfiltration process itself has proven to be highly scalable which offers the 
opportunity to apply this technique for mass production of high-value chemicals 
(Figure 1-12). Companies such as Medicago (www.medicago.com) are capable of 
large-scale vacuum infiltration of N. benthamiana for the production of virus-like 
particles. The development of Leaf Systems at the Norwich Research Park in 
England (leafsystems.com) will similarly allow for scaled production and purification 
of both proteins and small metabolites in the near future.  
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Figure 1-12: Strategies to increase terpenoid yield in N. benthamiana A) Manipulating the 
host plant metabolism can be achieved by overcoming endogenous rate-limiting steps or 
silencing competing pathways. Targeting the enzymes for the product of choice to 
alternative subcellular locations such as chloroplasts (or mitochondria) may also be used. B) 
Entire pathways can be encoded in a single vector which allows for the relative expression 
of individual proteins to be altered. C) Agroinfiltration can also be scaled through the use of 
techniques such as vacuum infiltration which allows for much higher throughput than 
infiltration by hand. 
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1.7– PhD overview: 
The number of characterised triterpene synthases, oxidases and 
glycosyltransferases has expanded greatly in recent years. This presents for the 
first time an opportunity to harness the vast structural diversity of this important 
class of molecules. While N. benthamiana has been investigated as a platform for 
production of other classes of terpenes, at present no systematic investigation has 
been conducted into the value of this plant as a host for triterpene production. This 
PhD thesis attempts to address this. In the following chapters, the system is first 
developed to enhance triterpene yields (Chapter 3). Following this, the possibility of 
using N. benthamiana as a general triterpene production platform is explored, 
resulting in synthesis of a range of both extant and previously-unreported 
triterpenes (Chapter 4). Furthermore, scaled production and purification of a series 
of triterpene analogues from N. benthamiana is performed to begin a systematic 
structure-function study of antiproliferative and anti-inflammatory activity (Chapter 
5). Finally, the system is used to screen and identify a number of previously-
unreported triterpene oxidases involved in avenacin biosynthesis (Chapter 6). 
Collectively this work suggests that N. benthamiana is likely to be an excellent 
system for the rapid production and purification of a diverse array of triterpenes. 
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2.1 – General methods 
2.1.1 – Gateway cloning 
2.1.1.1 – Entry clones 
For generating Gateway Entry clones, pDONR207 was used in all cases unless 
otherwise specified. Gateway cloning was performed by incubation of the insert 
DNA (purified PCR product or other vector) and pDONR207 in equal ratios 
(approximately 150ng each) in a total volume of 8µL of Tris-EDTA (TE) buffer 
(10mM Tris (pH 8.0 with HCl) and 1mM EDTA.). A further 2µL of BP clonase II 
(Invitrogen) was added and vortexed briefly. The enzyme reaction was incubated for 
approximately 1 hour at room temperature. Following this, 5µL of the BP clonase 
reaction was added to chemically competent E. coli for transformation as detailed in 
section 2.1.2.1. The remaining 5µL was kept aside at room temperature for 24 
hours and used in the event that the first transformation was unsuccessful. Positive 
cells were selected for on LB agar plates plus 50µg/ml gentamicin (pDONR207). 
Colony PCR was performed to screen colonies (section 2.1.1.3) and positive 
colonies were cultured overnight (37°C, 200rpm) in 10mL liquid LB (plus 50µg/ml 
gentamicin). Plasmids were recovered using a QIAprep spin miniprep kit (Qiagen) 
and sent for sequencing using attL-1/R-2 primers and where necessary, additional 
custom primers as detailed in Table 2-1. 
2.1.1.2 – Expression clones 
To generate pEAQ-HT-DEST1 vectors carrying the gene of interest, Gateway 
cloning was performed by incubation of the Entry vector (usually a pDONR207-
derived construct) with pEAQ-HT-DEST1 in equal ratios (approximately 150ng 
each) in 8µL TE buffer. A further 2µL of LR clonase II was added to the reaction and 
incubated at room temperature for a minimum of 6 hours. 5µL of the LR clonase 
reaction was used to transform chemically competent E. coli as in section 2.1.2.1. 
The remaining 5µL was kept aside at room temperature for up to 24 hours and 
reused if the first transformation was unsuccessful. Positive transformants were 
selected for on LB agar kanamycin plates plus 50µg/ml kanamycin. It was generally 
not necessary to perform colony PCR. Finally, a single colony was picked from the 
plate and grown overnight (37°C, 200rpm) in 10mL liquid LB media (plus 50µg/ml 
kanamycin).Plasmids were purified using a QIAprep spin miniprep kit (Qiagen) and 
used to transform A. tumefaciens LBA4404 (section 2.1.2.3). 
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2.1.1.3 – Colony PCR 
Individual colonies were labelled for identification and a small stab of the colony was 
taken using a 10µL pipette tip and resuspended in 30µL distilled water by pipetting 
up and down. 1µL of the suspension was used as the template in the PCR reaction 
as follows: 
Reagent Per sample 
Template 1µL 
attL1/2 primers (10µM each) 1µL 
2x GoTaq Green master mix 5µL 
H2O 3µL 
Total 10µL 
 
For thermal cycling, the following parameters were used: 
 
Step 
Temp 
(°C) Time 
 
Denaturation 98 30 sec 
3
0
 c
y
c
le
s
 
Denaturation 98 10 sec 
Annealing 55 10 sec 
Extension 72 1 min/kb 
 
Extension 72 5 minutes 
    
 
Following the PCR reaction, 5µL was analysed on a 1% agarose gel. Positive 
colonies were identified as those which had a band corresponding to the size of the 
expected insert (plus ~200bp due to the attL primer binding sites). 
2.1.1.4 – DNA electrophoresis 
For analysis of DNA by agarose gel electrophoresis, an agarose gel was made with 
addition of usually 1:99 w:v agarose (Sigma) to an appropriate volume of TAE buffer 
(Formedium) with approximately 0.01% ethidium bromide (1mg/mL solution). Gels 
were run at constant 120 V for approximately 20-40 minutes depending on the size 
of the gel. A 2-log ladder (NEB) was included Gels were visualised under UV light. 
2.1.1.5 – Sequencing 
Sequencing was performed by Eurofins (http://www.eurofinsgenomics.eu/). Purified 
plasmid templates were sent for sequencing. Sequencing primers are given in 
Table 2-1. 
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2.1.1.6 - 2-step Gateway PCR: 
For the first step, 10μL PCR reactions were setup as follows: 
 
 Reagent Per sample 
 
HF Buffer (5x) 2µL 
dNTPs (10mM) 0.2µL 
Primers (10mM) 2µL 
Template 0.5µL 
Phusion polymerase 0.1µL 
H2O 5.2µL 
 Total 10µL 
   
 
Tubes were sealed and thermal cycling was performed as below: 
 
Step Temp  Time 
 
Denaturation 98°C 30 sec 
1
0
 c
y
c
le
s
 
Denaturation 98°C 10 sec 
Annealing varied 10 sec 
Extension 72°C 1 min/kb 
 
Extension 72°C 3 minutes 
 
For the second step, master mix (40µL/sample) was made as shown below and 
pipetted into the 10µL PCR tube above. 
  Reagent 
Per 
sample 
 
Buffer (5x) 8µL 
dNTPs (10mM) 0.8µL 
attB1/2 primers (10mM) 4µL 
Phusion polymerase 0.4µL 
H2O 26.8µL 
 
Total 40µL 
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Thermal cycling was performed as shown below: 
 
Step Temp  Time 
 
Denaturation 98°C 30 sec 
1
0
 c
y
c
le
s
 
Denaturation 98°C 10 sec 
Annealing 45°C 10 sec 
Extension 72°C 1 min/kb 
2
0
 c
y
c
le
s
 Denaturation 98°C 10 sec 
Annealing 55°C 10 sec 
Extension 72°C 1 min/kb 
 
Extension 72°C 3 min 
 
2.1.1.7 – Common primers 
  Name Sequence 
S
e
q
u
e
n
c
in
g
 
P
ri
m
e
rs
 attL1-F TCGCGTTAACGCTAGCATGGATCTC 
attL2-R ACATCAGAGATTTTGAGACACGGGC 
M13-F GAGCGGATAACAATTTCACACAGG 
M13-R AGGGTTTTCCCAGTCACGACGTT 
 
   
   Name Adapter sequence 
G
a
te
w
a
y
 a
d
a
p
te
r 
s
e
q
u
e
n
c
e
s
 attB1F-1 GGGGACAAGTTTGTACAAAAAAGCAGGCTTA 
attB2R-1 GGGGACCACTTTGTACAAGAAAGCTGGGTA 
attB1F-2 GGGGACAAGTTTGTACAAAAAAGCAGGCT 
attB2R-2 GGGGACCACTTTGTACAAGAAAGCTGGGT 
attB1Fs-1 AAAAAGCAGGCTTA 
attB2Rs-1 AGAAAGCTGGGTA 
 
Table 2-1: A list of commonly used primer sequences. Top: Sequencing of Gateway Entry 
vectors was commonly performed using the attL1/2 F/R primers, while M13 F/R primers 
were commonly used for TOPO-based vector sequencing. Bottom: Gateway adapter 
sequences added to the 5’ end of cloning primers. attB1Fs and attB2Rs primers are 
truncated versions of the full-length Gateway attB primers and were used for the 2-step PCR 
as detailed in section 2.1.1.6. 
 
2.1.1.8 – Plasmids  
Name Vector Type Supplier Selection 
pDONR207 Gateway Entry Invitrogen Gentamicin 
pENTR-D-TOPO Gateway Entry Invitrogen Kanamycin 
Zero Blunt TOPO Non-Gateway cloning Invitrogen Kanamycin 
pEAQ-HT-DEST1 Gateway Destination Lomonossoff lab, JIC Kanamycin 
 
Table 2-2: List of plasmids used in the present thesis. 
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2.1.2 – Microbiological techniques 
2.1.2.1 – Transformation of chemically-competent E.coli 
Plasmid DNA was prepared as detailed in specific sections. E. coli was stored as 
50µL aliquots of cells at -80°C. For transformation, cells were removed from the 
freezer and transferred to ice to thaw. DNA was incubated with the cells on ice for 
approximately 30 minutes before heat shock in a water bath set to 42°C for 20-30 
seconds. Cells were transferred back to ice for a further 2 minutes before addition of 
200µL of media (LB or SOC). Cells were then incubated for 1 hour at 37°C at 
200rpm. Finally cells were removed from the incubator and plated onto LB agar 
plates with appropriate antibiotics for selection of positive transformants. Plates 
were incubated at 37°C overnight. 
2.1.2.2 – Preparation of chemically competent A. tumefaciens 
A glycerol stock culture (-80°C) of A. tumefaciens LBA4404 was streaked onto LB 
agar plates containing rifampicin and streptomycin (50μg/mL and 100μg/mL, 
respectively). These were grown overnight at 28°C in a standing incubator. A 
second overnight culture was performed in 50mL LB media (plus antibiotics as 
above) at 28°C, 200rpm. The following morning, the cultures were placed on ice for 
10 minutes before centrifugation at 4°C (4,500g) for 5 minutes. The supernatant 
was discarded and cells were resuspended in 1ml ice cold CaCl2 (20mM). The cells 
were again centrifuged as before and resuspended in cold 20mM CaCl2. Finally, 
cells were aliquoted in 50μL batches and flash frozen in liquid N2 before transfer to 
the -80°C freezer. 
2.1.2.3 – Transformation of A. tumefaciens LBA4404 
Chemically competent A. tumefaciens strain LBA4404 were taken from the -80°C 
freezer, thawed on ice (in microcentrifuge tubes) and incubated with 1-200ng of the 
pEAQ-HT-DEST1 vector carrying the gene of interest for approximately 30mins. 
The tubes were transferred to liquid N2 for 30 seconds before removal and thawing 
at room temperature. 200μl of SOC medium was added to each tube and the tubes 
were transferred to the 28°C shaking incubator at 200rpm for 2-4 hours. After this, 
tubes were centrifuged briefly and the bacterial suspension was transferred to LB 
agar plates containing rifampicin, kanamycin and streptomycin (50/50/100μg per mL 
respectively). The plates were stored in the 28°C standing incubator for three days 
until colonies could clearly be seen. After this period, a single colony was 
transferred to 5mL liquid LB media containing the same three 
antibiotics/concentrations as above and transferred to the 28°C shaking incubator 
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overnight. Around 1mL of the culture was then transferred to a labelled 
microcentrifuge tube containing 200µL glycerol and stored at -80°C. These freezer 
stocks were subsequently used for the culturing of the Agrobacteria for future 
infiltrations. 
2.1.2.4 – Antibiotics 
Antibiotics were made as detailed in Table 2-3. The same concentrations were used 
in both liquid and solid (agar) LB media. 
Antibiotic Stock Final 
Dilution 
factor 
Gentamicin 50mg/mL in H2O 50µg/mL  1/1000 
Kanamycin 50mg/mL in H2O 50µg/mL  1/1000 
Streptomycin 100mg/mL in H2O 100µg/mL  1/1000 
Rifampicin 50mg/mL in dimethylformamide 50µg/mL  1/1000 
Chloramphenicol 30mg/mL in Ethanol 30µg/mL  1/1000 
Ampicillin 100mg/mL in H2O 100µg/mL  1/1000 
 
Table 2-3: List of antibiotics used for culturing bacteria. All antibiotic stocks were stored at 
1mL aliquots in the specified solvent at -20°C. 
 
2.1.3 – Agroinfiltration 
2.1.3.1 – Growth of N. benthamiana 
N. benthamiana plants were grown under greenhouse conditions set to 25°C with 
16 hour lighting. Supplementary lighting was used during the winter months. 
Seedlings were sown in F1 compost (Levington) and grown for 2 weeks before 
transfer to individual cells containing F2 compost (Levington). Plants were grown for 
an additional 3-4 weeks before infiltration. 
2.1.3.2 – Preparation of A. tumefaciens for agroinfiltration 
A. tumefaciens cultures stored as glycerol stocks were streaked onto LB agar plates 
containing appropriate rifampicin, kanamycin and streptomycin (50/50/100μg per mL 
respectively) and transferred to a standing incubator at 28°C for 24 hours. A sterile 
pipette tip was used to transfer a small amount of the bacterial streak to liquid media 
(usually 10mL) with antibiotics as above. This was incubated overnight in the 28°C 
shaking incubator (200rpm). Depending on the application and volume required, a 
second subculture (up to 1.5L per strain for vacuum infiltration, but typically <200mL 
for hand infiltrations) was started by transferring the contents of the first culture to 
fresh LB media with antibiotics as above.  
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For preparation of the infiltration suspension, the cultures were centrifuged at 4000 
x g to pellet the cells and the supernatant was discarded. The cells were 
resuspended in an small volume (~5mL per 50mL culture) of MMA solution and 
incubated for 1 hour.  
To measure the optical density, a spectrophotometer was set to 600nm and blanked 
using MMA solution. The bacterial suspension was diluted (usually 1 in 10) in MMA 
in a 1mL cuvette to bring the suspension to within the accurate range of the 
spectrophotometer and measured. The reading was multiplied by the dilution factor 
to get the actual density of the cultures and recorded. For adjusting culture density 
to the desired OD600 the following equation was used: 
Current OD600 x current suspension volume (mL) 
Final OD600 
The figure used for ‘final OD600’ was n x 0.2 (where n is the number of strains to be 
coinfiltrated). This ensured that when mixed in equal ratios, each strain would be at 
a density of OD600 = 0.2, as required for ensuring plant cells received a copy of all 
genes. The figure from the equation above gave the total volume (mL) of 
suspension needed to reach the desired final OD600 and MMA solution was added to 
reach this volume. Appropriately diluted suspensions of individual strains were then 
combined in equal ratios. 
2.1.3.3 – Agroinfiltration of N. benthamiana 
Strains of A. tumefaciens were prepared as in section 2.1.3.2. For hand infiltration 
of N. benthamiana plants, expanded leaves of five-week-old plants were first 
perforated with a pipette tip (10μl) (Figure 2-1A-C). The holes were used to aid 
infiltration of the A. tumefaciens suspensions from the underside of the leaf using a 
5mL needleless syringe (Figure 2-1D-F). Unless otherwise indicated, the whole leaf 
was infiltrated. Following infiltration, plants were left under the same greenhouse 
conditions for an additional five days. Harvesting and downstream processing of 
leaves is detailed in specific sections. 
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Figure 2-1: Infiltration of N. benthamiana by hand A) A representative 5-week-old N. 
benthamiana plant grown under greenhouse conditions. B) Perforation of a leaf using a 
pipette tip. This does minimal damage to the leaf and makes the infiltration process much 
easier C) Multiple perforations are usually required for whole leaf infiltration D) The 
underside of the leaf is used for the infiltration. E) Infiltration using a 1mL syringe. F) The 
infiltrated area can be visualised easily as a darkened patch on the underside of the leaf. 
This process is usually repeated until the whole leaf is infiltrated. 
 
An infiltrator for vacuum agroinfiltration of N. benthamiana was built by Dr Bastiaan 
Brouwer and contained within the greenhouse housing the plants. Briefly, this 
consists of a chamber connected to a vacuum pump via an intermediary vacuum 
reservoir (Figure 2-2A). A 10L removable bath fits in the chamber and is filled with 
the appropriate agroinfiltration suspension. A bespoke acrylic holder was designed 
A) B)
C) D)
E) F)
Chapter 2 – General materials and methods 
41 
 
to hold up to four 5-6-week-old N. benthamiana plants simultaneously in 9cm pots 
(Figure 2-2B). The plants were positioned in the holder and inverted into the filled 
bath so that the aerial parts of the plants were completely submerged (Figure 2-2B-
C). For infiltration, the vacuum was applied to ~26mmHg and held for approximately 
one minute to draw the air out of the interstitial leaf space. The vacuum reservoir 
was then isolated and the chamber re-equilibrated with the external atmosphere 
over 20-30 seconds to allow the bacterial suspension to be drawn into the leaves. 
Generally this process efficiently infiltrates all of the submerged leaves. Plants were 
carefully removed from the chamber and returned to their former positions in the 
greenhouse and left for 5 days.  
 
Figure 2-2: Vacuum infiltration of N. benthamiana. A) The infiltrator as used in the present 
thesis. The vacuum chamber is located at the base and the vacuum pump sits atop the 
chamber. An intermediary reservoir vacuum increases the speed at which the necessary 
pressure can be achieved. B) Plants are loaded into an acrylic holder which can 
accommodate four plants simultaneously. C) The plants are inverted within the holder into 
the bath containing ~10L of agrobacterium suspension. D) The submerged plants are loaded 
into the vacuum chamber for infiltration. E) A plant after infiltration, the efficiency of 
infiltration can be seen by the darker infiltrated areas. F) A vacuum-infiltrated plant 
expressing GFP five days after infiltration as seen under UV. Leaves are arranged in 
approximate order of age, (youngest-oldest, left to right). The youngest leaves (top left) are 
not expressing GFP as these have emerged in the days following infiltration. Picture F) 
kindly provided by Dr Bastiaan Brouwer. 
A) B) C)
D) E) F)
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2.1.4 – General considerations for purification of compounds 
Leaf material was harvested five days after infiltration either by hand or vacuum as 
described in section 2.1.3, taking efforts to ensure that only the producing parts of 
the plants were sampled. Leaves were frozen at -80°C and lyophilised prior to use 
to remove water. Dried leaves were ground in liquid N2 using a pestle and mortar 
and saponified for 2 hours at 65°C. Following saponification, the ethanol was 
removed by rotary evaporation and the products were extracted by partitioning 
multiple times with ethyl acetate. The ethyl acetate was dried and the extract was 
subject to flash chromatography to isolate the compound of interest. Following flash 
chromatography, decolourisation and recrystallization were frequently performed to 
remove minor impurities. 
2.1.4.1 – Flash chromatography 
All flash chromatography steps were performed using a Biotage Isolera One. 
Samples were either wet loaded in toluene or dry loaded on silica gel. Flash 
chromatography was performed under normal phase conditions using a mobile 
phase of hexane (weak) and ethyl acetate (strong). Details of the various programs 
are given in Table 2-4. 
2.1.4.2 – Decolourisation. 
Compounds were dissolved in several mL of ethanol and decolourisation was 
performed by adding a small amount of activated charcoal powder (Sigma). This 
was incubated for several minutes at room temperature with intermittent agitation. 
The suspension was then transferred to a column made from a Pasteur pipette 
packed with diatomaceous earth (Celite, Sigma) between two thin layers of cotton 
wool and pre-equilibrated with ethanol. The suspension was passed through the 
column and the subsequent eluent was collected in a round bottom flask. The 
column was washed multiple times with ethanol to ensure maximal recovery of 
compound and this was likewise collected. Finally the collected solution was dried 
using rotary evaporation. 
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2.1.4.3 – Flash chromatography programs 
Program 
Strong  Col 
Program Strong 
solvent 
Col  
solvent Vols Vols 
P-1 
6% 2 
P-8 
15% 15 
6-100% 10 15-20% 10 
100% 7 20% 15 
P-2 0-50% 60 20-100% 5 
P-3 
5% 2 100% 5 
5-100% 18 
P-9 
6% 2 
100% 4 6-50% 6 
P-4 
20% 20 50-100% 1 
20-100% 3 100% 5 
100% 5 
P-10 
10% 1 
P-5 
20% 15 10-80% 10 
30% 10 80% 2 
30-100% 5 
P-11 
7% 1 
100% 5 7-70% 10 
P-6 
5% 2 70% 2 
5-100% 15 
P-12 
7% 1 
100% 5 7-60% 10 
P-7 
5% 1 60% 2 
5-40% 15 
P-13 
0-100% 20 
40% 2 100-100% 40 
40-100% 2   
100% 10    
 
Table 2-4: Flash chromatography programs. The solvent system was always hexane (weak) 
and ethyl acetate (strong). The volume of solvents are represented in column volumes (col 
vols) due to differences in column size. Details of these columns are given in the relevant 
sections. Flow rate was always the maximum recommended by the manufacturer (Biotage). 
 
2.1.4.4 – Recrystallization 
Two flasks containing ethanol and water were placed in a ~90°C water bath. 
Compounds were dissolved in a separate vessel in a minimal amount of ethanol 
(90°C). The flask was kept at 90°C and hot water was slowly added dropwise, 
allowing any precipitate to re-dissolve fully between drops. This was repeated until 
the solution became slightly turbid, at which point the flask was removed from the 
water bath and left at room temperature covered with a small glass plate without 
disturbing for ~30 mins. The flask was further transferred to ice for ~30 minutes to 
fully precipitate compounds. The recrystallized suspension was transferred to a 
15mL centrifuge tube and centrifuged briefly before removal of the supernatant. 
Crystals were then dissolved in an appropriate solvent (usually dichloromethane: 
ethyl acetate 1:1 and transferred to a vial before evaporation under N2 followed by 
lyophilisation overnight. 
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2.1.5 – GC-MS programs: 
2.1.5.1 – 31 minute program 
The GC system used was an Agilent 7890B fitted with a Zebron ZB5-HT Inferno 
column). 1μL of the sample was injected into the GC inlet (250°C) using a pulsed 
splitless method (30psi pulse pressure). The oven temperature gradient began at 
170°C (held 2 min), then ramped to 290°C at 6°C/min and held for 4mins. Finally 
the oven temperature was increased to 340°C at a rate of 10°C/min. The final time 
was 31mins. For analysis of mass spectra, the solvent delay was set to 15mins. The 
detector was set to scan mode over a range from m/z 60-800. 
2.1.5.2 – 20 minute program 
GC-MS analysis was performed using the GC-MS and column as described above. 
1μl of each sample was injected into the GC inlet (250°C) using a pulsed splitless 
mode (30 psi pulse pressure). The oven temperature program was set to 170°C for 
2 mins, followed by a ramp to 300°C at 20°C/min. This was held at 300°C for a 
further 11.5 min to give a final run time of 20 minutes. Electron-impact mass 
spectrometry was performed using an Agilent 5977A Mass Selective Detector, set 
to scan mode from 60-800 mass units. The solvent delay was set to 8 minutes. For 
quantification, the detector was set to 7.2 scans/sec. 
 
2.1.6 – Common reagents and solutions 
2.1.6.1 – Triterpene standards 
Compound Supplier 
Squalene Sigma 
2,3-Oxidosqualene Sigma 
β-Amyrin Extrasynthese 
Coprostanol (internal std) Sigma 
DD-II Dr R. Thimmappa 
EpDM Dr R. Thimmappa 
Erythrodiol Extrasynthese 
Glycyrrhetinic acid Extrasynthese 
Hederagenin Apin 
Oleanolic acid Extrasynthese 
Protopanaxadiol Extrasynthese 
Protopanaxatriol Extrasynthese 
Cycloartenol Sigma 
  
Table 2-5: List of triterpene standards as used to verify products in this thesis. Compounds 
from Dr Ramesha Thimmappa are as detailed in Salmon et al [137]. 
 
Chapter 2 – General materials and methods 
45 
 
2.1.6.2 – MMA solution: 
10mM 2-(N-morpholino) ethanesulphonic acid buffer (MES, Sigma) pH5.6 (KOH) 
10mM MgCl2 
150μM 3’5’-dimethoxy4’acetophenone (Acetosyringone, Sigma). 
2.1.6.3 – Saponification solution  
The saponification solution consisted of ethanol:H2O:KOH mixed 9:1:1 (v:v:w). The 
KOH was first fully dissolved in water 1:1 (w:v) before addition of ethanol. Where the 
internal standard (coprostanol, Sigma) was added, the saponification solution 
volume was first accurately measured using a measuring cylinder or volumetric flask 
before addition of the standard. 
 46 
 
 
 
 – Improving triterpene production in N. benthamiana Chapter 3
 
 
Chapter 3: 
 
Investigating strategies 
for improving triterpene 
production in N. 
benthamiana 
 
 
Acknowledgements: 
All of the work is this chapter is the author’s own. Constructs for tHMGR and 
CYP51H10 were provided by members of the Osbourn lab. Constructs for GFP 
were kindly provided by the Lomonossoff group.
Chapter 3 – Strategies for improving triterpene production in N. benthamiana 
47 
 
3.1 – Introduction 
Triterpenes are a structurally diverse class of specialised metabolites with great 
medical and agronomic potential [34, 35, 39, 48, 57]. However exploitation of these 
compounds is often hindered by their limited availability from natural sources and 
problems in isolating single products from extracts containing mixtures of 
structurally similar compounds [46]. Chemical synthesis of triterpenoids is hampered 
by their structural and stereochemical complexity, with total synthesis of even 
simple scaffolds requiring numerous synthetic steps [138, 139]. Collectively, these 
problems limit the sourcing and modification of triterpenoids to exploit their full 
potential. Engineering triterpene production in heterologous hosts opens up 
alternative routes to access triterpenoids, thereby addressing the above problems. 
Knowledge of the genes and enzymes responsible for triterpenoid biosynthesis in 
nature allows their transfer to suitable expression hosts for the biosynthesis of high 
value compounds. Nicotiana benthamiana, a wild relative to tobacco, is one such 
host.  N. benthamiana has gained popularity in recent years as a platform for 
reconstituting plant natural product pathways by transient expression [140, 141]. A 
number of studies have investigated strategies for enhancing the capacity of this 
system for biosynthesis of various terpenoids, primarily monoterpenes, 
sesquiterpenes and diterpenes (Figure 3-1). N. benthamiana shows potential for 
production of triterpenes [85, 93, 105]. However at present, little effort appears to 
have been made to optimise triterpene production in this system. 
Compound Class of molecule Quoted yield Reference 
Geraniol Monoterpene 27 µg/g FW  [142] 
Geraniol  Monoterpene 129 µg/g FW [127] 
Amorphadiene Sesquiterpene 6.2 mg/kg FW [132] 
Artemisinic acid diglucoside Sesquiterpene 39.5 mg/kg FW* [132] 
Costunolide Sesquiterpene 60 ng/g FW [133] 
Valencene Sesquiterpene 0.70 µg/g/24h [131] 
Casbene Diterpene 227 ng/cm
2
 [128] 
Cembratrienol Diterpene 2500 ng/cm
2
 [128] 
Isopimaric acid Diterpene 45–55 μg/g DW [129] 
Levopimaradiene Diterpene 100 ng/cm
2
 [128] 
EpHβA Triterpene 1.18 mg/g DW ǂ [85] 
    
 
Table 3-1: Reported yields of various terpenes produced in N. benthamiana 
Abbreviations: FW, fresh weight; DW, dry weight. NB: Yields are given as reported. It is not 
always possible to compare directly between studies due to differences in the units of 
reported yield. *The glycosylation of artemisinic acid results from endogenous N. 
benthamiana activity and corresponds to 16.6mg/kg FW free artemisinic acid. ǂ Indicates 
isolated yield. 
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Figure 3-1: Metabolic engineering for increased terpenoid yields in N. benthamiana [127-
129, 131-133]. Abbreviations: MT – mitochondria, CP – chloroplast, CYT - cytosol RL – 
expression of a rate-limiting enzyme. 
 
3.1.1 – Engineering early pathway steps in triterpene production 
Successful production of specialised metabolites in heterologous systems often 
benefits from overcoming the regulatory mechanisms within the host cell which 
might limit precursor availability. A common strategy is the overexpression of one or 
more ‘rate-limiting’ enzymes. Triterpene scaffolds such as β-amyrin are synthesised 
from acetyl-CoA via the mevalonate (MVA) pathway (Figure 3-2). The key 
regulatory enzyme in the MVA pathway is 3-hydroxy, 3-methylglutaryl-coenzyme A 
reductase (HMGR), which catalyses the irreversible conversion of HMG-CoA to 
mevalonate [60]. Both transcriptional and post-translational mechanisms exist to 
fine-tune HMGR activity based on both local feedback and global energy levels and 
highlights the central role that this enzyme plays in regulating flux through the MVA 
pathway [143, 144]. Importantly, post-translational regulation of HMGR activity 
suggests that increased expression of this enzyme may not be sufficient by itself to 
overcome this yield-limiting step. Hence overcoming the post-translational 
mechanisms regulating HMGR activity is an important strategy for increasing the 
yields of MVA pathway-derived terpenes. 
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Figure 3-2: Triterpene biosynthesis A) MVA and MEP pathways within the plant 
cell. Enzymes are indicated in red. Compound abbreviations: CoA, Coenzyme A; 
HMG, 3-hydroxy-3-methylglutaryl; MVA, mevalonate; IPP, isopentenyl diphosphate; 
DMAPP, dimethylallyl diphosphate; FPP, farnesyl diphosphate; GA-3P, D-
Glyceraldehyde-3-phosphate; GPP, geranyl diphosphate; GGPP, geranylgeranyl 
diphosphate. Enzyme abbreviations: HMGR, HMG-CoA reductase; FPS, FPP 
synthase; SQS, Squalene synthase; SQE, Squalene epoxidase; CAS, cycloartenol 
synthase; AsbAS1, Avena strigosa β-amyrin synthase; GPS, Geranyl diphosphate 
synthase; GGPS, Geranylgeranyl diphosphate synthase. B) Biosynthesis of β-
amyrin from acetyl-CoA.  The structures of key intermediates relevant to this study 
are shown.  
  
Cytosol Chloroplast
B)
A)
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The N-terminal membrane-spanning region of HMGR is dispensable for catalytic 
activity, but has a key regulatory role [60]. Phosphorylation and likely ubiquitination 
of this region serve to repress plant HMGR activity [145, 146]. Removal of the N-
terminal region can therefore alleviate regulatory control of the enzyme. Indeed 
expression of an N-terminal-truncated version of HMGR (tHMGR) has become a 
common strategy for boosting MVA pathway yields. Expression of tHMGR has been 
applied for enhancing triterpene and sterol content in yeast [108, 147, 148] and in 
stable transgenic lines of tobacco and rubber [149, 150]. Similarly, tHMGR has been 
used in transgenic tobacco to enhance the production of sesquiterpenes [120], 
which are also derived from the MVA pathway (Figure 3-2). This strategy is also 
applicable for transient expression and has been used for enhancing sesquiterpene 
yields in N. benthamiana [131, 132]. Therefore it is important to investigate how this 
may likewise be used to increase triterpene production in N. benthamiana. 
Although the importance of HMGR within the MVA pathway is clear, the latter 
enzymes downstream of the universal terpene intermediates IPP and DMAPP may 
also be relevant targets for enhancing triterpene yields (Figure 3-2). Studies have 
demonstrated that overexpression of FPP synthase (FPS) [151] or squalene 
synthase (SQS) [152, 153] may improve triterpene yields. Furthermore, there is 
growing evidence for a regulatory role of squalene epoxidase (SQE) [154, 155] and 
this enzyme has demonstrated value as a target for metabolic engineering in yeast 
[148, 156]. Again, the value of these enzymes for improving triterpene production in 
N. benthamiana remains to be investigated. 
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3.1.2 – The importance of compartmentalisation in terpene biosynthesis 
The realisation that plants have two subcellular isoprenoid biosynthetic pathways 
has prompted interest in the way plants synthesise and regulate production of the 
various classes of terpenes [60] (Figure 3-2). Although the cytosolic MVA and 
plastidic MEP pathways both produce the universal C5 terpene substrates IPP and 
DMAPP, the assembly of these into higher order terpenes generally follows a 
compartment-specific pattern. Production of sesquiterpenes and triterpenes results 
from the exclusive synthesis of the C-15 FPP in the cytosol, whereas plastidial 
production of monoterpenes, diterpenes and carotenoids (which are tetraterpenes) 
occurs through the production of C10 GPP and C20 GGPP intermediates [157].  
In recent years, a number of studies have demonstrated that it is possible to 
synthesise sesquiterpenes in other compartments, often with dramatically increased 
yields. For example, redirection of FPS and a patchoulol synthase to the 
chloroplasts of tobacco plants resulted in approximately 10-fold increase in 
patchoulol content when compared to control lines expressing cytosolic FPS and 
PTS [158]. Similarly, targeting sesquiterpene cyclases to mitochondria has been 
demonstrated to be an effective strategy in both transgenic [120] and transient 
expression [132, 133]. Enhanced production of the triterpene precursor squalene 
has also been achieved in transgenic tobacco by targeting FPS and SQS to the 
chloroplasts [159]. However this strategy does not appear to have been applied to 
the production of cyclised triterpenes. These studies highlight the importance of 
considering alternative subcellular compartments in strategies to optimise terpene 
biosynthesis. 
 
 
 
 
 
 
 
 
Chapter 3 – Strategies for improving triterpene production in N. benthamiana 
52 
 
3.1.3 – Aims 
Metabolic engineering is an important practice for improving yields of target 
metabolites in biological production systems. N. benthamiana has significant 
potential as a host system for the production of triterpenes, however to date no 
efforts appear to have been made to optimise triterpene production in this host. 
Therefore this chapter aims to systematically evaluate strategies for enhancing 
triterpene production in N. benthamiana through transient expression. The first 
approach investigates a series of possible rate-limiting enzymes in the MVA 
pathway which could be used to enhance triterpene yields. The second approach 
explores the potential of exploiting alternative subcellular sources of triterpene 
precursors by redirecting triterpene biosynthetic enzymes to the chloroplasts. These 
approaches provide important insight into transient expression strategies which may 
be employed for enhanced triterpene production in N. benthamiana. 
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3.2 – Results and discussion 
3.2.1 – Production of β-amyrin in N. benthamiana 
To assess the efficacy of the strategies employed herein for improving triterpene 
production in N. benthamiana, a candidate triterpene was first considered as a 
‘read-out’ through quantification by gas chromatography mass spectrometry (GC-
MS). The simple triterpene β-amyrin has previously been produced successfully by 
transient expression of the Avena strigosa (oat) β-amyrin synthase (AsbAS1) in N. 
benthamiana leaves [85]. This study utilised a cowpea mosaic virus (CPMV)-based 
expression system [160]  whereby the AsbAS1 gene was inserted between 5’ and 3’ 
untranslated regions (UTRs) of the CPMV RNA-2 present within a binary vector 
transfer DNA (T-DNA). The 5’ UTR is modified resulting in enhanced translation of 
mRNA and high level protein accumulation [160]. This ‘hypertranslatable’ (CPMV-
HT) system has since been developed into the pEAQ vector series [161]. In 
particular, the pEAQ-HT-DEST1 is a Gateway-compatible cloning system and 
contains a P19 silencing suppressor within the T-DNA [161]. This facilitates 
generation of constructs and prevents the need to coinfiltrate a separate P19-
expressing strain of A. tumefaciens. This system was therefore chosen for the 
present work. 
The AsbAS1 coding sequence was cloned into the pEAQ-HT-DEST1 vector and the 
resulting construct used to transform A. tumefaciens strain LBA4404. A second A. 
tumefaciens strain carrying the green fluorescent protein gene (GFP) in pEAQ-HT-
DEST1 was also generated for use as a control for the N. benthamiana infiltration 
experiments (methods 3.4.2.1). These strains were infiltrated into the leaves of 5-
week-old N. benthamiana plants (methods 3.4.5.1). After 5 days, the leaves were 
harvested and extracts analysed by GC-MS. A novel peak was detected in the 
leaves infiltrated with the AsbAS1 strain which could be identified as β-amyrin. This 
was not present in the GFP-infiltrated leaves (Figure 3-3).  Since β-amyrin was 
readily detectable in extracts from AsbAS1-treated leaves and absent from the 
control treatment it was considered to be a suitable molecule to use for 
quantification in subsequent experiments directed at optimising the system. 
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Figure 3-3: Production of β-amyrin in N. benthamiana. GC-MS analysis of extracts from N. 
benthamiana leaves expressing A) GFP only or B) AsbAS1. A mass spectrum for the peak 
at 21.3 (β-amyrin) is shown on the right. This matched previously reported mass spectral 
data [162] IS = internal standard (coprostanol) 
 
3.2.2 – Improving production of β-amyrin in N. benthamiana with MVA genes 
The effects of expression of AsbAS1 with upstream MVA pathway enzymes was 
then investigated, since boosting the expression of rate-limiting enzymes may 
enhance β-amyrin levels.  Coding sequences for HMGR, FPS, SQS and SQE were 
identified in an oat root tip transcriptome database by searching with sequences 
from characterised enzymes in A. thaliana [29] (Figure 3-2). Details of the oat 
isoforms are given in Supplementary Table 1. Briefly, only a single full-length 
isoform was present in the 454 database for each of the FPS, SQS and SQE genes. 
Two full-length isoforms of HMGR were found, plus a third for which only part of the 
sequence was present (Supplementary Figure 1). It is possible that other isoforms 
of the four enzymes identified here may be present within the oat genome but not 
expressed in the root tips. 
Next, full-length clones of FPS, SQS and SQE were cloned from A. strigosa root tip 
cDNA (methods 3.4.2.2). For HMGR, the N-terminus serves a regulatory role and 
removal of this region has been reported to increase the activity of the protein [150]. 
Therefore a truncated form of HMGR (tHMGR) was generated by using an internal 
forward primer to eliminate the first 5’ 417 bp in the coding sequence of contig 
17852. A V139M substitution was also introduced to initiate protein translation at 
this point, resulting in a 1275 bp construct (methods 3.4.2.3). Following cloning and 
GFP
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sequence verification, the constructs were transferred to pEAQ-HT-DEST1 vectors 
and transformed into individual strains of A. tumefaciens strain LBA4404.  
Next, transient expression of these MVA pathway genes with AsbAS1 was 
performed in N. benthamiana. This was achieved by co-infiltration of two strains of 
A. tumefaciens, each carrying a single expression construct and mixed in equal 
ratios. A total inoculum density of A. tumefaciens OD600 of 0.4 was used giving a 
final OD600 of 0.2 per strain (methods 3.4.5.2). The combinations used were 
tHMGR/AsbAS1, FPS/AsbAS1, SQS/AsbAS1 and SQE/AsbAS1. The GFP-carrying 
strain was used as a negative control (GFP/GFP) and also in place of MVA pathway 
gene expression strains for the AsbAS1 control (GFP/AsbAS1). An additional 
AsbAS1/AsbAS1 control was also included for comparison. As before, 5-week-old 
N. benthamiana plants were infiltrated with the various strains, using 3 separate 
plants per condition as biological replicates. Following harvesting, three disks were 
cut from each leaf and analysed separately, to give a total of 9 samples per 
condition tested. Extracts were made from the leaf disks and subjected to GC-MS 
analysis using an external standard to quantify β-amyrin (methods 3.4.6). 
Analysis of the control samples showed that β-amyrin was undetectable in the 
GFP/GFP-expressing plants, while the production of β-amyrin in GFP/AsbAS1 
plants was estimated at 1.1 mg/g dw (Figure 3-4A). No significant difference was 
found between the AsbAS1/AsbAS1-treated leaves compared to the GFP/AsbAS1 
control. Similarly, analysis of leaf extracts from plants infiltrated with FPS/AsbAS1 
and SQE/AsbAS1 combinations showed no significant difference in β-amyrin levels 
compared to the GFP/AsbAS1 leaves. In contrast, the SQS/AsbAS1 combination 
resulted in accumulation of 2.6 mg/g dw β-amyrin, representing a 2.4-fold increase 
relative to the GFP/AsbAS1 treatment. Larger increases were seen for the 
tHMGR/AsbAS1 treatment, which yielded 4.5mg/g dw. This is an increase in excess 
of 4-fold compared to the GFP/AsbAS1 control. These results suggest that the 
availability of the precursor supply is likely to be limiting triterpene production in N. 
benthamiana. In accordance with this, GC-MS analysis of tHMGR/GFP plants 
revealed the presence of large peaks corresponding to squalene and 2,3-
oxidosqualene in these samples.  These precursors were not detectable in extracts 
from the GFP/GFP-expressing controls (Figure 3-4B). Finally, a small increase in 
cycloartenol was also observed, indicating that expression of tHMGR also impacts 
sterol biosynthesis (Figure 3-4B). 
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Figure 3-4:  Manipulation of the MVA pathway in N. benthamiana A) Quantification of β-
amyrin content in N. benthamiana leaves expressing AsbAS1 with combinations of MVA 
genes. GFP-expressing leaves are also included as a negative control. Statistical 
significance against the GFP/AsbAS1 control is shown (an additional comparison between 
tHMGR/AsbAS1 and SQS/AsbAS1 is also shown) where * = p<0.05 and ns = not significant 
(methods 3.4.6) B) GC-MS total ion chromatograms (TIC) for leaves expressing tHMGR in 
the absence of coexpressed AsbAS1. Leaves expressing GFP are shown as a control. Peak 
labels are squalene (Sq), 2,3-oxidosqualene (OS) and cycloartenol (CA). IS = internal 
standard (coprostanol).  
 
A striking observation was that the infiltrated N. benthamiana leaves showed clear 
phenotypic effects in response to some of the treatments. While there were no 
obvious effects observed for the leaves infiltrated with the GFP-carrying strain, 
infiltration with the AsbAS1-expressing strain resulted in mild chlorosis (Figure 3-5). 
While FPS/GFP and SQS/GFP-treated plants showed little or no signs of chlorosis, 
the symptoms markedly increased in severity with the SQS/AsbAS1 treatment, but 
not with FPS/AsbAS1 (Figure 3-5). The elevated levels of β-amyrin in the 
SQS/AsbAS1 samples could indicate that β-amyrin is responsible for the toxic 
effects. At the same time however, toxic effects were seen in all SQE- and tHMGR-
expressing leaves, regardless of the presence of AsbAS1 (Figure 3-5). Therefore 
the toxicity might be related to the protein itself, or (particularly with tHMGR) effects 
on other pathways, such as sterol biosynthesis.  
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Figure 3-5: Phenotypes of leaves following agroinfiltration. The genes encoded by the 
various strains are given above the relevant photographs. Photographs were taken five days 
after infiltration. 
 
3.2.3 – Combination of tHMGR and SQS further improves β-amyrin yields 
Of the four enzymes tested, tHMGR gave the most substantial increase in β-amyrin. 
SQS gave a modest increase in β-amyrin while FPS and SQE did not improve 
yields. However it is possible that these latter genes could afford further yields if 
used in conjunction with tHMGR. To investigate this, a second set of infiltrations 
were performed. In these experiments, two strains of A. tumefaciens, one containing 
the tHMGR expression construct and the other the AsbAS1 construct were co-
infiltrated along with a third strain carrying expression constructs for either GFP, 
FPS, SQS or SQE. For coinfiltration of three strains, the total OD600 of the infiltrate 
was adjusted to 0.6 (methods 3.4.5.3). 
GC-MS analysis of the leaf extracts revealed that leaves infiltrated with the strains 
carrying tHMGR/FPS/AsbAS1 produced similar levels of β-amyrin to control 
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tHMGR/GFP/AsbAS1 leaves. Similar results were observed for the 
tHMGR/SQE/AsbAS1 combination. In contrast, the tHMGR/SQS/AsbAS1 treatment 
gave a modest (1.4-fold) but significant increase in β-amyrin relative to the controls 
(Figure 3-6A). Thus co-expression of SQS may be useful in further increasing flux 
towards triterpene biosynthesis. 
3.2.4 – SQE allows production of alternative cyclisation products 
The lack of any discernible impact on β-amyrin accumulation following infiltration 
with strains carrying FPS or SQE could imply that these steps are not rate-limiting 
for triterpene production in N. benthamiana leaves. An alternative possibility is that 
the proteins are simply non-functional in this system. However, surprisingly, 
examination of the total ion chromatogram from GC-MS analysis of 
tHMGR/SQE/AsbAS1 leaves revealed a new peak at 26.1 min which was not seen 
in tHMGR/GFP/AsbAS1 controls (Figure 3-6B). Given that the novel compound 
was specific to leaves infiltrated with the SQE-carrying strain; this compound could 
arise from the cyclisation of dioxidosqualene, rather than oxidosqualene. 
Squalene has two chemically identical termini arising from head-to-head 
condensation of FPP. This allows for epoxidation by SQE at either end of the 
molecule to form 2,3-oxidosqualene (OS). Further oxidation by SQE results in 
2,3(S):22(S),23-dioxidosqualene (DOS) (Figure 3-6C). Accordingly, N. 
benthamiana leaves infiltrated with the tHMGR-carrying strain accumulate abundant 
amounts of both squalene and OS (Figure 3-7). In contrast, leaves coinfiltrated with 
both tHMGR- and SQE-carrying strains resulted in total consumption of squalene 
and appearance of a large peak that is likely to be DOS (Figure 3-7). Cyclisation of 
DOS by AsbAS1 results in the product 20S,24S-epoxydammarane (epDM) [137] 
(Figure 3-6C). Analysis of the novel product that accumulated in N. benthamiana 
revealed that it had the same retention time and mass spectrum as that of an epDM 
standard (Figure 3-6B). Collectively, these results indicate that the A. strigosa SQE 
is indeed functional, if not rate-limiting for β-amyrin biosynthesis.  
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Figure 3-6: Effects of expressing multiple MVA pathway genes in N. benthamiana. Leaves 
were infiltrated with strains carrying tHMGR plus AsbAS1 and either GFP, FPS, SQS or 
SQE. A) GC-MS quantification of leaf estimated β-amyrin content represented as mg/g dry 
weight. Statistical significance against the tHMGR/GFP/AsbAS1 control is indicated where * 
= p<0.05 and ns = not significant (methods 3.4.6).  B) GC-MS total ion chromatograms (TIC) 
of leaves expressing tHMGR/GFP/AsbAS1 (top) or tHMGR/SQE/AsbAS1 (middle). The 
tHMGR/SQE/AsbAS1 plants feature a novel product at 26.1 min (the mass spectrum is 
shown to the right). The new product has an identical retention time and mass spectrum to 
epoxydammarane (epDM) C) Proposed mechanism of dioxidosqualene cyclisation by 
AsbAS1 to form epDM as described in Shan et al [163]. 
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Figure 3-7: SQE allows for select production of dioxidosqualene (DOS) in N. benthamiana. 
GC-MS total ion chromatograms (TIC) of leaves expressing either tHMGR/GFP/GFP (top) or 
tHMGR/SQE/GFP (bottom). The large peak at 19.7min accumulating in tHMGR/SQE/GFP 
samples has a mass spectrum consistent with DOS (right) [164]. 
 
3.2.5 – Oxidation of the β-amyrin scaffold in N. benthamiana. 
The results presented in section 3.2.2 demonstrated that the use of tHMGR 
substantially increases β-amyrin levels in transient expression in N. benthamiana. 
Previously, it has been shown that coexpression of AsbAS1 with the A. strigosa 
cytochrome P450 CYP51H10 in N. benthamiana results in accumulation of the 
oxidised β-amyrin product 12,13β-epoxy,16β-hydroxy-β-amyrin (EpHβA) [85].  
Therefore, an investigation was carried out to determine if increased yields of the 
oxidised product could be obtained upon coinfiltration of strains carrying AsbAS1 
and CYP51H10 with tHMGR. 
The full length sequence of CYP51H10 was amplified by PCR from a plasmid 
template, cloned into the pEAQ-HT-DEST1 vector and transformed into A. 
tumefaciens LBA4404 (methods 3.4.2.1). Strains of A. tumefaciens carrying the 
pEAQ-HT-DEST1 expression constructs for GFP, tHMGR, AsbAS1 and CYP51H10 
were cultured before combining in equal ratios to give suspensions of 
tHMGR/AsbAS1/CYP51H10 and GFP/AsbAS1/CYP51H10, each at a total density 
(OD600) of 0.6 (0.2 per strain) (methods 3.4.5.4). These were infiltrated into N. 
benthamiana leaves and harvested after 5 days. GC-MS analysis of leaf extracts 
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confirmed that levels of the CYP51H10 product EpHβA were also significantly 
increased upon coinfiltration of the strain carrying tHMGR (Figure 3-8).  
 
 
Figure 3-8: tHMGR enhances production of 12,13β-epoxy, 16β-hydroxy-β-amyrin (EpHβA). 
GC-MS total ion chromatograms (TIC) of N. benthamiana leaves expressing either 
GFP/AsbAS1/CYP51H10 (black) or GFP/AsbAS1/CYP51H10 (blue). Chromatograms are 
normalised to the internal standard (IS - coprostanol). A mass spectrum for the product at 
25.7min is shown on the right and is consistent with a silylated form of EpHβA[85]. 
 
 
 
Previously, a yield of 1.17 mg EpHβA per gram dry leaf material was reported upon 
expression of AsbAS1 and CYP51H10 [85]. To investigate how use of tHMGR 
translated into isolable yields of EpHβA, a large-scale infiltration of approximately 70 
plants with A. tumefaciens strains carrying tHMGR, AsbAS1 and CYP51H10 was 
performed. After five days the leaves were harvested (110g fresh weight) and 
lyophilised to yield 20g dry leaf material. After saponification and metabolite 
extraction, flash chromatography was used to isolate the CYP51H10 product from 
the bulk of the leaf extract. Further recrystallization to enhance the purity of the 
product yielded 79 mg of EpHβA crystals, equating to ~4mg/g dw (methods 3.4.8). 
This is around 3.4-fold higher than previously reported [85]. It should be noted that 
differences in constructs and extraction/purification techniques might be responsible 
for some of the differences between the two yields. Nevertheless, the difference in 
yields is in a similar range to the observed difference in β-amyrin content between 
GFP/AsbAS1 and tHMGR/AsbAS1 plants as predicted by GC-MS (Figure 3-4A). 
Together, these results demonstrate the potential of using tHMGR in transient 
expression experiments for enhancing yields of both simple and oxidised triterpenes 
in N. benthamiana.  
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3.2.6 – Exploring alternative subcellular compartmentalisation for triterpene 
production. 
In recent years, a number of studies have highlighted how yields of monoterpene 
and sesquiterpenes can differ dramatically depending on the subcellular 
compartment in which they are synthesised [120, 127, 133]. The MEP and MVA 
pathway genes show large tissue- and development-specific variations in 
expression in A. thaliana [11]. In particular, in photosynthetic leaf tissue, it has been 
shown that components of the plastidial MEP pathway are highly expressed [11]. 
Consequently, it is possible that higher levels of triterpene production in N. 
benthamiana leaves might be attainable by redirecting the triterpene biosynthetic 
machinery to the chloroplast. High level production of the triterpene precursor 
squalene has been successfully produced in chloroplasts of transgenic tobacco, but 
it is unknown whether this strategy is applicable for production of cyclised 
triterpenes [159].  
To investigate this, biosynthesis of squalene in N. benthamiana chloroplasts was 
first attempted. To this end, the A. strigosa FPS and SQS enzymes were modified 
by N-terminal fusion of a 58-residue chloroplast signal peptide (CP) from the A. 
thaliana RuBisCO small subunit 1A protein (Figure 3-9A). Furthermore, the SQS 
protein contains a small C-terminal hydrophobic anchor believed to aid localisation 
of this enzyme to the endoplasmic reticulum. As this is non-essential for activity, 
truncated forms of SQS (tSQS) were also generated for both chloroplast-targeted 
and cytosolic forms by removal of the final 21 residues (methods 3.4.3). This gave 
a total of six constructs, which were transferred to pEAQ-HT-DEST1 vectors. Six 
new strains of A. tumefaciens were generated by transformation with the two FPS 
(FPS and CP-FPS) and four SQS (SQS, tSQS, CP-SQS and CP-tSQS) pEAQ 
constructs (methods 3.4.9).  
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Figure 3-9: Chloroplast targeting of FPS and SQS in N. benthamiana. A) Schematic of 
cytosolic and chloroplast-targeted (CP) FPS and SQS constructs.  The chloroplast-targeting 
signal peptide is indicated in green. Two SQS variants were made either with (SQS) or 
without (tSQS) the native ER-retention peptide (purple). B) TLC analysis of N. benthamiana 
leaf extracts after 5 days expressing various combinations of genes. A squalene standard is 
included in the right-most lane. 
 
The six A. tumefaciens strains were infiltrated into N. benthamiana either 
individually or in pairs of cytosolic (FPS/SQS and FPS/tSQS) and plastid-targeted 
(CP-FPS/CP-SQS and CP-FPS/CP-tSQS) combinations. After five days, leaf 
extracts were screened by thin layer chromatography (TLC) (methods 3.4.9.1). TLC 
analysis revealed a distinct band co-migrating with a squalene standard in extracts 
of leaves expressing chloroplast-targeted FPS and SQS (CP-FPS/CP-SQS and CP-
FPS/CP-tSQS). By contrast this was not seen in the extracts of leaves expressing 
pairs of cytosolic (FPS/SQS and FPS/tSQS), or any of the individually-expressed 
Sq
CP-FPS
CP-SQS
CP-tSQS
FPS
SQS
tSQS
Cytosol/ER Plastid
B)
A)
Chapter 3 – Strategies for improving triterpene production in N. benthamiana 
64 
 
genes (Figure 3-9B). This suggested that squalene was indeed more abundant only 
in the leaves expressing both chloroplast-targeted FPS and SQS.  
To further confirm this result, additional tests were performed in triplicate and leaf 
extracts were analysed by GC-MS (methods 3.4.9.2). Large peaks with identical 
mass spectra and retention times to a squalene standard were present in the 
extracts from leaves expressing CP-FPS/CP-SQS or CP-FPS/CP-tSQS (Figure 
3-10A, CP-FPS/CP-SQS not shown for clarity). In accordance with the results of the 
TLC, squalene was more abundant in CP-FPS/CP-SQS and CP-FPS/CP-tSQS than 
in the cytosolic FPS/SQS samples. Furthermore, squalene was approximately 2-fold 
more abundant in CP-FPS/CP-tSQS-expressing plants, compared to CP-FPS/CP-
SQS plants. This suggests that removal of the ER-anchoring peptide from the 
chloroplast-targeted SQS permits better enzyme activity (Figure 3-10B). 
Further examination of the chromatograms from leaves expressing the cytosolic 
FPS/SQS revealed prominent peaks corresponding to OS and cycloartenol (Figure 
3-10). This implies that the squalene produced in the cytosol is further consumed by 
endogenous N. benthamiana SQE and cycloartenol synthase. By contrast, OS and 
cycloartenol were only minor constituents of the extracts from chloroplast-targeted 
CP-FPS/CP-SQS and CP-FPS/CP-tSQS. This suggests that the squalene in these 
samples is generally unavailable to the endogenous downstream enzymes, as 
might be expected from biosynthesis in the chloroplast.  
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Figure 3-10: Chloroplast targeting of triterpene biosynthetic genes. A) Representative GC-
MS chromatograms of N. benthamiana leaves expressing GFP/GFP, FPS/SQS  or CP-
FPS/CP-tSQS. Peaks labels are squalene (Sq), oxidosqualene (OS), Cycloartenol (CA). 
Chromatograms are normalised to the Internal standard (IS - coprostanol). B) Histogram of 
the relative amounts of squalene, oxidosqualene and cycloartenol produced in leaves 
expressing cytosolic or plastid-targeted FPS and SQS. Bars represent the average peak 
area of each compound divided by the peak area of the internal standard. Error bars show 
standard deviation. 
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3.2.7 – Plastid-synthesised squalene is unavailable for the cytosolic 
biosynthesis of β-amyrin. 
As the results of the previous section implied that squalene was synthesised in the 
chloroplasts of N. benthamiana, an attempt was subsequently made to synthesize 
β-amyrin by targeting four enzymes (FPS, SQS, SQE and AsbAS1) to this 
compartment. However this approach was unsuccessful and did not result in β-
amyrin production (data not shown).  
Instead, a preliminary investigation was performed to look into the effect of 
synthesising FPP and squalene in the chloroplast with simultaneous expression of 
the native-localised (cytosolic-facing ER membrane) AsbAS1 protein. Here, different 
areas of a single leaf were infiltrated with combinations of AsbAS1, AsbAS1 plus 
CP-FPS or AsbAS1, CP-FPS and CP-tSQS. A control GFP-expressing strain was 
used in place of CP-FPS and CP-tSQS as appropriate. This was repeated for three 
leaves. Disks were harvested from the relevant sections of leaves after 5 days and 
the subsequent extracts were analysed by GC-MS (methods 3.4.9.2). 
GC-MS analysis of samples revealed that samples expressing CP-FPS and 
AsbAS1 gave comparable levels of β-amyrin to an AsbAS1-only control. Upon 
further introduction of CP-tSQS however, a large decrease in β-amyrin was 
observed compared to an AsbAS1-only control. At the same time, a peak 
corresponding to squalene was also observed in these samples (Figure 3-11). This 
would seem to support the findings in the previous section (3.2.6) suggesting that 
squalene produced via this route is not available to enzymes outside of the 
chloroplast. Furthermore, the observed drop in β-amyrin content implies that the 
production of squalene in chloroplasts effectively sequesters a source of carbon 
which might otherwise be utilised for β-amyrin production. By extension, this 
suggests that the MEP pathway may contribute to the production of β-amyrin upon 
transient expression of AsbAS1. 
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Figure 3-11: Impact of chloroplast production of squalene on cytosolic β-amyrin synthesis. 
Representative GC-MS total ion chromatograms (TIC) of N. benthamiana leaves expressing 
AsbAS1/GFP/GFP (top) AsbAS1/CP-FPS /GFP (middle) and AsbAS1/CP-FPS/CP-tSQS 
(bottom). Peak labels are Sq = Squalene, IS = Internal standard βA = β-amyrin. 
 
It is widely accepted that a trafficking system exists for shuffling prenyl diphosphate 
precursors between various compartments of the cell [60]. Transport appears to 
predominantly involve IPP/DMAPP and (to a lesser extent) GPP and FPP, but not 
GGPP [165]. Supporting this, transient expression of a GPP synthase (GPPS) in N. 
benthamiana has been found to boost the yields of the monoterpene geraniol even 
when GPPS and geraniol synthase were targeted to different subcellular 
compartments [127]. In the present study, the simultaneous expression of AsbAS1 
and CP-FPS did not appear to either enhance or be detrimental to β-amyrin 
production. Given that CP-FPS was apparently necessary for efficient activity of CP-
tSQS (section 3.2.6) it is expected that this enzyme is functional. Therefore it is 
possible that while FPP was produced in the chloroplast, it was capable of being 
transported to the cytosol while squalene was not. In future, microscopy could be 
employed to provide further evidence that the proteins used herein are indeed 
localised to the chloroplast as expected.  Fusion of GFP to the RuBisCO targeting 
peptide would provide a simple means of achieving this as has been previously 
demonstrated [127]. 
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Further investigation into strategies to manipulate triterpene biosynthesis in plant 
subcellular compartments is worth pursuing. The investigation here into squalene 
production in chloroplasts suggests that the MEP pathway may contribute to 
triterpene biosynthesis in N. benthamiana leaves. With this in mind it will be 
particularly interesting to see whether overexpression of the rate-limiting MEP 
pathway genes such as DXS could also further enhance triterpene production as 
has previously been shown [166]. Transient expression offers an excellent means to 
rapidly explore a variety of different approaches to metabolic engineering in plants. 
The outcome of these studies may ultimately have important applications for 
engineering stable transgenic plant lines. 
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3.3 – Conclusions and perspectives 
3.3.1 – Discussion of results 
The expression of transgenes following agroinfiltration is a transient process. 
Therefore maximising the metabolic output of the host plant during the post-
infiltration period is vital to realise the capacity of N. benthamiana for triterpene 
production. Here two strategies were explored to this end. In the first instance, 
expression of rate-limiting enzymes in the native triterpene biosynthetic MVA 
pathway was undertaken. Secondly, redirecting triterpene biosynthetic enzymes to 
the plastid was explored.  
Investigation of MVA pathway genes showed that of the four possible rate-limiting 
enzymes tested, tHMGR was most effective at increasing yields of β-amyrin in N. 
benthamiana when coexpressed with AsbAS1. Furthermore, coexpression of 
tHMGR was applicable for enhancing the isolation of an oxidised form of β-amyrin. 
The yield of EpHβA was increased by more than 3-fold compared to previous 
reports (section 3.2.5). 
Of the other MVA pathway genes tested, SQS also gave a small increase in β-
amyrin yields, while FPS and SQE by contrast did not give an appreciable increase 
in β-amyrin content. A similar scenario was observed upon combination of tHMGR 
and AsbAS1 with FPS, SQS or SQE, suggesting that coexpression of both tHMGR 
and SQS might be useful in future for further boosting product yields (section 3.2.3). 
It is unlikely that the failure of FPS and SQE to enhance β-amyrin content under any 
condition is simply due to inactivity of the enzymes, as subsequent tests showed 
that SQE expression allowed for the production of DOS (section 3.2.4) while FPS 
expression in the chloroplast was necessary for maximal SQS activity (section 
3.2.6). Therefore the most likely explanation is that FPS and SQE activity are not 
limiting for triterpene biosynthesis under the conditions tested. 
It will be worthwhile testing other forms of HMGR in N. benthamiana to see if 
differences in activity can be observed. Analysis of the A. strigosa 454 database 
revealed an additional full-length HMGR isoform which was not tested here. 
Transient expression of HMGR from other species has also been successfully used 
for sesquiterpene production in N. benthamiana. Coexpression of an A. thaliana 
tHMGR with a (mitochondrially-targeted) amorphadiene synthase (ADS) resulted in 
more than 300-fold increases over ADS alone [132]. This would seem to be a 
dramatic contrast to the 4-fold increase reported here, however at the same time the 
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maximum reported yields of amorphadiene were below the yields of triterpenes in 
this study. For example, the capacity of N. benthamiana amorphadiene production 
was estimated by GC-MS at 27mg per kg fresh weight [132]. The isolated yield of 
EpHβA in this study (79mg per 110g fresh weight), equates to 718mg per kg fresh 
weight. It is worth reiterating that this latter value represents an isolated yield of 
purified product rather than a predicted value. Inevitably the purification process 
results in product losses during chromatography and recrystallization as performed 
here. As a result, these comparisons are most likely a conservative estimate of the 
differences in yield. 
Given their shared biosynthetic pathway (Figure 3-2), why the capacity in N. 
benthamiana for triterpene biosynthesis might seemingly be higher than for 
sesquiterpenes is an interesting question. It has previously been suggested that the 
endogenous N. benthamiana SQS may outcompete the sesquiterpene synthases 
for FPP. Accordingly RNAi silencing of SQS was shown to be an effective strategy 
for enhancing sesquiterpene yields [131]. In the present study, expression of 
tHMGR resulted in readily detectable quantities of squalene and 2,3-oxidosqualene 
without expression of AsbAS1. Although small increases could be observed in 
endogenous sterols, the remaining abundance of these immediate β-amyrin 
precursors would indicate that there is relatively little competition for AsbAS1 with 
the endogenous N. benthamiana OSCs. Hence, N. benthamiana may prove to be a 
highly favourable system for production of triterpenes, although further tests with a 
range of triterpene synthases will be required to see if this generally applicable. 
3.3.2 – Investigating other candidate enzymes 
Although the current study focussed on four genes for enhancing triterpene yields in 
N. benthamiana, continued investigation of other potential yield-enhancing enzymes 
is highly worthwhile. For example it was recently shown that isopentenyl phosphate 
kinase (IPK), an enzyme forming a core part of the archaeal (but not eukaryotic) 
MVA pathway remains active in plants, where it serves to regulate availability of IPP 
from a pool of isopentenyl phosphate (IP) [167]. Likewise, other genes within the 
MVA pathway such as HMG-CoA synthase (HMGS) have been implicated as 
potential targets for metabolic engineering [168, 169]. Finally, as discussed in 
section 3.2.7, it is also worth further investigating the impact of manipulating key 
steps in the MEP pathway. 
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3.3.3 – Further optimising production 
The present study took a metabolic engineering approach to enhance triterpene 
content in N. benthamiana. However in conjunction with optimisation at the 
molecular level, it is important not to overlook environmental factors. For example, 
the plants used in these experiments were grown under greenhouse conditions, 
which results in significant seasonal variations in the morphology and growth rate of 
the plants. Although this has not been formally investigated, this variability might be 
expected to have a significant impact on the production capacity. As a result, 
optimisation of lighting, temperature and humidity conditions would be merited to 
both further improve yields and ensure batch-to-batch consistency.  
In the present study, tens of milligrams of oxidised triterpene were produced by 
hand using a syringe to infiltrate 70 plants over multiple weeks. In order to translate 
this to larger preparative scales, it is important to develop practical techniques to 
increase the infiltration throughput. Recently, a vacuum chamber was developed in 
the Osbourn group for scaling production of triterpenes in N. benthamiana (Dr 
Bastiaan Brouwer, personal communication). This process involves inverting the 
entire aerial parts of the plants into a solution of A. tumefaciens and can 
accommodate four plants simultaneously per run. One run takes approximately five 
minutes and thus allows in excess of 100 plants to be infiltrated in a single 
afternoon. Use of this vacuum infiltrator coupled with the tHMGR enzyme described 
here has allowed for the production of a gram of β-amyrin from 459 plants (Dr M. 
Stephenson, personal communication). β-Amyrin has a value of £24.50 per 
milligram (based on Sigma-Aldrich 2016 prices). This offers the possibility for 
isolating useful quantities of costly metabolites for downstream applications such as 
synthetic chemical diversification and bioactivity screens. These possibilities are 
explored in subsequent chapters. 
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3.4 – Materials and methods for Chapter 3 
3.4.1- Searching the oat 454 database for MVA pathway genes 
The Ensembl Plants (http://plants.ensembl.org/) Biomart database was used to 
obtain amino acid sequences from known A. thaliana HMGR, FPS, SQS and SQE 
genes from gene models given by Vranova et al [11].  These sequences were used 
as queries to search the A. strigosa root tip 454 transcriptome database using the 
tBLASTn search tool with a cutoff value of e-10. 
3.4.2 – Cloning and generation of expression constructs 
3.4.2.1 – Cloning of AsbAS1, CYP51H10 and GFP 
AsbAS1 and CYP51H10 were amplified by PCR from existing vectors as described 
in Geisler et al [85]. Cloning of CYP51H10 was performed by Prof Robert Minto 
using primers AsbAS1-attB1-F/2-R and CYP51H10-attB1-F/2-R (Table 3-2).  
Gateway cloning was performed as described in section 2.1.1. The GFP-
expressing pEAQ-HT-DEST1 construct was kindly provided by the Lomonossoff 
group at JIC. Transformation of A. tumefaciens LBA4404 with the pEAQ-HT-DEST1 
constructs is described in section 2.1.2.3. 
3.4.2.2- Cloning oat FPS/SQS/SQE 
The oat FPS, SQS and SQE genes were cloned from oat root tip cDNA (cDNA 
provided by Dr Thomas Louveau). Primers were designed to incorporate a small 5’ 
overhang to allow optional restriction enzyme-based cloning (which was not used in 
this study). The primers for FPS, (FPS-SacI-F/FPS-NotI-R), SQS (SQS-HindIII-
F/SQS-XbaI-R) and SQE (SQE-SacI-F/SQE-XbaI-R) are given in (Table 3-2). FPS 
and SQS were amplified by using Q5 polymerase (NEB) and SQE was amplified 
with Phusion polymerase (NEB). PCR products were purified by gel extraction using 
a QIAquick gel extraction kit (Qiagen). Purified products were ligated into a TOPO 
vector using a Zero Blunt TOPO PCR cloning kit (Invitrogen) according to the 
manufacturer’s instructions. Following ligation, the vector was used to transform 
chemically competent E. coli TOP-10 cells (FPS and SQS) or subcloning efficiency 
DH5α cells (SQE) with Kanamycin selection (50μg/mL). Constructs were sequenced 
with M13 primers (Table 2-1) to verify the correct insert sequence.  
To further generate Gateway Entry clones of these genes, FPS, SQS, and SQE 
were amplified by PCR from the relevant TOPO vectors as described above. 
Primers were designed to carry 5’ full-length attB sites adjacent to the gene-specific 
sequence. Primer sequences for FPS (FPS-attB1-F/2-R), SQS (SQS-attB1-F/2-R) 
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and SQE (SQE-attB1-F/2-R) are given in Table 3-2. A truncated form of SQS, 
(tSQS) was amplified using SQS-attB1-F and tSQS-attB2-R. Purified PCR products 
were then transferred into pDONR207, sequenced with attL1-F/attB2-R (Table 2-1) 
and further transferred into pEAQ-HT-DEST1 (protocol as described in section 
2.1.1). 
3.4.2.3 - Cloning oat tHMGR 
Cloning the truncated form of HMGR (contig17852), was carried out by Dr Aymeric 
Leveau. Oat root cDNA was used as a template for PCR, tHMGR was amplified 
using t-AsHMGR-17852-F-GW and AsHMGR-17852-R-GW (Table 3-2). The 
forward primer contained an additional 5’ CACC overhang to allow directional 
cloning into the Gateway-compatible Entry vector pENTR-D-TOPO (Invitrogen). 
PCR products were purified and ligated into pENTR-D-TOPO according to the 
manufacturer’s instructions. E. coli TOP-10 cells were transformed and selected for 
on kanamycin (50μg/mL) media. Positive colonies were sequenced to verify the 
insert.  
The pENTR-D-TOPO and pEAQ-HT-DEST1 vector both utilise kanamycin selection, 
preventing efficient selection of positive colonies. Therefore the HMGR-containing 
pENTR-D-TOPO vectors were first digested using NruI to cut the vector backbone 
in the NPT-II gene. These were then run on a 1% agarose gel to separate the 
linearised and undigested plasmid. The products were excised from the gel and 
purified with a QIAquick gel extraction kit (Qiagen). The purified gel products were 
cloned into pEAQ-HT-DEST1 and transformed into A. tumefaciens LBA4404. 
3.4.3 – Generating constructs for chloroplast-targeting work 
3.4.3.1 – CP-FPS-pDONR207 
To generate a chloroplast-targeted form of FPS, the FPS gene was fused to the first 
174bp of the A. thaliana RuBisCO small subunit 1A gene (AT1G67090) by a fusion 
PCR-based method. The 174bp chloroplast-targeting sequence was first amplified 
from Arabidopis thaliana leaf cDNA (Columbia ecotype – kindly supplied by Dr Hans 
Nützmann) using RuB-attB1 and RuB-FPS-R (Table 3-2). This gave a product 
containing a 5’ attB1 sequence for Gateway cloning and 3’ 18nt which were 
complementary to the first 18nt of the oat FPS gene. Similarly the oat FPS was 
amplified from the FPS-TOPO construct (Section 3.4.2.2) with FPS-RuB-F and 
FPS-attB2 primers (Table 3-2). This resulted in a product featuring 5’ 18nt 
complementary to the 3’ end of the above 174bp chloroplast targeting sequence 
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and 3’ attB2 site for Gateway-based cloning. Together the overlap between the two 
PCR products contained 36nt of complementary sequence.  
Following amplification, the two products were analysed by gel electrophoresis 
before excision and purification (QIAquick gel extraction kit, Qiagen). The two 
products were pooled and 2ng of this mix was used as a template for a second PCR 
reaction with the RuB-attB1 and FPS-attB2 primers (Table 3-2). The resulting 
product was purified and inserted into the pDONR207 with a BP clonase reaction to 
generate CP-FPS-pDONR 207. E. coli TOP-10 cells were transformed with 
gentamicin selection. The resulting clones were sequenced (attL1-F/attB2-R Table 
2-1) and found to contain the correct CP-FPS fusion product. These were then 
cloned into pEAQ-HT-DEST1 and transformed into A. tumefaciens LBA4404. 
3.4.3.2 – CP-SQS- and CP-tSQS-pDONR207 
For the different forms of CP-SQS, a similar strategy was used to CP-FPS. The 
RuBisCo chloroplast targeting sequence (with 3’ SQS overhang) was amplified from 
CP-FPS-pDONR207 (Section 3.4.3.1) using RuB-attB1s-F and RuB-SQS-R (Table 
3-2). The full-length SQS (with 5’ RuBisCO overhang) was amplified from the SQS-
TOPO plasmid (Section 3.4.2.2) using SQS-RuB-F and either SQS-attB2s-R 
(Table 3-2). The two PCR products were analysed by gel electrophoresis, before 
excision and purification (QIAquick gel extraction kit, Qiagen). The purified 
fragments were pooled and adjusted to 2ng. These were further used as a template 
for PCR to amplify CP-SQS or CP-tSQS using RuB-attB1 and SQS-attB2-R or 
tSQS-attB2-R, respectively (Table 3-2). The resulting products were purified and 
inserted into pDONR207 (section 2.1.1.1) and sequenced using attL1-F/attB2-R 
primers (Table 2-1). After sequencing, the constructs were cloned into pEAQ-HT-
DEST1 (section 2.1.1.2) and used to transform A. tumefaciens LBA4404 (section 
2.1.2.3).  
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3.4.4 – Primers 
  Name Adapter/5'sequence Gene-specific sequence 
T
O
P
O
 c
lo
n
in
g
 FPS-SacI-F GAGCTC ATGGCGGCGGCAGCGGTGAAC 
FPS-NotI-R GCGGCCGC CTACTTCTGCCTCTTGTAGATC 
SQS-HindIII-F AAGCTT ATGGGGGCGCTGTCG 
SQS-XbaI-R TCTAGA TCACTTGGCGTACAGTACACC 
SQE-SacI-F GAGCTC ATGGCTGAGGTCGCCGCC 
SQE-XbaI-R TCTAGA TTAGAACTCCGCTTCCGGAGG 
p
-E
N
T
R
-D
-T
O
P
O
 c
lo
n
in
g
 
      
  
 
t-AsHMGR-
17852- 
F-GW    
CACC ATGGCGCCCGAGA- 
AAATGCCCGAG 
 
AsHMGR-17852- 
R-GW  
 
 
TCMGCAGGCGATC- 
TTGGACATGTCC 
      
G
a
te
w
a
y
 c
lo
n
in
g
 
FPS-attB1-F attB1F-1 ATGGCGGCGGCAGCGGTG 
FPS-attB2-R attB2R-1 CTACTTCTGCCTCTTGTAG 
SQS-attB1-F attB1F-1 ATGGGGGCGCTGTCGCGG 
SQS-attB2-R attB2R-1 TCACTTGGCGTACAGTACACC 
SQE-attB1-F attB1F-1 ATGGCTGAGGTCGCCGCC- 
SQE-attB2-R attB2R-1 TTAGAACTCCGCTTCCGGAGG 
tSQS-attB2-R attB2R-1 TCACCTATACTTTGACTTTTC 
AsbAS1-attB1-F attB1F-1 ATGTGGAGGCTAACAATAGGTG 
AsbAS1-attB2-R attB2R-1 TCAGCTCTTAATCGCAAGAAGTCG 
CYP51H10-
attB1-F attB1F-2 ATGGACATGACAATTTGCGTCGT 
CYP51H10-
attB2-R attB2R-2 TTAGTTTGCAGGCATACGACATC 
C
h
lo
ro
p
la
s
t 
ta
rg
e
ti
n
g
 RuB-attB1 attB1F-1 ATGGCTTCCTCTATGCTC 
RuB-FPS-R CACCGCTGCCGCCGCCAT CACCTGCATGCAGTTAACTC 
FPS-RuB-F GTTAACTGCATGCAGGTG ATGGCGGCGGCAGCGGTGAAC 
FPS-attB2 attB2R-1 CTACTTCTGCCTCTTGTAG- 
RuB-attB1s-F attB1Fs-1 ATGGCTTCCTCTATGCTCTC 
RuB-SQS-R CGACAGCGCCCCCAT CACCTGCATGCAGTTAAC 
SQS-RuB-F GTTAACTGCATGCAGGTG ATGGGGGCGCTGTCG 
SQS-attB2s-R attB2Rs-1 TCACTTGGCGTACAGTACACC 
S
e
q
u
e
n
c
in
g
    
AsbAS1-seq-F  CCACATTTTCTTCCGATTCA 
AsbAS1-seq-R  CCAACAAGGTCAGCGGATA 
   
Table 3-2: Primer sequences as used in Chapter 3. Gene-specific sequences are given in 
the column on the right, while adapter sequences incorporated into the 5’ end of the primer 
are given in the middle column. Adapter sequences given in bold refer to the sequences in 
Table 2-1.  
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3.4.5 – Infiltrations 
3.4.5.1 – Infiltration and analysis of AsbAS1 in N. benthamiana 
Strains of A. tumefaciens carrying AsbAS1 or GFP were cultured and prepared as 
detailed in section 2.1.3.2. An inoculum density of OD600 = 0.2 was used to infiltrate 
leaves of 5-week-old N. benthamiana (section 2.1.3.3). Leaves were harvested 
after 5 days before being freeze dried. Leaf material was weighed and 
saponification solution containing internal standard was added to give 0.4μg 
coprostanol per mg dry leaf. Saponification was performed at 65°C for 2 hours 
before partitioning with hexane. The hexane extract was analysed directly by GC-
MS using the program detailed in section 2.1.5.1. 
3.4.5.2 – Coexpression of single MVA genes with AsbAS1 
Infiltration suspensions of A. tumefaciens were made according to section 2.1.3.2 
using an OD600 = 0.4. The two upper-most fully-expanded leaves of five-week old N. 
benthamiana plants were infiltrated as described in section 2.1.3.3. Three plants 
were infiltrated for each test condition (biological replicates). After five days, leaves 
were harvested. For the upper-most leaf from each plant, three 12mm diameter 
disks were cut using a #7 cork borer and stored as separate technical replicates, 
giving a total of nine samples per test condition. Leaf disks were stored in 1.5mL 
microcentrifuge tubes and flash-frozen in liquid N2 before storage at -80°C. The 
lower leaves from representative plants were used for photography (Andrew Davis, 
JIC). Extraction and analysis was performed as detailed in section 3.4.6. 
3.4.5.3 – Coexpression of tHMGR and AsbAS1 with other MVA genes 
Infiltration of leaves with tHMGR and AsbAS1 and either FPS, SQS, SQE or GFP 
was performed as in section 3.4.5.2 with the exception that the OD600 = 0.6. 
Extraction and analysis was performed as detailed in section 3.4.6. The 
chromatogram in Figure 3-6B is from analysis of the same samples used for 
quantification in Figure 3-6A, but with the exception that GC-MS program was 
performed according to 2.1.5.1. 
3.4.5.4 – Coexpression of tHMGR/AsbAS1/CYP51H10  
Infiltration of leaves with tHMGR, AsbAS1 and CYP51H10 was performed as in 
section 3.4.5.2 with the exception that the OD600 = 0.6. Extraction was performed as 
in section 3.4.7 with derivatisation. GC-MS analysis was performed as in section 
2.1.5.1. 
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3.4.6 – Extraction and quantification of β-amyrin in plant leaves 
Leaf disks were removed from the -80°C freezer and directly lyophilised for 24 
hours. Individual dried disks were weighed using a microbalance (Sartorius) to the 
nearest 10μg and weights recorded. The leaf disks were further transferred to 2mL 
autosampler vials before extraction and analysis as detailed below. 
For quantification of β-amyrin in N. benthamiana leaf disks, a ten-step calibration 
series of β-amyrin was made from 50μg down to 0.098μg (these values represent 
dry weight of β-amyrin per vial). This was achieved by making a 0.5mg/mL solution 
of β-amyrin in ethanol and performing 2-fold serial dilutions starting with 100μl 
(50μg). The β-amyrin dilution series was dried under N2. Next a saponification 
solution (section 2.1.6.3) was made containing the internal standard (IS) 
coprostanol (Sigma) to 10μg/mL. 500μl of this was pipetted to each sample (leaf 
disks and dried β-amyrin calibration standards) to give a total of 5μg of IS per 
sample. Liquid handling steps for β-amyrin calibration and pipetting of saponification 
solution were performed using a Gerstel MultiPurpose Sampler (MPS) to minimise 
pipetting errors. 
Samples were heated in an oven at 65°C for 2 hours to saponify. Following this 
250μl of distilled water was added per sample and mixed briefly followed by addition 
of 500μl of hexane. Samples were each vortexed vigorously twice for 5-10 seconds 
and allowed to stand for 5 minutes to partition. Finally, 100μl of hexane from each 
sample was taken and transferred to a new autosampler vial. These were dried 
using a Genevac EZ-2 evaporator. Finally the dried samples were resuspended in 
50μl of Tri-Sil Z (Sigma) and heated at 70°C to derivitise. Samples were analysed 
by GC-MS according to section 2.1.5.2. 
Data analysis was performed using the Agilent Masshunter Quantification software. 
Quantification of β-amyrin was performed using the ion at m/z 218 while 
quantification of the internal standard was performed using the ion at m/z 370. The 
external standard was used to determine the relative response factor of β-amyrin 
and quantify β-amyrin in the leaf samples. Finally estimates of dry leaf β-amyrin 
content were determined by dividing the quantification values by the leaf disk 
weight. Statistical tests were performed using GraphPad Prism software (version 5). 
A one way ANOVA was performed with post-hoc analysis performed by Tukey’s 
multiple comparison test. 
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3.4.7 – Dispersive liquid-liquid microextraction  
For extraction of sterols and triterpenes from N. benthamiana, a protocol was 
developed by Prof Robert Minto (Indiana University-Purdue University, Indianapolis, 
USA) using dispersive liquid-liquid microextraction (DLLME) ([170]). A saponification 
solution was prepared according to section 2.1.6.3 and the internal standard 
(coprostanol 1mg/mL stock in DMSO) was added to 1.6μg per mL. Lyophilised leaf 
disks from N. benthamiana were weighed and recorded before adding the 
saponification mixture to 250μl/mg dry leaf disk weight (equivalent 0.4μg 
coprostanol per mg dry leaf). Samples were then heated at 65°C for two hours with 
intermittent vortexing. After incubation, 125μl of the saponified extract was 
transferred to a second tube containing 900μl 60mM HCl, plus a small amount of 
bromophenol blue as a pH indicator. A colour change from orange to blue was 
observed upon addition of the saponified extract. The samples were vortexed 
briefly, before adding 400μl of a 4:46 Chloroform:Acetonitrile solution. Samples 
were vortexed again for approximately five seconds before being centrifuged at full 
speed for 30 seconds to partition a lower yellow organic phase and an upper blue 
aqueous phase. The lower phase (approximately 60μl) was carefully extracted using 
a 200μl pipette. This could either be analysed directly by GC-MS, or first derivitised 
using 50µL Tri Sil-Z (Sigma) and heated 70°C for 30mins. 
3.4.8 – Scaled production and purification of EpHβA 
Three separate cultures of A. tumefaciens strain LBA4404 carrying tHMGR, 
AsbAS1 and CYP51H10 were grown as per the protocol in section 2.1.3.2. These 
were resuspended in MMA to an OD600 = 0.6 and combined in equal ratios. The 
bacterial suspension was used to infiltrate approximately 70 N. benthamiana plants 
by hand using a 5mL syringe. After 5 days the infiltrated leaves were harvested 
(109.6 fresh weight) and lyophilised to yield 20.4g dry weight. Extraction of the 
EpHβA product was performed as in section 2.1.4. The crude extract was dissolved 
in toluene prior to loading on a SNAP KP-Sil 25g silica gel column (Biotage). A flash 
chromatography gradient was setup as in program P-1 (Table 2-4) collecting 9mL 
fractions. Fractions were analysed by TLC and GC-MS and the fractions containing 
the most concentrated EpHβA product were combined and dried by rotary 
evaporation. The solid was dissolved in dichloromethane and adsorbed onto silica 
gel by rotary evaporation. A second flash chromatography step was performed as 
per program P-2 (Table 2-4) using a SNAP Ultra 10g column (Biotage). The 
fractions were again monitored by TLC and GC-MS and the purest EpHβA-
containing fractions were combined and dried to give a yellow solid weighing 
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approximately 100mg. This crude solid was decolourised and recrystallized 
according to sections 2.1.4.2 and 2.1.4.4 to give a total of 79mg of the EpHβA 
product.  
3.4.9 – Expression and analysis of chloroplast-targeted FPS and SQS 
N. benthamiana leaves were infiltrated with cytosolic (FPS,SQS,tSQS) and 
chloroplast-targeted (CP-FPS,CP-SQS,CP-tSQS) constructs as described in the 
main text. Infiltrations were performed according to section 2.1.3.3 using a single 
leaf per combination (for TLC analysis) or in triplicate (for GC-MS analysis). After 5 
days the leaves were harvested, ground and saponification solution was added 
(section 2.1.6.3) before heating at 65°C for 2 hours. Hexane was used to extract 
the metabolites for analysis by TLC (section 3.4.9.1). 
3.4.9.1 – TLC analysis of leaves expressing chloroplast-targeted constructs 
TLC analysis was performed using 10cm x 5cm aluminium-backed silica gel plates 
(Sigma). For analysis of squalene production in chloroplasts, extracts of N. 
benthamiana leaves were run using a mobile phase of ethyl acetate:hexane 3:97. 
For development of TLC plates, a solution of p-anisaldehyde:sulphuric acid:acetic 
acid (1:1:48 v:v:v) was used. The plates were developed using a TLC heater plate 
(Cameg) at 130°C for approximately 30 seconds. 
3.4.9.2 – GC-MS analysis of leaves expressing chloroplast-targeted constructs 
Extraction of the leaves was performed according to section 3.4.7. The samples 
were not derivatised. GC-MS analysis was performed according to section 2.1.5.1. 
For quantification, data analysis was performed using Agilent MassHunter 
Quantitative Analysis software. The products were identified based on their 
retention time (rt) and qualifier ion as follows (squalene rt=17.07 min, m/z=69; 
oxidosqualene rt=18.37 min, m/z=69; coprostanol rt=19.63 min m/z=373; β-amyrin rt 
= 22.37 mz=218; cycloartenol rt=22.86 m/z=393). Total ion peak areas were 
obtained by extracting 1000 mass units either side of the qualifying ion. Peak areas 
of the compounds of interest were divided by the peak area of the internal standard. 
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4.1 – Introduction 
Cytochrome P450s are important enzymes that expand the chemical diversity of 
natural products through stereo- and regio-specific oxidation [73]. A growing number 
of triterpene-oxidising P450s have been characterised in recent years [171] (Table 
1-1). Expression of these P450s with triterpene synthases in heterologous systems 
offers an attractive means to produce and selectively oxidise triterpenes in a 
manner which is not currently possible by other methods. This method thus has 
important applications for exploring the structural features underlying triterpene 
bioactivity and also facilitates further modification by synthetic chemistry. 
4.1.1 – Combinatorial biosynthesis of triterpenes in N. benthamiana 
Transient expression of triterpene biosynthetic enzymes in N. benthamiana has the 
potential to enable production of both simple and oxidised triterpenes within a 
matter of days. In addition, this technique allows the coexpression of multiple genes 
through simultaneous infiltration of different A. tumefaciens strains, each containing 
a different expression construct. This approach can therefore be used to rapidly 
assemble different combinations of biosynthetic enzymes providing a powerful 
system for screening enzyme compatibility [112].  
Amongst the triterpene oxidases described above, a large number are known to 
oxidise β-amyrin (1) [171] (Table 1-1). This triterpene is one of the most ubiquitous 
scaffolds found in plants [62] and is found at the heart of a number of medicinally 
and commercially important triterpene saponins and synthetic derivatives [39, 57]. 
Therefore combinatorial expression of β-amyrin oxidising P450s in N. benthamiana 
offers the potential to engineer novel derivatives of β-amyrin through combinatorial 
biosynthesis [101, 108]. 
4.1.2 – Analysis of triterpenes by mass spectrometry  
Gas chromatography with mass spectrometry (GC-MS) is a powerful technique for 
analysis of simple triterpenes. This technique relies on separation of the molecules 
in the gas phase and offers excellent resolving power. Mass spectrometry is 
frequently performed using electron impact (EI) ionisation. The fragmentation 
spectra of β-amyrin (oleanane) triterpenoids by EI mass spectrometry are well 
documented [162, 172-174]. Briefly, the breakdown of β-amyrin predominantly 
proceeds via a retro-Diels-Alder (rDA) cleavage mechanism due to the presence of 
the C-12-13 double bond in the C-ring. This results in the production of a 
characteristic ion at m/z 218 which corresponds to the diene fragment (C*DE rings - 
where C* represents the partial C-ring) of the molecule (Figure 4-1). This 
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breakdown mechanism is generally conserved even with additional substituents 
within the C/D/E rings. Thus the shift of the m/z 218 ion and subsequent 
fragmentation can inform as to the nature of the modification. Similarly, the ABC* 
rings are also represented by a characteristic ion at m/z 279 (or m/z 207 if β-amyrin 
is not silylated). This fragment is derived from hydrogen transfer rather than rDA 
cleavage and is a minor constituent of the spectrum [162, 174]. Likewise, the 
presence of other substituents on this portion of the molecule is often indicated by 
the loss of m/z 279 [173]. Thus mass spectra can be regarded as unique 
‘fingerprints’ enabling structural identification of novel oleanane compounds. 
 
 
Figure 4-1: EI fragmentation of β-amyrin  (1). The predominant mechanism of fragmentation 
proceeds via retro Diels-Alder cleavage (top). The radical cation from the C*DE ring 
fragment yields a characteristic ion at m/z 218. A less common ABC* fragment can also be 
generated from hydrogen transfer and gives an ion at m/z 279.  
 
 
 
 
 
 
 
1
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4.2 – Aims  
The ability of P450s to selectively functionalise relatively inert C-C and C-H bonds 
makes them attractive tools for engineering natural product diversity. Significant 
progress has been made in recent years in identifying P450s participating in 
triterpene biosynthesis, providing an opportunity to produce and selectively 
functionalise triterpene scaffolds for various downstream applications. This chapter 
aimed to explore the capacity for engineering structurally diverse triterpenes in N. 
benthamiana. In particular, here a ‘toolkit’ of characterised β-amyrin oxidases from 
different plant species is established and evaluated for function in the N. 
benthamiana transient expression system. Systematic ‘combinatorial’ expression of 
both known and novel mutant oxidases is also employed for the generation of 
previously unreported novel β-amyrin derivatives. Finally, the potential of this 
system for production and oxidation of other triterpene scaffolds is demonstrated. 
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4.3 – Results and discussion. 
4.3.1 – Part 1: Establishing a toolkit for functionalisation of β-amyrin 
Chapter 3 demonstrated that enhanced production of β-amyrin in N. benthamiana 
could be achieved through coexpression of a truncated, feedback-insensitive form 
of 3-hydroxy-3-methylglutaryl-CoA reductase (tHMGR) with the oat β-amyrin 
synthase AsbAS1. In turn, increased yields of an oxidised form of β-amyrin (12,13β-
epoxy,16β-hydroxy-β-amyrin (EpHβA)) were also achieved by coexpression of the 
oat cytochrome P450 CYP51H10 with tHMGR and AsbAS1 (Figure 4-2). 
 
Figure 4-2: Oxidation of β-amyrin by CYP51H10  to form 12,13β-epoxy,16β-hydroxy-β-
amyrin (EpHβA). 
 
To investigate the potential of the system for production of other β-amyrin 
derivatives, coexpression of AsbAS1 with other characterised triterpene-modifying 
P450s was carried out. A set of P450s that have previously been shown to oxidise 
the β-amyrin backbone directly were selected for functional analysis in the plant 
transient expression system. Using a Gateway-based cloning strategy 
(www.thermofisher.com), a series of Entry vectors were generated, each containing 
a P450-encoding gene (Table 4-1) (methods 4.5.1). These were each 
subsequently transferred to the pEAQ-HT-DEST1 binary vector and transformed 
into A. tumefaciens strain LBA4404 [161]. The individual P450 expression strains 
were then used to infiltrate N. benthamiana leaves along with strains carrying 
tHMGR and AsbAS1. After five days, leaves were harvested and GC-MS analysis of 
leaf extracts was performed (methods 4.5.3). Where authentic standards were 
available for the expected compounds, these were included for comparison.  
 
 
1
β-amyrin
2
EpHβA
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Table 4-1: β-amyrin oxidases used in this study. * CYP72A65 activity is known from 
personal communication with the Goossens lab, Ghent, Belgium. ** Osbourn lab, 
unpublished. 
 
 
 
 
 
 
 
 
 
Species Name Position Product Accession Ref 
Avena 
strigosa 
CYP51H10 C-12/13 
C-16 
12,13β-epoxy-
16β-hydroxy-β-
amyrin 
ABG88961 [85] 
Medicago 
truncatula 
CYP716A12 C-28 Oleanolic acid FN995113 [97, 175] 
Glycine  
max 
CYP93E1 C-24 24-hydroxy- 
β-amyrin 
AF135485 [96] 
Glycyrrhiza 
uralensis 
CYP88D6 C-11 11-oxo- 
β-amyrin 
AB433179 [98] 
Medicago 
truncatula 
CYP72A63 C-30 11-deoxo-
glycyrrhetinic 
acid 
AB558146 [100] 
Glycyrrhiza 
uralensis 
CYP72A154 C-30 30-hydroxy- 
β-amyrin 
AB558153 [100] 
Medicago 
truncatula 
CYP72A65 C-30 30-hydroxy- 
β-amyrin 
XM_ 
003628019.2 
This 
study* 
Avena 
strigosa 
CYP51H10- 
I471M 
C-12/13 12,13β-epoxy- 
β-amyrin 
N/A This 
study** 
Avena 
strigosa 
CYP51H10- 
A354L 
C-16 16β-hydroxy- 
β-amyrin 
N/A This 
study** 
Chapter 4 – Engineering triterpene diversity in N. benthamiana 
86 
 
4.3.1.1 – Production of oleanolic acid by CYP716A12 
CYP716A12 is a C-28 oxidase from Medicago truncatula that catalyses the three-
step oxidation of β-amyrin (1) to oleanolic acid via alcohol (erythrodiol) and 
aldehyde (oleanolic aldehyde) intermediates [97, 176] (Figure 4-3A). When 
CYP716A12 was coexpressed with AsbAS1 and tHMGR, obvious peaks were 
evident at 24.3 min and 25.1 min that matched the retention time and mass spectra 
of the authentic erythrodiol (3) and oleanolic acid (5) standards, respectively (Figure 
4-3B). Of the two new peaks, oleanolic acid was by far the most abundant 
compound, indicating efficient conversion to the end product. This was consistent 
with the substantial decrease in β-amyrin relative to the controls (Figure 4-3B).  
 
Figure 4-3: Oxidation of β-amyrin by CYP716A12. A) Schematic for stepwise C-28 oxidation 
of β-amyrin to oleanolic acid. B) GC-MS data from coexpression of 
tHMGR/AsbAS1/CYP716A12 in N. benthamiana. Mass spectra for the numbered peaks are 
shown to the right of the relevant chromatograms. Mass spectra for erythrodiol and oleanolic 
acid standards are also given. 
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4.3.1.2 – Production of 24-hydroxy-β-amyrin by CYP93E1 
CYP93E1 is a C-24 oxidase involved in soyasaponin biosynthesis in Glycine max 
[96]. Although predominantly a C-24 hydroxylase, it has also been shown to be 
capable of further oxidation at the C-24 position to the aldehyde and carboxylic 
acids [99] (Figure 4-4A). Coexpression of tHMGR/AsbAS1/CYP93E1 resulted in a 
large peak at 24.0 min which had a GC-MS profile that matched a previously 
published spectrum for 24-hydroxy β-amyrin (6) [96, 99]. As observed with 
CYP716A12, the conversion of β-amyrin by CYP93E1 appeared to be highly 
efficient (Figure 4-4B). In addition to 24-hydroxy β-amyrin (6), numerous additional 
products could be detected. One such peak at 25.3 min was identified as the C-24 
carboxylic acid (8) as previously reported [99]. The identity of the other peaks is not 
known. These may be extraction or GC-MS-related artefacts (Supplementary 
Figure 3). However the major product by far was 24-hydroxy-β-amyrin, as expected 
(6). 
 
Figure 4-4: Oxidation of β-amyrin by CYP93E1. A) Schematic for the step C-24 oxidation of 
β-amyrin by CYP93E1. B) GC-MS data of extracts of N. benthamiana leaves expressing 
tHMGR/AsbAS1/CYP93E1 plus controls. Mass spectra for numbered peaks are shown to 
the right of the chromatograms. Mass spectra for peaks 9-11 not shown above are given in 
Supplementary Figure 3. 
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4.3.1.3 – Production of 11-oxo-β-amyrin by CYP88D6 
CYP88D6 is involved in glycyrrhizin biosynthesis in Glycyrrhiza uralensis and is 
responsible for the two-step C-11 oxidation of β-amyrin to 11-oxo-β-amyrin (13) via 
11α-hydroxy-β-amyrin (12) (Figure 4-5A) [98]. GC-MS analysis of 
tHMGR/AsbAS1/CYP88D6-expressing leaves revealed a large peak at 25.6 min 
with a mass spectrum consistent with that of 11-oxo-β-amyrin [98] (13) (Figure 
4-5B). A second peak at 22.4 mins (15) is expected to be a derivative of 11-oxo-β-
amyrin containing an additional trimethylsilyl (TMS) group due to tautomerisation of 
the C-11 carbonyl (13) (Supplementary Figure 4A). Re-analysis of the sample 
without derivatisation yielded a single major product with the expected mass for 
underivitised 11-oxo-β-amyrin (440) (Supplementary Figure 4B). This confirms 
that the previous product 15 is likely to be an artefact of the derivatisation process. 
The identities of the other peaks, including 14 and 16, are not known 
(Supplementary Figure 4A). 
 
Figure 4-5: Oxidation of  β-amyrin by CYP88D6. A) Schematic for the 2-step C-11 oxidation 
of β-amyrin to 11-oxo-β-amyrin. B) GC-MS total ion chromatograms (TIC) from leaves 
expressing tHMGR/AsbAS1/CYP88D6 plus controls. Mass spectra for 11-oxo-β-amyrin (13) 
is shown to the right. 11-oxo-β-amyrin and derivatives undergo McLafferty rearrangement as 
well as retro Diels-Alder (rDA) cleavage to give the fragments indicated. A schematic for this 
is shown in Supplementary Figure 5. Spectra for peaks 14-16 not shown here are given in 
Supplementary Figure 4A.  
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4.3.1.4 – Production of 30-hydroxy-β-amyrin by CYP72A63 and CYP72A65 
CYP72A63 and CYP72A154 are C-30 oxidases capable of acting on β-amyrin 
directly, as well as on numerous oxidised forms of this scaffold [100, 101] (Figure 
4-6A). Analysis of N. benthamiana leaves expressing tHMGR/AsbAS1/CYP72A63 
revealed a new peak present at 25.6 mins corresponding to 30-hydroxy-β-amyrin 
(17) [100]. In contrast to other P450s tested so far, CYP72A63 showed relatively 
poor substrate conversion, with most of the β-amyrin remaining unmodified (Figure 
4-6B).  
 
Figure 4-6: Oxidation of β-amyrin by CYP72A63, CYP72A65 and CYP72A154. A) 
Schematic for the step oxidation of β-amyrin at C-30. CYP72A65 and CYP72A154 are only 
known to perform the first hydroxylation step. The dashed arrow indicates an undefined 
oxidation step. B) GC-MS total ion chromatograms (TIC) for plants expressing 
tHMGR/AsbAS1/CYP72A63 and tHMGR/AsbAS1/CYP72A65 (normalised to internal 
standard, coprostanol, not visible above). 30-hydroxy-β-amyrin has a close retention time to 
another product in the AsbAS1-only control sample marked with an asterisk (shown in close 
detail on the upper right). Mass spectra for these products are shown to the right. 
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A second C-30 oxidase - CYP72A154 - was also tested but did not show any 
detectable activity towards β-amyrin (not shown). When previously tested in yeast, 
this enzyme was suggested to prefer 11-oxo-β-amyrin as a substrate (13) [100]. 
However the combination of this enzyme with CYP88D6 (tHMGR/AsbAS1/ 
CYP88D6/CYP72A154) likewise failed to reveal any obvious conversion of 11-oxo-
β-amyrin (data not shown). Thus CYP72A154 may be inactive or poorly expressed 
in N. benthamiana. Finally, the test was repeated with a closely related P450 from 
M. truncatula which is 95% similar at the protein level and has also been found to 
have C-30 oxidase activity in yeast (Accession XM_003628019.2) herein called 
CYP72A65 (Prof A. Goossens, Dr. T. Moses, personal communication). This had 
comparable activity to CYP72A63, resulting in production of a small amount of 30-
hydroxy-β-amyrin (Figure 4-6B). 
4.3.1.5 – Part 1 Summary 
These results demonstrate that selective oxidation of β-amyrin at the C-11, C-24, C-
28 and C-30 positions is possible by coexpressing a series of triterpene-oxidising 
P450s with AsbAS1 in N. benthamiana. Expression of CYP716A12, CYP88D6 or 
CYP93E1 (with tHMGR and AsbAS1) resulted in conversion of the majority of the β-
amyrin to oxidised products. Thus, as demonstrated previously for CYP51H10 
(Section 3.2.5), substrate availability appears to be the main factor limiting product 
yields. In contrast, CYP72A63 and CYP72A65 only converted a relatively small 
proportion of the available β-amyrin (Figure 4-6). In these cases it may be that β-
amyrin is not the optimal substrate, or that these enzymes are poorly expressed or 
inactive in N. benthamiana.  Supplementary Table 2 shows the various β-amyrin-
derived compounds produced in section 4.3.1 and key ions within their mass 
spectra with the corresponding predicted fragment. 
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Figure 4-7: Summary of the major products produced by the β-amyrin oxidases expressed 
in the present study.  
 
4.3.2 – Part 2 – Combinatorial biosynthesis in N. benthamiana  
The P450s evaluated in the present study collectively oxidise six different positions 
on the β-amyrin backbone (Figure 4-7). This opens up opportunities to investigate 
the compatibility of these enzymes when expressed in combination with the aim of 
producing ‘hybrid’ oxidised forms of β-amyrin. To explore this possibility, pairwise 
combinations of the P450s were tested by transient coexpression in N. 
benthamiana. All combinations included tHMGR and AsbAS1. After five days the 
leaves were harvested and extracts were analysed by GC-MS. Compounds were 
identified by comparison of the chromatograms of the pairwise combinations with 
those for control plants expressing tHMGR, AsbAS1 and the single respective 
P450s (methods 4.5.4).  
Analysis of the GC-MS data revealed that, remarkably, new products could be 
detected for almost every combination tested. From a total of ten possible pairwise 
combinations including CYP51H10, CYP716A12, CYP93E1, CYP88D6 and 
CYP72A65, all were found to yield new products. These are summarised below in 
Table 4-2. For simplicity, most chromatograms are provided as supplementary data, 
also detailed in Table 4-2. 
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(C-11) 
CYP51H10 
(C-12/13/16) 
C
Y
P
7
1
6
A
1
2
 
(C
-2
8
) 
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Supplementary 
Figure 7A 
1 peak  
(21) 
Supplementary 
Figure 7B 
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Figure 4-11 
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Supplementary 
Figure 14B 
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Figure 9 
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Supplementary 
Figure 8A 
1 peak 
(36) 
Supplementary 
Figure 12 
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1
) 
      
4 peaks 
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Supplementary 
Figure 14A 
 
Table 4-2: Summary of P450 combinations. The number of new peaks identified in the 
sample is given, with the numbers in brackets used to assign these peaks. The 
chromatograms are generally included as supplementary data, in the box.  Although two C-
30 oxidases were characterised above, CYP72A63 was the least active of the two and failed 
to give peaks when combined with either CYP716A12 or CYP51H10 (see Supplementary 
Figure 6A). Furthermore, combinations of CYP72A63 with CYP88D6 or CYP93E1 resulted 
in only trace amounts of new products (Supplementary Figure 6B and C). CYP72A63 is 
functionally equivalent to CYP72A65, and these trace products were found to be identical to 
these in the equivalent CYP72A65 samples where they were far more abundant. Therefore 
for simplicity, only the combinations with CYP72A65 are included here. 
 
Four of the ten combinations resulted in putative products that have been previously 
reported and EI mass spectral data are available for comparison. These included 
24-hydroxy oleanolic acid (19) (4-epi hederagenin) from CYP93E1 and CYP716A12 
[101]; 30-hydroxy oleanolic acid (or queretaroic acid - 21) from CYP72A65 and 
CYP716A12 [101, 173]; 11-oxo-30-hydroxy-β-amyrin (23) [100] from CYP72A65 
and CYP88D6 and 24,30-dihydroxy-β-amyrin (24) from CYP72A65 and CYP93E1 
[101]. These structures are shown in Figure 4-8. Supplementary Table 3 presents 
a summary of these compounds and their fragmentation patterns.  
The remaining combinations contained products for which reference EI spectra 
were not available and several of the anticipated products were expected to be 
previously unreported. However, the identity of products from three combinations 
could be reasonably assumed by analysis of their mass spectra. The major product 
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derived from combination of CYP51H10 and CYP93E1 had a mass spectrum 
consistent with 12,13β-epoxy, 16β,24-dihydroxy-β-amyrin (29 - Supplementary 
Figure 9). A very minor peak in this sample was also identified as 12,13β-
epoxy,16β-hydroxy-β-amyrin (28). The combination of CYP51H10 and CYP72A65 
resulted in a product consistent with 12,13β-epoxy, 16,30-dihydroxy-β-amyrin (36). 
Finally, the combination of CYP93E1 and CYP88D6 gave a novel product which 
had a fragmentation pattern consistent with 11-oxo-24-hydroxy-β-amyrin (37). This 
latter combination of CYP93E1 and CYP88D6 was chosen for purification and is 
detailed below in section 4.3.2.1. Work is currently underway in the Osbourn lab to 
determine the identity of the remaining structures. The putative structures are 
shown below in Figure 4-8 and a breakdown of their fragmentation is given in 
Supplementary Table 4. 
The major products in the remaining three combinations were difficult to identify with 
any certainty. These included products from coexpression of CYP88D6 with 
CYP716A12, and from CYP51H10 coexpressed with either CYP716A12 or 
CYP88D6. The CYP88D6 and CYP716A12 combination was chosen for purification 
to determine the identity of the product and is described below in section 4.3.2.3. 
Work is ongoing to determine the structure of the products from the latter 
CYP51H10 combinations, however trace parent ions were visible in the spectra of 
the new products which allowed for putative assignment of their identities. For 
combination of CYP51H10 with CYP88D6, the most abundant product was 
assigned as 11α-hydroxy,12,13β-epoxy,16β-hydroxy-β-amyrin (47). A second 
product was assigned as 11-oxo-12,13β-epoxy,16β-hydroxy-β-amyrin (49). A third 
minor product in the sample had a mass spectrum which could be interpreted as 11-
oxo,16β-hydroxy-β-amyrin (48). For the combination of CYP51H10 and 
CYP716A12, the most abundant novel peak was assigned as 12,13β-epoxy 
oleanolic acid (50). These putative structures are given in Figure 4-8. 
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Figure 4-8: Schematic of combinatorial compounds identified in the present study (shown in 
numerical order clockwise from top). β-amyrin is shown in the centre and the major oxidised 
product for each individual P450 is represented in the inner blue circle. Combinatorial 
products are shown in the outer circle. Compounds drawn in grey are putative structures. 
Those shown in black are known structures based either on comparison with mass spectra 
from other studies, or from purification and NMR analysis in this work. The compounds for 
which NMR data is given in this study are represented with a green background. Finally, 
asterisks indicate those structures that do not appear to have previously been reported. 
 
4.3.2.1– Determining the combinatorial products of CYP93E1 and CYP88D6 
In addition to the products identified above, several of the combinations resulted in 
the formation of other products which were often not possible to assign an identity 
based on mass spectra. In many cases these products were only minor, however 
the combination of tHMGR/AsbAS1/CYP88D6/CYP93E1 resulted in an unknown 
product (42) which was of a similar abundance to the major product putatively 
identified as 11-oxo,24-hydroxy-β-amyrin (37) (Figure 4-9). The mass spectrum of 
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this compound indicated that it was closely related to 11-oxo-24-hydroxy-β-amyrin 
(37) and 11-oxo-β-amyrin (13), due to the presence of prominent shared ions such 
at m/z 273 and 232 (Figure 4-9B). However the product had a putative parent mass 
of 570 which could not obviously be accounted for by the known activity of 
CYP88D6 and CYP93E1. Therefore, a large-scale infiltration of 
tHMGR/AsbAS1/CYP88D6/CYP93E1 was performed in order to confirm the identity 
of 11-oxo,24-hydroxy-β-amyrin (37) and determine the identity of the unknown 
product (methods 4.5.6). 
Extracts were taken from leaves infiltrated with tHMGR/AsbAS1/ 
CYP88D6/CYP93E1 and flash column chromatography was performed to isolate 
two series of fractions containing the putative 11-oxo, 24-hydroxy-β-amyrin (37), 
and the unknown compound (42) respectively (methods 4.5.6).  
Preliminary proton (1H) NMR analysis was performed on the isolated compound 37. 
This revealed the presence of a singlet which integrated to a single hydrogen atom 
at δ5.59ppm. This suggested the presence of an alkene hydrogen atom between 
two quaternary carbons, as would be expected from the lone hydrogen at C-12 
resulting from incorporation of a ketone moiety at C-11. This hydrogen atom 
appears as a triplet in β-amyrin due to coupling with the two protons at C-11. The 
eight methyl groups in β-amyrin are visible as singlets in the 1H spectrum. Only 
seven such singlets were observed in the new compound 37, which indicated that 
one of the methyl groups had been modified, as would be expected by incorporation 
of a primary alcohol at C-24. Further evidence for this was seen by the appearance 
of doublets at δ3.33 and δ4.21 ppm, which were found to be geminal hydrogens by 
DEPT-edited HSQC. These were expected to be the remaining C-24 hydrogens, 
with the downfield shift characteristic of a geminal oxygen atom. The NMR spectra 
for β-amyrin and compound 37 are provided as Supplementary Figure 10 and 
Supplementary Figure 11 respectively. 
As minor impurities were visible within the sample containing 37, this was further 
purified by semi-preparative HPLC. The purified product then underwent further 
NMR analysis allowing full assignment of the compound (methods 4.5.8.1). The 
identity of compound 37 was consistent with 11-oxo, 24-hydroxy-β-amyrin. 
The semi-purified unknown product 42 was further analysed by LC-MS and found to 
have a mass of 498 (Figure 4-9C) (methods 4.5.6.1). Thus addition of a single 
trimethylsilyl (TMS) group during derivatisation for GC-MS would be sufficient to 
account for the previously observed mass at m/z 570. Furthermore, while simple 
Chapter 4 – Engineering triterpene diversity in N. benthamiana 
96 
 
triterpenes such as β-amyrin show poor UV absorbance, 42 showed strong 
absorption at ~250nm, suggesting the presence of the C-ring α,β-unsaturated 
ketone (Figure 4-9C). Taken together, this suggested that 42 featured the 11-oxo 
functionality and a single hydroxyl group available for silylation (likely the C-3 
hydroxyl) and suggested the compound was modified at the C-24 position. Given 
these observations, a possible identity for 42 was suggested to be 11-oxo,24-
acetoxy-β-amyrin (Figure 4-9B, right). If so, it should be possible to hydrolyse the 
esterified C-24 group to recover the expected product, 11-oxo,24-hydroxy-β-amyrin. 
To test this possibility, saponification of the semi-purified 42 was performed. Thin-
layer-chromatography (TLC) analysis of the saponified sample revealed a new spot  
which was not present in the pre-saponified extract and co-migrated with 11-oxo, 
24-hydroxy-β-amyrin (37) (Figure 4-9D). The presence of 11-oxo, 24-hydroxy-β-
amyrin in the saponified extract was further confirmed by GC-MS (data not shown). 
This demonstrated that compound 42 could be hydrolysed by saponification to form 
11-oxo, 24-hydroxy-β-amyrin. 
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Figure 4-9: Production of 11-oxo,24-hydroxy-β-amyrin and acetylated derivatives. A) GC-
MS total ion chromatogram (TIC) of N. benthamiana leaves expressing tHMGR, AsbAS1, 
CYP93E1 and CYP88D6. B) Mass spectra for the major products 37 (left) and 42 (right). 
Structures of the compounds are given above, with the putative product 11-oxo,24-acetoxy-
β-amyrin given in grey. Labels above the ions indicate likely fragments as detailed in 
Supplementary Table 4. Mass spectra for peaks 38-41 not shown here are given in 
Supplementary Figure 13. C) LC analysis of the putative 11-oxo,24-acetoxy-β-amyrin. 
Charged aerosol detector (CAD - black) and Photodiode array (PDA - blue) (250nm) data 
are overlaid (top) with mass spectral (MS) data for the product at 6.9 mins shown below. D) 
TLC analysis of the semi-purified extract of 11-oxo,24-acetoxy-β-amyrin before (left) and 
following hydrolysis by saponification (middle). The purified 11-oxo,24-hydroxy-β-amyrin 37 
is in the lane on the right. The arrow denotes the appearance of the new spot co-migrating 
with this compound after saponification of the semi-purified extracts containing 42. 
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4.3.2.2 – Acetylated compounds are caused by transesterification during 
extraction 
The presence of an acetyl group results in a compound 30 mass units lower than 
would be predicted from a TMS group at the same position. This therefore allowed 
for putative identification of other acetylated compounds in other combinations, most 
commonly in samples from leaves expressing CYP93E1. These compounds are 
given above the mass spectra in the relevant supplementary figures. Acetylated 
triterpenes could result from modification by N. benthamiana. However given that 
saponification was routinely performed during processing of the leaf material it was 
somewhat surprising that these should still be abundant in the final extracts. 
Therefore, it was considered possible that these products were an extraction 
artefact. Saponification is a useful means of processing leaf material prior to organic 
phase extraction allowing removal of unwanted chlorophylls and fats. However the 
saponification solution (ethanol, water and KOH 9:1:1) is miscible with a range of 
organic solvents preventing liquid-liquid partitioning. To overcome this, following 
saponification the solution was routinely evaporated prior to direct addition of ethyl 
acetate (methods 4.5.5). However the residual KOH might catalyse 
transesterification, with transfer of the acetyl group from ethyl acetate onto the 
primary alcohol at C-24.  
To test this possibility, two disks were taken from a tHMGR/AsbAS1/CYP93E1 leaf. 
One was treated with the previous extraction method detailed above, while the other 
was immersed directly into ethyl acetate (methods 4.5.5.1). GC-MS analysis of the 
samples revealed that while 24-hydroxy-β-amyrin (6) could be detected in both 
samples, a peak corresponding to a putative 24-acetoxy-β-amyrin (11) was present 
only in the sample which had undergone saponification (Figure 4-10A). This 
strongly suggests that the extra products were formed by transesterification (Figure 
4-10B).  
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Figure 4-10: Transesterification of 24-hydroxy-β-amyrin  upon ethyl acetate extraction A) 
GC-MS total ion chromatogram (TIC) analysis of leaf disks from a single N. benthamiana 
leaf expressing tHMGR/AsbAS1/CYP93E1. Saponification followed by ethyl acetate 
extraction (blue) may cause transesterification of 24-hydroxy-β-amyrin (6) resulting in the 
product 11. This is not observed in leaves extracted with ethyl acetate directly (black). B) A 
possible mechanism for the base-catalysed transesterification reaction between 24-hydroxy-
β-amyrin and ethyl acetate is shown. 
 
4.3.2.3 – Identification of 11-oxo oleanolic acid from combination of CYP88D6 
and CYP716A12. 
The second product chosen for purification was compound 44, found in 
tHMGR/AsbAS1/CYP88D6/CYP716A12 leaf extracts. Based on the activity of the 
two P450s, this combination was expected to result in the formation of 11-oxo-
oleanolic acid. However none of the novel peaks could be obviously identified as 
such from their EI mass spectrum. The most abundant product (44) had a putative 
molecular mass at m/z 496, which does not correspond to the expected mass for 
11-oxo oleanolic acid (MW = 614) or potential intermediates (Figure 4-11A). 
A large-scale tHMGR/AsbAS1/CYP88D6/CYP716A12 infiltration was performed and 
the leaves were processed and metabolites were extracted (methods 4.5.7). 
Unexpectedly, GC-MS analysis of this crude extract revealed a previously 
unobserved peak at 28.3 min (45) which showed the correct parent mass (614) for 
11-oxo-oleanolic acid (Figure 4-11B).  However, further attempts to isolate 45 
failed. Despite this, it was possible to isolate compound 44. The purified compound 
was analysed by ion trap time-of-flight (IT-TOF) mass spectrometry to get an 
accurate mass and predict a molecular formula (methods 4.5.7.2). 44 was 
determined to have a mass of 493.3283, consistent with the sodium adduct of a 
compound with the molecular formula C30H46O4 (1.13ppm). Surprisingly, this is the 
expected mass of 11-oxo oleanolic acid (Figure 4-11C), which suggested that this 
was the identity of 44. Further NMR analysis of the purified compound 44 was also 
consistent with 11-oxo oleanolic acid (methods 4.5.8.2). GC-MS analysis of the 
purified 11-oxo-oleanolic acid showed that the purified compound likewise appeared 
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predominantly as peak 44 (data not shown). The mass differences between 44 and 
45 would imply the loss of the C-28 carboxylic acid group (Figure 4-11D). This may 
point to pyrolytic degradation of the compound within the GC inlet. It is possible that 
in future this artefact may be alleviated by the use of a cooled injection system. 
 
Figure 4-11: Combinatorial biosynthesis of CYP716A12 and CYP88D6. A) GC-MS Total ion 
chromatogram (TIC) of N. benthamiana leaves expressing 
tHMGR/AsbAS1/CYP716A12/CYP88D6 (left). Chromatograms for controls samples are 
shown in blue and orange with the combinatorial sample in black. The mass spectrum (right) 
of the major product at 28.2 mins does not correspond to the expected spectrum for 11-oxo 
oleanolic acid. Mass spectra for compound 43 is shown in Supplementary Figure 13B. B) 
GC-MS analysis of the large-scale infiltration of tHMGR/AsbAS1/CYP716A12/CYP88D6  
(left) revealed minor amounts of a novel product which has the expected fragmentation of 
11-oxo-oleanolic acid. C) Structure of 11-oxo-oleanolic acid D) Pyrolytic breakdown of 11-
oxo-oleanolic acid may occur in the GC inlet and be responsible for the product with a parent 
mass of m/z = 496.  
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4.3.3 – Incorporating CYP51H10 mutant enzymes into the toolkit. 
CYP51H10 is a multifunctional P450 that catalyses both the hydroxylation and 
epoxidation of β-amyrin, forming 12,13β-epoxy,16β-hydroxy-β-amyrin [85] (EpHβA 
(2) Figure 4-2) No other triterpene oxidases have been reported to catalyse either 
of these modifications, which makes CYP51H10 an important enzyme for triterpene 
engineering. However selective incorporation of each of these two groups 
individually is not currently possible. If these two activities could be separated this 
would enable introduction of the C-12,13 epoxide and C-16β hydroxyl functionalities 
separately, thus enhancing the triterpene engineering toolkit. 
Previously, in silico modelling was performed to identify a series of 15 residues 
lining the active site of CYP51H10 and which are predicted to be functionally 
important [85]. To expand upon this work, three of these residues were considered 
for mutagenesis to determine the impact of the various mutations on product 
specificity. These include an isoleucine at position 471 and a pair of alanine 
residues at positions 353 and 354. These residues lie in close proximity within the 
active site and have been suggested to play important roles in determining the size 
of the active site as well as interacting with β-amyrin and a putative oxidised 
intermediate (16β-hydroxy-β-amyrin) en route to EpHβA [85] (Figure 4-12A). 
Saturation mutagenesis experiments were performed at each of these three 
residues in the Osbourn lab by Prof Robert Minto. The CYP51H10 mutants were 
transiently expressed in N. benthamiana with AsbAS1 and screened by GC-MS. 
This resulted in the identification of a series of mutants with altered product profiles. 
Amongst these, mutants of CYP51H10 were identified that each perform only one of 
the two oxidations normally carried out by the wild type enzyme. Mutant CYP51H10-
I471M produces predominantly 12,13β-epoxy-β-amyrin (52), while retaining the 
ability to produce a small amount of the wild-type product (2) (Figure 4-12B). 
Conversely, CYP51H10-A354L produces 16β-hydroxy-β-amyrin (53), which lacks 
the epoxide group found in the wild-type product (Figure 4-12B). Mass spectra for 
the two mutant products are shown in Figure 4-12B. A scheme for the EI 
fragmentation of CYP51H10 wild-type and mutant products is given in 
Supplementary Figure 17. These mutants therefore allow bifurcation of the 
CYP51H10 wild type activity and represent useful additions to the toolkit for 
selective functionalisation of the β-amyrin scaffold. 
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Figure 4-12: CYP51H10 model and mutant product profiles. A) A model of the active site of 
CYP51H10 is shown with putative precatalytic binding modes of β-amyrin (left) and 16β-
hydroxy-β-amyrin (right). Residues lining the active site cavity are labelled within their 
respective substrate recognition sites (SRS). The three residues selected for mutagenesis 
are indicated with orange text. Figure adapted from Geisler et al [85]. B) GC-MS profiles of 
CYPH10 mutants. CYP51H10-I471M acts on β-amyrin to form 12,13β-epoxy-β-amyrin (52), 
while CYP51H10-A354L forms 16β-hydroxy-β-amyrin (53). GC-MS analysis of extracts from 
N. benthamiana leaves expressing CYP51H10 and the mutants are shown. Total ion 
chromatograms (TIC) are given on the left hand side with EI mass spectral data and 
structure of the major new product given to the right. Key ions in the mass spectra of the 
mutant products are highlighted. Further details of this mechanism are given in 
Supplementary Figure 17. 
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4.3.4 – Combinatorial biosynthesis of CYP51H10 mutant enzymes 
Further combinatorial experiments were performed with CYP51H10 mutants in 
combination with the other β-amyrin oxidases, CYP716A12, CYP88D6, CYP93E1 
and CYP72A65. Each combination was also coinfiltrated with tHMGR and AsbAS1 
as before (section 4.3.2). The results are summarised in Table 4-3. 
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Table 4-3: Summary of combinations involving CYP51H10 mutants. The number of new 
peaks seen by GC-MS is given along with their numbered assignments.  
 
4.3.4.1 – Combinatorial biosynthesis using CYP51H10-A354L 
Combination of CYP51H10-A354L with CYP88D6 accumulated a single new peak 
with the same retention time and mass spectrum as the putative 11-oxo, 16β-
hydroxy-β-amyrin (48) as previously identified by combination of the wild-type 
CYP51H10 and CYP88D6. Coexpression of CYP51H10-A354L with CYP93E1 
resulted in detection of a new product identified as 16β,24-dihydroxy-β-amyrin (54). 
Only trace amounts of this compound could be found from expression of CYP93E1 
with the wild-type CYP51H10 (not shown). The putative structures for these 
products are given in Figure 4-13. 
A peak was found in the combination of CYP51H10-A354L and CYP72A65 with a 
spectrum which would be expected of 16β,30-dihydroxy-β-amyrin (56). However 
this peak had the same retention time and a similar mass spectrum to a peak in the 
CYP51H10-A354L control (57) (Supplementary Figure 15). Therefore the 
uniqueness of this peak to the combinatorial sample could not be ascertained. In 
future, an alternative GC-MS program or column might allow separation of these 
products. Finally, no new products were observed upon coexpression of 
CYP51H10-A354L with CYP716A12. 
4.3.4.2 – Combinatorial biosynthesis of CYP51H10-I471M. 
Combination of CYP51H10-I471M with CYP716A12 gave a single novel peak which 
was found to have an identical retention time and mass spectra to the product 50 in 
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the corresponding wild-type CYP51H10 and CYP716A12 sample. Coexpression of 
CYP51H10 with CYP72A65 gave a novel peak which was assigned an identity of 
12,13β-epoxy, 30-hydroxy-β-amyrin (58). This product had not been identified in 
leaves expressing CYP72A65 with the wild-type CYP51H10. Hence here, the use of 
CYP51H10-I471M allows access to compounds which are unobtainable with the 
wild-type enzyme. In contrast, no new products were observed with the combination 
of CYP51H10-I471M with CYP88D6 or CYP93E1 (not shown). 
 
Figure 4-13: Combinatorial products formed using CYP51H10 mutants. The putative 
structures for the combinatorial products are indicated in grey. Compounds marked with an 
asterisk were present in only trace amounts or undetectable in the equivalent combinations 
with wild type CYP51H10. These two putative compounds do not appear to have previously 
been reported in the literature. Please note that the CYP51H10 mutants are shown first 
acting on β-amyrin for simplicity, however the order of oxidations is unknown. 
 
4.3.4.3 – Part 2 summary 
One of the ideals of combinatorial biosynthesis is the rational design of molecules 
from selection of available enzyme components. When systematically expressed 
together in planta, impressively almost all pairs of β-amyrin oxidases resulted in the 
formation of new products. This suggests that these enzymes may indeed be used 
interchangeably for directing the biosynthesis of custom triterpenes. 
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The identity of the new compounds was predicted from analysis of their EI mass 
spectra resulting in putative assignment of 13 compounds (Figure 4-8). The identity 
of four of these was confirmed by comparison to other studies, while two of the 
novel compounds, 11-oxo oleanolic acid (45) and 11-oxo,24-hydroxy-β-amyrin (37) 
were verified by purification and NMR. 11-oxo oleanolic acid has been isolated from 
a number of plant species [177-179] however it does not appear to have been 
reported from G. uralensis or M. truncatula from which the two P450s (CYP88D6 
and CYP716A12 respectively) are derived. By contrast 11-oxo, 24-hydroxy-β-amyrin 
does not appear to have been reported previously, although the C-24 and C-11 
modifications are both present in the liquorice saponin G2 (24-hydroxy glycyrrhizin) 
from G. uralensis [180, 181]. Therefore it is possible that this compound may be 
present at low levels in this species as an intermediate, however extraction from the 
natural source is unlikely to be a viable option. This demonstrates the utility of this 
approach to obtain otherwise inaccessible metabolites.  
Work is currently ongoing in the Osbourn lab to verify the identity of the remaining 
compounds which are all derived from combinations of CYP51H10 (structures given 
in grey in Figure 4-8). CYP51H10 is presently the only reported triterpene oxidase 
from monocots and is involved in the biosynthesis of antifungal triterpene glycosides 
in oat (avenacins – see Chapter 6) [85, 86]. Aside from the C12,13β epoxide and C-
16β hydroxyl groups incorporated by CYP51H10, the avenacins are also oxidised at 
the C-21, C-23 and C-30 positions [182]. Thus, none of the regiospecific 
modifications introduced by CYP716A12 (C-28), CYP88D6 (C-11) and CYP93E1 
(C-24) are featured in the avenacins. Furthermore, use of two CYP51H10 mutants 
allowed access to compounds which accumulated either in trace amounts (54) as 
well as products which were not detected at all in the wild-type (58) (Figure 4-13). 
This provides substantial potential for engineering new antifungal saponins and for 
performing in-depth structure-function investigations. 
Finally, there remains significant potential for further combinatorial biosynthesis of β-
amyrin, both with other β-amyrin oxidases which were not tested here, as well as 
other P450s which oxidise derivatives of β-amyrin. For example CYP72A67 and 
CYP72A68v2 are inactive on β-amyrin directly, but oxidise oleanolic acid [101, 102]. 
These have also been found to be functional in N. benthamiana (Supplementary 
Figure 18 and Supplementary Figure 19) and could be incorporated into 
combinatorial biosynthesis utilising three or more P450s.  
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4.3.5 – Part 3 – Beyond β-amyrin: Diversifying triterpene production in N. 
benthamiana 
The triterpene β-amyrin was the focus of the present study due to the number of 
characterised oxidases available, however β-amyrin represents only a single 
scaffold amongst more than 100 possible OSC cyclisation products [62]. Numerous 
other scaffolds are commonly found throughout the plant kingdom and are further 
derivatised in specialised pathways [39, 72]. The type of scaffold and the ways in 
which it is tailored may be an important contributor to bioactivity [57]. As new 
pathways continue to be characterised for non-β-amyrin scaffolds [89, 114, 183], 
further opportunities to apply combinatorial biosynthesis to these other scaffolds will 
be made possible.  
To explore the capacity to produce other triterpene scaffolds in N. benthamiana, a 
series of OSCs were chosen which synthesise a variety of triterpene scaffolds 
commonly found in higher plants [72]. These included an α-amyrin synthase from 
Malus domestica (MdOSC1), a lupeol synthase from Lotus japonicas (LjOSC3) and 
a cucurbitadienol synthase from Cucumis sativus (CsCPQ). These OSCs were 
cloned into pEAQ-HT-DEST1 and transformed into A. tumefaciens for expression in 
N. benthamiana (Supplementary Table 5). GC-MS analysis of extracts from leaves 
expressing the various OSCs with tHMGR confirmed that all of the expected 
products could be detected in abundance (Figure 4-14). This therefore suggests 
that N. benthamiana is a suitable platform for production of a range of triterpene 
scaffolds. 
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Figure 4-14: Production of diverse triterpene scaffolds in N. benthamiana  through 
coexpression of tHMGR  and various OSCs. GC-MS total ion chromatograms (TIC) of the 
samples are shown on the left with mass spectra for the peaks indicated on the right. A) 
Production of α-amyrin by expression of Malus domestica α-amyrin synthase (MdOSC1). B) 
Production of lupeol by expression of Lotus japonicus Lupeol synthase (LjOSC3). C) 
Production of cucurbitadienol by expression of Cucumis sativus cucurbitadienol synthase 
(CsCPQ). Standards of α-amyrin and lupeol are shown is shown below the relevant 
chromatograms and mass spectra. Details of the genes used here are given in 
Supplementary Table 5. 
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4.3.5.1 – Production of bioactive triterpenes from ginseng in N. benthamiana  
Recently an AsbAS1-S728F mutant was described which produces alternative 
cyclisation products, resulting in the predominant production of the tetracyclic 
triterpene (20S)-dammarenediol-II (60) (DD-II) [137]. DD-II is the core scaffold found 
in dammarane-type ginsenosides, a class of biologically-active triterpene saponins 
produced by Panax species [45, 46]. DD-II can be oxidised at the C-12β position by 
CYP716A47 to form protopanaxadiol (PPD) (61) and this can undergo further C-6α 
oxidation by CYP716A53v2 to form protopanaxatriol (PPT) (62) [88, 103] (Figure 
4-15). PPD and PPT form the aglycones for two major branches of 
pharmaceutically-active ginsenosides [44].  
The significant interest in these scaffolds prompted an investigation into the 
potential for production of these ginsenosides in N. benthamiana. Therefore, the 
genes encoding the AsbAS1-S728F mutant and two P. ginseng P450s were cloned 
into pEAQ-HT-DEST1 and transformed into A. tumefaciens (methods 4.5.1). The 
various strains were infiltrated in different combinations in N. benthamiana along 
with a strain carrying tHMGR. Infiltration densities were maintained at a total OD600 
of 0.8 through use of a strain carrying GFP in the absence of other strains 
(methods 4.5.3). GC-MS analysis of tHMGR/AsbAS1-S728F/GFP/GFP leaf 
extracts revealed a large peak corresponding to a (20S)-dammarenediol-II standard 
(Figure 4-15). Further inclusion of the strain carrying CYP716A47 resulted in a 
major new peak which matched a standard of PPD, indicating that the major product 
of the mutant AsbAS1 enzyme was a suitable substrate for this enzyme (Figure 
4-15). CYP716A53v2 was inactive directly against the DD-II backbone as previously 
reported [88], but in combination with tHMGR, AsbAS1-S728F and CYP716A47, a 
peak corresponding to PPT was observed. Together, this demonstrates that high-
value ginsenoside aglycones can be efficiently produced in high yield in N. 
benthamiana.  
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Figure 4-15: Production of ginsenosides in N. benthamiana. (Left) GC-MS total ion 
chromatograms (TIC) of extracts of N. benthamiana leaves expressing tHMGR with 
AsbAS1-S728F and combinations of the two P450s, CYP716A47 and CYP716A53v2. 
Standards of DD-II, PPD and PPT are shown at the bottom. Mass spectra for the standards 
are given in Supplementary Figure 21. (Right) AsbAS1-S728F cyclises oxidosqualene to 
20S-dammarenediol-II (DD-II). DD-II is oxidised at the C-12β position to protopanaxadiol 
(PPD) by CYP716A47. CYP715A53v2 is inactive directly against DD-II but oxidises PPD at 
the C-6α position to protopanaxatriol (PPT). Details of the enzymes are given in 
Supplementary Table 5. 
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Panax species are highly prized for their medicinal value; however they are slow 
growing and threatened in the wild by overhunting. More than 150 unique 
ginsenosides are known derived from a number of backbones and displaying 
different patterns of glycosylation [44]. Hence extracts of ginseng species are 
complex and sophisticated analytical and purification methods may be required for 
the isolation of individual compounds [184]. Expression of specific enzymes in N. 
benthamiana therefore offers the ability for select production of individual 
ginsenosides. Recently, a variety of glycosides of PPD and PPT were successfully 
produced through transient expression of P. ginseng glycosides in N. benthamiana 
recently (Dr Thomas Louveau, Mr Charlie Owen, (Osbourn lab), personal 
communication). Therefore there is particularly exciting potential for further 
combinatorial biosynthesis in this area.  
4.3.5.2 – Part 3 summary 
The above work demonstrates that N. benthamiana holds significant potential as a 
production platform for a diverse range of triterpenes besides β-amyrin. Although a 
relatively small range of common scaffolds were used here as proof of concept, the 
system has also proven to be suitable for synthesis and modification of uncommon 
scaffolds, such as thalianol (Supplementary Figure 20). There is now significant 
capacity to expand combinatorial biosynthesis approaches to different scaffold-
oxidase combinations [97, 108]. The ability to coinfiltrate different strains of A. 
tumefaciens from the toolkit will greatly facilitate these studies and work is currently 
underway in the Osbourn lab to explore this potential. 
 
4.4 – Conclusions 
Here, N. benthamiana is demonstrated as a versatile production host for 
engineering a diverse collection of triterpenes. In particular, numerous oxidised 
derivatives of the pentacyclic triterpene β-amyrin were produced by coexpression of 
the β-amyrin synthase AsbAS1 with previously-characterised β-amyrin oxidases 
from different plant species. Further combinatorial biosynthesis with these P450s 
showed that almost all of the P450 pairings were compatible, resulting in the 
production of hybrid oxidised forms of β-amyrin. This work has significant future 
potential for production of ‘customised’ triterpenes and saponins. This will permit 
systematic studies of important structure-function relationships with regards to 
biological activity. This is further explored in Chapter 5.  
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4.5 – Materials and Methods for Chapter 4 
4.5.1 – Cloning toolkit enzymes 
4.5.1.1 – CYP72A65, CYP72A68v2, CYP716A12, CYP93E1, CYP88D6, 
CYP716A47 and CYP716A53v2 
A number of the P450s were kindly supplied by Prof Alain Goossens (VIB Ghent). 
These included CYP72A65, CYP72A68v2, CYP716A12, CYP93E1, CYP88D6, 
CYP716A47 and CYP716A53v2. Of these, CYP72A65, CYP72A68 and 
CYP716A12 were supplied in pEAQ-HT-DEST1, allowing direct transformation of A. 
tumefaciens LBA4404. CYP93E1, CYP88D6, CYP716A47 and CYP716A53v2 were 
supplied in the Gateway-compatible yeast expression vector pAG423GAL-1 vectors. 
To transfer the genes in pAG423GAL-1 vectors into the pDONR207 Entry vector, a 
BP reaction was performed followed by transformation of subcloning efficiency 
E.coli DH5α. Colonies were screened by PCR and sequenced with attL1-F/attB2-R 
primers (Table 2-1) to verify the presence and integrity of the insert. Finally, the 
genes were transferred to pEAQ-HT-DEST1 via an LR reaction and the resulting 
constructs were used to transform A. tumefaciens LBA4404. 
4.5.1.2 – CYP51H10 mutants 
Strains of A. tumefaciens LBA4404 carrying mutant constructs CYP51H10-A354L 
and CYP51H10-I471M were kindly supplied by Prof Robert Minto (Indiana 
University-Purdue University, Indianapolis, USA).  
4.5.1.3 – AsbAS1-S728F 
A strain of LBA4404 carrying AsbAS1-S728F was kindly supplied by Dr Ramesha 
Thimmappa. 
4.5.1.4 – MdOSC1, CYP72A63, CYP72A154, CYP72A67 and LjOSC3 
Synthesised versions of MdOSC1, CYP72A63 and CYP72A154 were supplied by 
Dr Aymeric Leveau in the Golden Gate level 0 [135] vectors PL0M-SC-cMdOSC1, 
pL0M-SC-cCYP72A63 and pL0M-SC-cCYP72A154 respectively. LjOSC3 was 
kindly provided by Prof Kalliope Papadopoulou. The coding sequences for these 
genes were amplified from these vectors using PCR (Phusion polymerase, NEB), 
primers were MdOSC1-attB1-F/2-R, 72A63-attB1-F/2-R, 72A154-attB1-F/2-R and 
LjOSC3-attB1-F and LjOSC3-attB2-R (Table 4-4).  
CYP72A67 was cloned by PCR from M. truncatula root cDNA. cDNA was kindly 
supplied by Dr Sonali Roy (John Innes Centre). Phusion polymerase and primers 
Chapter 4 – Engineering triterpene diversity in N. benthamiana 
112 
 
72A67-attB1-F/2-R were used to amplify the CYP72A67 coding sequence (Table 
4-4).  
The resulting PCR products for the genes above were purified (QIAquick PCR 
purification kit, Qiagen) and cloned into pDONR207. Colonies were screened by 
PCR and sequenced using attL1-F/2-R primers Table 2-1. OSCs were additionally 
sequenced with primers in Table 4-4 Following this, purified Entry vectors 
containing the P450s was transferred to the pEAQ-HT-DEST1 vector and used to 
transform A. tumefaciens LBA4404. 
4.5.1.5 – THAS, CYP708A2 and CYP705A5 
The THAS, CYP708A2 and CYP705A5 genes were cloned from A. thaliana root 
cDNA (kindly provided by Dr Hans Nützmann) using the primers THAS-attB1s-F, 
THAS-attB2s-R, CYP708A2-attB1s-F, CYP708A2-attB2s-R, CYP705A5-attB1s-F, 
CYP705A5-attB2s-R (Table 4-4). These primers contained half-length Gateway attB 
sites, requiring a 2-step Gateway PCR to introduce the full-length attB sites. 
CYP705A5 was successfully amplified in this manner and was subsequently used to 
perform a BP reaction with pDONR207.  
For THAS and CYP708A2, a single 30-cycle PCR was performed using the same 
primers as above (Phusion polymerase, NEB) resulting in the full-length product 
flanked by truncated Gateway attB sites. These PCR products were purified 
(QIAquick PCR purification kit, Qiagen) and inserted into a Zero Blunt TOPO PCR 
cloning kit (Invitrogen) according to the manufacturer’s instructions. This vector was 
then used as a template for a second PCR using the full-length attB primers attB1F-
1 and attB2R-1 (Table 2-1). The resulting PCR product was likewise purified and 
inserted into pDONR207. Finally, the genes were transferred to pEAQ-HT-DEST1 
vector and used to transform A. tumefaciens LBA4404. 
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4.5.2 – Primer sequences 
  Name Adapter/5'sequence Gene-specific sequence 
G
a
te
w
a
y
 c
lo
n
in
g
 
MdOSC1-attB1-F attB1F-1 ATGTGGAAGATCAAGTTTGGAGAG 
MdOSC1-attB2-R attB2R-1 TCAAGCGATCTTTTTGATAGGCAAC 
72A63-attB1-F attB1F-1 ATGGAAGTGTTTATGTTTCCCACAG 
72A63-attB2-R attB2R-1 TTACAGTTTATGCAAAATGATGCTTG 
72A154-attB1-F attB1F-1 ATGGATGCATCTTCCACACCAGG 
72A154-attB2-R attB2R-1 TTACAGTTTATGCAGAATGATGGG 
LjOSC3-attB1-F attB1F-1 ATGTGGAAGTTGAAGGTAGCAGAAGG 
LjOSC3-attB2-R attB2R-1 TCATGCACATAAGACTCTGCGACGG 
72A67-attB1-F attB1F-1 ATGGAAGCATCATTGGCC 
72A67-attB2-R attB2R-1 TTATGCTTTCACTTTGCGTAG 
THAS-attB1s-F attB1Fs-1 ATGTGGAGGCTGAGAACTGG 
THAS-attB2s-R attB2Rs-1 TTAAGGGAGGAGACGTCGCAG 
CYP708A2-attB1s-F attB1Fs-1 ATGGATCGACGGGGCAAG 
CYP708A2-attB2s-R attB2Rs-1 CTAGAGTGACTGGGAAATCTTG 
CYP705A5-attB1s-F attB1Fs-1 ATGGCATCAATGATCACTGTTG 
CYP705A5-attB2s-R attB2Rs-1 TTAAGTGTTTAGGTTTCGAGGAAC 
G
e
n
e
-s
p
e
c
if
ic
 
s
e
q
u
e
n
c
in
g
 
p
ri
m
e
rs
 
THAS_seq_F  GCCACAGTGTTATGTTCTG 
THAS_seq_R  CCGTACATTCTACATACC 
MdOSC1 
 
GTTCTGCTACTGTAGGTTGAC 
LjOSC3 
 
CTGTCGCTTAGTTTACATGCC 
   
   
 
Table 4-4: Primer sequences as used in Chapter 4. The gene-specific sequences are given 
on the right, with 5’ adapters for Gateway cloning indicated in the column to the left and 
detailed in Table 2-1. 
 
4.5.3 – Testing the toolkit enzymes in N. benthamiana 
Strains of A. tumefaciens carrying the relevant constructs were cultured and 
prepared as detailed in section 2.1.3.2. Infiltrations were performed as in section 
2.1.3.3. Control infiltrations were also performed without P450s (tHMGR and OSC) 
or without the OSC (tHMGR and P450) to ensure that new products were 
dependent on the presence of β-amyrin (not shown in main text). In these cases, a 
strain expressing GFP was used in place of the missing strain. 
4.5.4 – Combinatorial biosynthesis 
Strains of A. tumefaciens were cultured and prepared as detailed in section 2.1.3.2. 
Strains were made to a total OD600 of 0.8 and four strains carrying tHMGR, AsbAS1 
and two P450s were mixed in equal ratios. For single P450 controls, an equivalent 
volume of MMA buffer was used in place of the missing strain. Infiltrations were 
performed as in section 2.1.3.3. 
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4.5.5 – Extraction and analysis of leaf samples 
Following leaf harvesting at 5 days, a 16mm (#11) cork borer was used to cut a 
single disk from each leaf. Disks were stored at -80°C before being lyophilised 
overnight. Disks were weighed using a microbalance (Sartorius) before transfer to a 
1.5mL centrifuge tube. Next a saponification solution was made containing an 
internal standard (coprostanol, Sigma) to 10µg/mL. The saponification solution was 
added to each disk based on weight (100µL/mg) giving a final internal standard 
concentration of 1mg/g dw. Saponification was performed in a water bath at 75°C 
for 1 hour in sealed tubes. Tubes were then opened and incubated for an additional 
hour at 75°C to evaporate ethanol. Tubes were removed from the water bath and 
allowed to cool before addition of 300µL ethyl acetate and vortexing briefly. Finally, 
500μL of water was added before vortexing again. Samples were centrifuged for 1 
minute at full speed (16,000g) before removal of the upper organic phase. This was 
transferred to a 2mL autosampler vial and dried under N2. 50µL Tri-Sil Z (Sigma) 
was added per sample and heated at 70°C for 30 minutes before addition of an 
equal volume of ethyl acetate. GC-MS was performed as in section 2.1.5.1. 
4.5.5.1 – Comparing extraction methods for investigating transesterification 
Two leaf disks from a single leaf expressing tHMGR/AsbAS1/CYP93E1 were taken 
using a cork borer. One was saponified (without use of an internal standard) and 
extracted as per the method detailed above (section 4.5.5). The other was 
immersed directly into 500μL ethyl acetate in a 1.5mL microcentrifuge tube and 
shaken at 1000rpm at room temperature for 2 hours.  
4.5.6 – Production, analysis and purification of 11-oxo,24-hydroxy-β-amyrin 
and 11-oxo,24-acetoxy-β-amyrin. 
Large volume (~1.5L) cultures of strains of A. tumefaciens carrying tHMGR, 
AsbAS1, CYP88D6 and CYP93E1 were prepared (section 2.1.3.2) and used to 
infiltrate 112 plants by vacuum infiltration (section 2.1.3). These were harvested 
after five days (154g fresh weight) to give 18.5g dry leaves. Extraction was 
performed as in section 2.1.4. The crude extract was adsorbed onto silica gel and 
loaded onto a SNAP KP Sil 25g column (Biotage). Flash chromatography was 
performed according to program P-3 (Table 2-4). Fractions were analysed by GC-
MS and those expected to contain 11-oxo,24-hydroxy-β-amyrin were pooled. The 
fractions containing the unknown compound were also pooled. Fractions containing 
11-oxo,24-hydroxy-β-amyrin were dry loaded onto silica gel and a second 
chromatography step was performed using a SNAP Ultra 10g column (Biotage) 
(Program P-4). The absorption at 256nm was used to direct fraction collection of 11-
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oxo,24-hydroxy-β-amyrin. Once dried, these gave a white crystalline powder which 
weighed 41mg. 
For 11-oxo-24-acetoxy-β-amyrin, pooled fractions were dry loaded in silica gel onto 
a SNAP Ultra 10g column (Biotage) and run according to program P-5. All fractions 
were collected, and GC-MS and TLC analysis was used to determine those 
containing 11-oxo-24-acetoxy-β-amyrin. 
4.5.6.1 – LC-MS analysis of 11-oxo,24-acetoxy-β-amyrin 
Analysis of the semi-purified 11-oxo,24-acetoxy-β-amyrin was performed using a 
Shimadzu Nexera X2 installed with a Kinetex 2.6µ XB-C18 100Å 20 x 2.1mm 
column. A mobile phase of methanol and water (with 0.1% formic acid) was run 
(300μl/min) from 70-100% methanol over 17 minutes. The sample was monitored by 
MS (Shimadzu LC-2020 dual source MS), PDA (Shimadzu SPD-M20A) and CAD 
(Thermo Dionex Corona Veo RS). 
4.5.6.2 – Saponification of 11-oxo, 24-acetoxy-β-amyrin 
Approximately 100µg of the crude extract containing 11-oxo,24-hydroxy-β-amyrin 
was dissolved in 500μL of saponification mix and saponified as in section 4.5.5. 
TLC analysis was performed using a mobile phase of hexane:ethyl acetate (1:1) 
and visualised as previously described in section 3.4.9.1. 
4.5.7 – Production and purification of 11-oxo-oleanolic acid 
Large volume (~1.5L) cultures of strains of A. tumefaciens carrying tHMGR, 
AsbAS1, CYP716A12 and CYP88D6 were made (section 2.1.3.2). This suspension 
was used to inoculate 141 plants by vacuum infiltration (section 2.1.3). These were 
harvested after 5 days (702g fresh leaves) and lyophilised giving 70g dry material. 
Extraction of the compound was performed (section 2.1.4). The extract was 
adsorbed onto silica gel and loaded onto a Biotage SNAP Ultra 50g column. 
Chromatography was performed according to program P-6 (Table 2-4). Fractions 
were analysed by GC-MS, those containing the products of interest were pooled 
and dried. This was further dry-loaded in silica gel onto a Biotage SNAP10 ultra 
cartridge and chromatography performed according to program P-7 (Table 2-4). 
Finally the extracts were dry loaded onto another SNAP10 ultra cartridge (Biotage) 
and run according to program P-8. This gave 46mg of a semi-pure extract which 
was further purified by HPLC as below.  
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4.5.7.1 – Semi-preparative HPLC purification of 11-oxo-oleanolic acid. 
Semi-preparative HPLC was performed using a Shimadzu Nexera X2 system 
installed with a Phenomenex Luna 5μm C18 100Å 250x10mm column. The mobile 
phase was a methanol/water mix with 0.1% formic acid. A 4mL/minute gradient was 
set up from 70-100% methanol over 14mins and held for a further 6 minutes. The 
gradient was returned back to 70% methanol over 1 minute before equilibration over 
a further 4 minutes. 11-oxo-oleanolic acid typically eluted between 14-15mins. 
Fraction collection was directed by PDA monitoring absorbance at 252nm.  
4.5.7.2 – Accurate mass measurement of 11-oxo-oleanolic acid 
HPLC-purified 11-oxo-oleanolic acid was made to a 10μM solution in methanol. The 
sample was subject to flow injection analysis using a Shimadzu-IT-TOF. Analysis 
was performed by Dr Lionel Hill using ESI in positive mode (4.5kV). The nebulising 
gas flow was set to 1.5L/min, CDL temperature was 250°C and heat block was set 
to 300°C. The instrument was calibrated using trifluoroacetate according to the 
manufacturer’s instructions. 
4.5.8 – NMR spectroscopy 
NMR analysis was performed by Dr Michael Stephenson. Spectra were recorded in 
fourier transform mode using a 400MHz nominal frequency (1H NMR) and 100MHz 
(13C NMR). Chemical shifts (δ) are recorded in parts per million (ppm), referenced to 
either a residual solvent peak or the tetramethylsilane internal standard as 
indicated. Coupling constants are reported in hertz. Abbreviations: br, broad; s, 
singlet; d, doublet; m, multiplet; dd, doublet of doublets; td, triplet of doublets; dt, 
doublet of triplets; br, broad; gem, geminal; ovlp, overlapping.  
4.5.8.1 – 11-oxo,24-hydroxy-β-amyrin 
Prior to NMR, semi-preparative HPLC purification of 4.2mg 11-oxo, 24-hydroxy-β-
amyrin was performed by Dr Michael Stephenson using the same method as in 
section 4.5.7.1. NMR was performed in deuterated pyridine (pyridine-d5) and 
referenced to the most downfield residual solvent peak (1H δ 8.74, 13C δ 150.35). 
Full assignment of the compound is given in Table 4-5.  
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Table 4-5: NMR assignments for 11-oxo,24-hydroxy-β-amyrin in pyridine d5. Carbon atom 
numbering is as detailed in the structure above the table. Abbreviations are as detailed 
above in section 4.5.8 and specific details of the method are detailed in section 4.5.8.1 
 
 
Atom 
number
13
C δ
(ppm)
13
C 
Multiplicity
1
H δ
(ppm) Integration
1
H 
Multiplicity JHH (Hz) COSY HMBC
11 200.03 C / / / / / /
13 170.62 C / / / / / /
12 128.88 CH 5.80 1 s / / 9, 14, 18
3 80.33 CH 3.70 1 dt 11.8, 4.4 2, COH /
24 64.98 CH2
[3.78] 
[4.78]
[1]
[1]
[dd]
[dd]
[10.5, 8.4]
[10.8, 1.9]
gem, C24-
OH
3, 23
9 62.67 CH 2.54 1 s / / 8, 10, 11, 25, 26
5 56.43 CH 1.01 1 m (ovlp) / 6 /
18 48.17 CH 2.14 1 m (ovlp) / / /
8 46.08 C / / / / / /
19 45.75 CH2
[1.67] 
[0.99]
[1]
[1]
[m (ovlp)]  
[m (ovlp)]
/ / /
14 44.09 C / / / / / /
4 44.02 C / / / / / /
1 40.08 CH2
[3.23]
[1.22]
[1]
[1]
[dt]                                 
[m (ovlp)]
[13.3, 3.5]
[/]
[2]
[/]
/
10 37.86 C / / / / / /
22 37.18 CH2
[1.42]
[1.23]
[1]
[1]
[m (ovlp)] 
[m (ovlp)]
/ / /
21 35.03 CH2
[1.40]
[1.11]
[1]
[1]
[m (ovlp)]   
[m (ovlp)]
/ / /
7 33.75 CH2
[1.64]
[1.33]
[1]
[1]
[m (ovlp)] 
[m (ovlp)]
/ / /
29 33.52 CH3 0.91 3 s / / 19, 20, 21, 30
17 32.97 C / / / / / /
20 31.55 C / / / / / /
28 29.21 CH3 0.85 3 s / / 16, 17, 18, 22
2 28.94 CH2
[2.22]
[1.98]
[1]
[1]
[m (ovlp)]    
[m (ovlp)]
/
[3]
[3]
/
15 27.13 CH2
[1.71]
[1.07]
[1]
[1]
[m (ovlp)]   
[m (ovlp)]
/ / /
16 26.96 CH2
[2.01]
[0.86]
[1]
[1]
[m (ovlp)]   
[m (ovlp)]
/ / /
23 24.08 CH3 1.60 3 s / / 3, 4, 5, 24
30 23.95 CH3 0.87 3 s / / 19, 20, 21, 29
27 23.95 CH3 1.36 3 s / / 8, 13, 14, 15
26 19.17 CH3 1.13 3 s / / 7, 8, 9, 14
6 18.82 CH2
[1.77]
[1.52]
[1]
[1]
[m (ovlp)]   
[m (ovlp)]
/
[/]
[5]
/
25 17.79 CH3 1.36 3 s / / 1, 5, 9, 10
COH / / 6.73 1 d 4.7 3 /
C24-OH / / 5.39 1 dd 8.2, 2.2 24 /
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4.5.8.2 – 11-oxo-oleanolic acid 
11-oxo-oleanolic acid was analysed in deuterated DMSO (DMSO d6) – referenced 
to the residual solvent peak at 2.50ppm. 1H NMR spectrum was consistent with 
previously-reported literature [185]. δ 12.40 (1H, brs), 5.44 (1H, s), 4.31 (1H, d, J= 
5.1), 3.01 (1H, td, J=11.4, 5.1), 2.85 (1H, dd, J= 13.7, 4.1), 2.60 (1H, dt, J= 13.4, 
3.3), 2.30 (1H, s), 2.14-0.69 (18H, m) 1.34 (3H, s), 1.01 (3H, s), 0.91 (3H, s), 0.90 
(3H, s), 0.89 (3H, s), 0.87 (3H, s), 0.68 (3H, s). Abbreviations are as detailed in 
section 4.5.8. 
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5.1 – Introduction 
Natural products have proven to be highly important for development of 
pharmaceutical products [186]. Triterpenes have a long history of medicinal use 
[187] and are believed to be the major bioactive constituents of medicinal plants 
such as ginseng [44] and liquorice [47, 180]. Simple triterpenes are also abundant in 
commonly consumed fruits and herbs [188] and have a diverse range of activities, 
showing particular promise as anti-cancer and anti-inflammatory agents [48, 189].  
Inflammation is an important physiological process that occurs in response to tissue 
damage and infection. This process involves the localised release of cytotoxic 
components such as reactive oxygen species (ROS) [190, 191].  These cytotoxins 
are beneficial for killing potential pathogens; however they can also cause tissue 
damage. Consequently, inflammation is typically a transient process that subsides 
to allow for subsequent tissue repair. Prolonged aberrant inflammation is a hallmark 
of a number of diseases including arthritis and asthma, and can be a causative 
factor in the development of malignancies [192, 193]. Thus therapeutics aimed at 
targeting both the inflammatory processes and the cancer cells themselves are a 
promising avenue for drug development. Triterpenes have frequently been shown to 
down-regulate pro-inflammatory targets and upregulate cellular detoxification 
mechanisms, as well as showing selective toxicity towards cancer cells. These 
compounds therefore offer significant promise as a safe and effective class of 
therapeutic agents for the treatment of inflammatory disorders and malignancies 
[48, 50, 187, 189]. 
Most naturally occurring triterpenoids are not considered potent enough to be 
deployed therapeutically. Hence there is a need to understand the structural 
features underlying bioactivity and improve upon the therapeutic potential of these 
molecules. Although some efforts have been made in this area [40, 194, 195], 
detailed understanding is lacking. The chemical complexity and vast structural 
diversity of naturally occurring triterpenes exacerbates this problem and the lack of 
availability of suites of closely related structural variants has hampered a systematic 
approach. Currently, the most detailed understanding of structure-function 
relationships for triterpenes has resulted from synthetic derivatisation of common 
starting scaffolds. For example the synthetic triterpene 2-cyano-3,12,-dioxooleana-
1,9(11)-dien-28-oic acid (CDDO - hereafter referred to by its generic name 
bardoxolone) was developed from the naturally occurring β-amyrin-derived 
triterpene oleanolic acid, which has weak anti-inflammatory and anti-cancer activity, 
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using a synthetic chemistry approach [57] (Figure 5-1). Bardoxolone and other 
related synthetic analogues were found to be highly potent anti-inflammatory agents 
capable of upregulating the ‘phase 2’ antioxidant response [196] and inhibiting pro-
inflammatory mediators, including nuclear-factor-kappa-B (NFκB) [197]. 
 
 
Figure 5-1: Synthetic triterpenes from β-amyrin. The structures of the simple triterpene 
scaffold β-amyrin, its C-28 acid (oleanolic acid) and the synthetic derivative bardoxalone 
methyl are shown. The synthetic modifications to oleanolic acid are highlighted in red.  
 
Stage III clinical trials of bardoxolone methyl for the treatment of chronic kidney 
disease and type 2 diabetes were ultimately terminated due to an increased risk of 
heart failure. Later analyses determined a key subpopulation of patients who were 
‘at risk’, including those who had previously been treated for heart conditions [198, 
199]. This allowed future trials to avoid this group of patients. Further phase II trials 
in this area are now underway in Japan (ClinicalTrials.gov identifier - 
NCT02316821). Bardoxolone also shows potential as a treatment for pulmonary 
arterial hypertension with phase II trials currently underway in the US 
(NCT02036970). The clear potential of bardoxolone methyl has prompted significant 
interest in the further development of triterpenes as therapeutics.  
Considerable advances have been made in our understanding of triterpene 
biosynthesis over the last few years, including for several medicinally important 
plant species [88, 98, 100, 103].  This provides a unique opportunity to utilise these 
enzymes to produce and selectively functionalise a range of structurally distinct 
scaffolds in a manner which is currently difficult or impossible using synthetic 
chemistry. In Chapter 4, triterpene oxidases from various plant species were 
expressed in N. benthamiana to give a series of oxidised derivatives of the common 
triterpene scaffold, β-amyrin.  This enzymatic toolkit opens up opportunities to 
deconstruct the complexity of naturally occurring triterpenes and build a systematic 
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understanding of the structural features underlying bioactivity as well as providing 
novel scaffolds for chemical derivatisation. 
 
5.2  – Aims 
Many triterpenoids are known to have anti-inflammatory and anti-proliferative 
activity. However the structural features that govern these activities are poorly 
understood. Recent advances in understanding the biosynthesis of triterpenoids in 
plants provides a means to produce these molecules in heterologous hosts. This 
offers a means to obtain previously inaccessible structures and build a systematic 
understanding of the features underlying activity. To take a first step towards this 
goal, in this chapter a suite of structurally related analogues of oxidised β-amyrin 
are generated by heterologous expression in N. benthamiana and purified in 
milligram quantities.  The bioactive properties of these compounds are then 
compared for anti-proliferative and anti-inflammatory activity using a range of 
human cancer cell lines.  
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5.3 - Results and discussion 
5.3.1 - Obtaining a series of oxidised β-amyrin derivatives  
In Chapter 4, co-expression of β-amyrin synthase in combination with different β-
amyrin oxidases (P450s) in the N. benthamiana transient expression system was 
used to generate a series of β-amyrin derivatives that differed in the type and 
position of oxidation.  This suite of P450s allowed modification of the β-amyrin 
scaffold at six different positions (Figure 5-2, centre). The products included 
oleanolic acid and other oxygenated forms of β-amyrin.  The triterpene biosynthetic 
toolkit established in the Osbourn lab also contains enzymes enabling production of 
other structurally diverse triterpenes including protopanaxadiol, a bioactive 
triterpene produced by Panax (ginseng) species (Figure 5-2, right). This enzyme 
toolkit provides an invaluable resource for generating structural analogues, enabling 
for the first time a systematic investigation of structure-activity relationships within 
the triterpenes.  
 
Figure 5-2: Structures of oxidised forms of β-amyrin investigated in this study. The β-amyrin 
scaffold is shown in the centre with carbons that were shown to be oxidised by P450s in 
Chapter 4.  The non-β-amyrin-based ginsenoside triterpene dammarenediol-II (61) was also 
included in this study (shown on the right.  The numbering of the compounds is as in 
Chapter 4. * These compounds were purchased commercially but are known to be products 
of CYP716A12 [97] (section 4.3.1.1). Abbreviations: βA – β-amyrin.  
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Based on the activity of the P450s characterised in Chapter 4, a set of eight 
oxidised forms of β-amyrin (1) were selected for investigation (Figure 5-2). These 
compounds included the product of the CYP51H10 enzyme, 12,13β-epoxy,16β-
hydroxy-β-amyrin (EpHβA (2)); the CYP716A12 products, the C-28 alcohol 
(erythrodiol (3)) and carboxylic acid (oleanolic acid (5));  the C-24-hydroxylated (6) 
and C-30-hydroxylated (17) forms of β- amyrin, produced by CYP93E1 and 
CYP72A65, respectively; and two C-11-oxidised forms of β-amyrin, 11-α-hydroxy-β-
amyrin (12) and 11-oxo-β-amyrin (13), which are produced by CYP88D6. Finally, 
the A354L mutant form of CYP51H10 was selected to allow production of the C-
16β-hydroxylated form of β-amyrin (53) (Figure 5-2). A full list of the compounds 
and constructs used to generate them is given in Table 5-1. 
# Compound Constructs 
# Plants 
(DW) 
Yield 
(total) 
Yield  
(per g DW) 
1 β-Amyrin Purchased - - - 
2 EpHβA 
tHMGR/AsbAS1/ 
CYP51H10 
70 
(20.4 g) 
79 mg 3.87 mg 
3 Erythrodiol  Purchased - - - 
5 Oleanolic acid Purchased - - - 
6 
24-Hydroxy-  
β-amyrin 
tHMGR/AsbAS1/ 
CYP93E1 
17 
(3 g)  
4.7 mg 1.56 mg 
12 
11α-Hydroxy-  
β-amyrin 
tHMGR/AsbAS1/ 
CYP88D6 
23 
(10.4 g) 
7 mg 0.67 mg 
13 
11-Oxo-  
β-amyrin 
tHMGR/AsbAS1/ 
CYP88D6 
23 
(10.4 g) 
10.4 mg 1 mg 
17 
30-Hydroxy-  
β-amyrin 
tHMGR/AsbAS1/ 
CYP72A65 
30 
(19 g) 
6.5 mg 0.34 mg 
37 
11-Oxo, 
24-hydroxy- 
β-amyrin 
tHMGR/AsbAS1/ 
CYP88D6/ 
CYP93E1 
112 
(18.5 g) 
41 mg 2.2 mg 
45 
11-Oxo-  
oleanolic acid 
tHMGR/AsbAS1/ 
CYP716A12/ 
CYP88D6 
141 
(70 g) 
46 mg 0.66 mg 
53 
16β-Hydroxy-  
β-amyrin 
tHMGR/AsbAS1/ 
CYP51H10-A354L 
45 
(17.9 g) 
6.6 mg 0.37 mg 
61 Protopanaxadiol 
tHMGR/AsbAS1-
S728F/CYP716A47 
90 
(31 g) 
18 mg 0.58 mg 
63 
Glycyrrhetinic 
acid 
Purchased - - - 
 
Table 5-1: Triterpenes tested in the present study. Compounds are numbered as in Chapter 
4. Where compounds were purified from N. benthamiana, the combination of A. tumefaciens 
strains (OSCs and P450s) are indicated under ‘Constructs’ (compounds 1, 3, 5 and 63 were 
purchased from commercial suppliers). The number of plants and purified yield of compound 
are provided here for quick reference. Further detail on purification methods of individual 
compounds is provided in the methods sections. Supplier information is given in section 
2.1.6.1. Abbreviations: DW, Dry weight; EpHβA, 12,13β-epoxy,16β-hydroxy-β-amyrin. 
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With the exception of erythrodiol (3) and oleanolic acid (5), none of these oxidised 
forms of β-amyrin are available to purchase commercially, therefore these 
compounds were accessed by production in N. benthamiana.  In Chapter 3, 
strategies to enhance the production capacity of N. benthamiana were explored. 
This demonstrated that tHMGR (a truncated form of the MVA pathway rate-limiting 
enzyme 3-hydroxy, 3-methylglutaryl-CoA reductase) could significantly increase 
yields of both simple and oxidised triterpenes in transient expression experiments in 
N. benthamiana. Using this strategy, over 70mg of pure EpHβA (2) was obtained by 
co-expression of tHMGR with the oat β-amyrin synthase (AsbAS1) and the 
CYP51H10 oxidase in N. benthamiana (section 3.2.5). This strategy was therefore 
employed to obtain sufficient quantities of the other oxidised derivatives for use in 
bioassays.  Separate A. tumefaciens strains harbouring tHMGR, AsbAS1 and 
individual P450 expression constructs were co-infiltrated into N. benthamiana 
leaves in order to generate the relevant compound (Table 5-1). This enabled 
purification of β-amyrin derivatives 6, 12, 13, 17 and 53 (Figure 5-2). Full details 
concerning infiltration and purification of individual products are given in method 
section 5.5.1. Verification of the products was performed by GC-MS analysis of the 
purified compounds 6, 12, 13, 17 compared to previously published spectra [98-
100]. The structure of 53 has been verified by NMR analysis (Prof Robert Minto, 
personal communication). GC-MS chromatograms of the purified compounds 
versus the crude N. benthamiana extracts are given in Supplementary Figure 22-
Supplementary Figure 26. 
Finally, the tetracyclic triterpene dammarenediol-II (DM-II) was produced by 
expression of a mutant enzyme AsbAS1-S728F [137] (also see section 4.3.5). 
Conversion of this product to the ginsenoside triterpene protopanaxadiol 61 (Figure 
5-2 right) was then achieved by coexpression of this enzyme with CYP716A47 [103] 
(section 4.3.5). Protopanaxadiol was purified from N. benthamiana leaves 
expressing tHMGR/AsbAS1-S728F/CYP716A47 by Dr Michael Stephenson and Dr 
Ramesha Thimmappa, Osbourn lab. This compound was also included in the 
bioassays, giving a total of ten test compounds (Figure 5-2).  
5.3.2 – Investigating anti-proliferative activity 
A common means of assessing the activity of a test compound is to measure its 
ability to inhibit the growth of cells when incubated across a range of concentrations. 
The concentration at which a test compound inhibits cell growth by 50 percent 
relative to controls (IC50) can subsequently be calculated. For structure-activity 
studies, comparison of IC50 values between compounds provides a simple means to 
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ascertain the relative potency of individual modifications. Therefore the anti-
proliferative activities of the ten compounds shown in Figure 5-2 were tested on a 
range of human cancer cell lines. The cell proliferation assay utilises MTS (5-[3-
(carboxymethoxy)phenyl]-3-(4,5-dimethyl-2-thiazolyl)-5-[(phenylamino)-carbonyl]-
2H-tetrazolium inner salt), a tetrazolium reagent that undergoes a colour change 
upon reduction to a formazan product. This reduction depends on NADH (or 
NADPH), which is produced by actively respiring cells. MTS reduction is facilitated 
by use of phenazine methyl sulphate (PMS) as an intermediate electron acceptor, 
since MTS has poor cellular permeability [200] (Figure 5-3). The formation of the 
formazan product can be measured by absorption at 490nm and provides a simple 
readout for ascertaining cell proliferation.  
 
 
Figure 5-3: Schematic of the MTS assay, as used to detect actively respiring cells.  The 
reduction of MTS by NADH (via PES) creates a formazan product that absorbs strongly at 
490nm. Therefore the relative abundance of living cells can be quantified by measuring 
absorbance of the MTS reagent at this wavelength. 
 
The anti-proliferative effects of each of the ten compounds were evaluated using 
four different human cancer cell lines. These included MCF-7 (breast 
adenocarcinoma); HL60 (promyelocytic leukaemia); MIA PaCa-2 (pancreatic 
cancer); and M202 (melanoma). Due to the lipophilic nature of the simple 
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triterpenes, compounds were dissolved in dimethyl sulphoxide (DMSO) to make the 
relevant stock and serial dilutions.  A series of eight two-fold dilutions of each test 
compound were made with the aim of determining the IC50 values (methods 5.5.2). 
The synthetic triterpene bardoxolone methyl was included as a positive control, with 
the vehicle (DMSO) as a control. Cell lines were incubated for 72 hours in the 
presence of the test compounds at various concentrations prior to assessment of 
viability using the MTS assay (methods 5.5.4).  
Analysis of the results revealed clear differences in the relative activities of the 
various triterpenes tested.  Six of the test triterpenes, including β-amyrin, appeared 
to be completely inactive across the full range of concentrations tested.  However 
the remaining four showed clear dose-dependent anti-proliferative activity for the 
four cell lines tested. These compounds included the ginsenoside protopanaxadiol 
(61); the β-amyrin C-28 alcohol erythrodiol (3); the C-28 carboxylic acid (oleanolic 
acid (5); and 11-oxo-β-amyrin (13), which features a C-11 ketone. Some 
precipitation was evident after 72 hours at the highest concentrations tested 
(generally 100-200μM) owing to the poor water solubility of the triterpenes. However 
this was observed for all of the test compounds and is unlikely to account for the 
differences in observed activity between the different compounds. A summary of the 
IC50 values for these compounds is provided in Table 5-2. 
  M202 MCF-7 MIA PaCa-2 HL60 
Erythrodiol (3) 19.1 ± 4.9 15.9 ± 1.8 17.4 ± 3.1 23.7 ± 4.9 
Oleanolic acid (5) 44.6 ± 6.7 45.4 ± 3.8 50.5 ± 3.8 26.5 ± 6.7 
11-oxo-β-amyrin (13) 86.8 ± 37.3 64.8 ± 8.4 59.7 ± 24.0 26.3 ± 1.1 
Protopanaxadiol (61) 57.1 ± 34.8 48.5 ± 1.9 43.7 ± 13.7 27.9 ± 3.9 
Bardoxolone methyl 4.5 2.4 4.8 0.7 
 
Table 5-2: Antiproliferative effects of oxidised triterpenes. IC50 values (μM) are shown for the 
four cell lines.  The data are means of at least three biological and technical replicates in 
each of the cell lines (± SD), with the exception of bardoxolone methyl, for which only a 
single biological replicate (three technical replicates) was included. 
Erythrodiol (3) showed the strongest anti-proliferative activity for all four cell lines, 
with IC50 values in the region of 15-25 μM. Oleanolic acid (5) and protopanaxadiol 
(61) had similar IC50 values for each of the cell lines. 11-Oxo-β-amyrin (13) overall 
had the weakest anti-proliferative activity, with the exception of the HL60 cell line, 
where it was comparable with oleanolic acid. When comparing between cell lines, 
the four active compounds had similar IC50 values across the three adherent cell 
lines, M202, MCF-7 and MIA PaCa-2. Values were generally lower for the HL60 
cells for all compounds except erythrodiol for which the HL60 IC50 value was 
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highest. Finally, as expected, the IC50 values for these test triterpenes were several 
fold higher than the bardoxolone methyl control which was found to compare well 
with previous results in the O’Connell lab. Bardoxolone is reported to have a growth 
inhibitory range between 0.1µM and 1µM in most cell lines with up to 5µM required 
for inducing apoptosis [187]. Therefore these observed values are slightly higher 
than might be expected, but still within in a similar range. 
The IC50 values for the test triterpene compounds appear to compare well with 
previous studies where data was available. Oleanolic acid has previously been 
reported to have IC50 values of 28µM and 30µM after 72 hours incubation for MCF-7 
and HL60 cells respectively [201]. Erythrodiol has been reported to have an IC50 
value of 48.8µM after 72 hours in a human colon cancer cell line HT-29 [202] and 
18.3µM after 48 hours in a bladder cancer cell line (NTUB1) [203]. Furthermore,  a 
direct comparison between oleanolic acid and erythrodiol found that erythrodiol was 
generally more potent across a range of concentrations (0-100µM) between one 
and five days in MCF-7 cells [204]. 
There are relatively few studies examining the bioactivity of 11-oxo-β-amyrin. 
However this compound has been isolated from the tropical forest tree Duabanga 
grandiflora and found to have IC50 values between 35-66µM in six cancer cell lines 
including one leukaemia (MOLT-3) and five carcinoma lines (HuCCA-1, A549, 
HeLa, HepG2 and MDA-MB-231) [205]. 
Finally, for protopanaxadiol, IC50 values of 68.4 µM have been reported in MCF-7 
lines [206]. Similar ranges (20-78 µM) were also observed across a range of 
cancers from various tissues [206]. 
5.3.3 – Utilising combinatorial biosynthesis to further investigate structure-
function relationships 
Amongst the β-amyrin derivatives that showed activity in the anti-proliferation 
assays, the presence of the C-11 ketone and C-28 alcohol/acid functionalities on 
the β-amyrin scaffold appear to be important for activity. The effects of combining 
both of these modifications on a single scaffold was therefore investigated. The 
pairwise combination of CYP88D6 (C-11 oxidase) and CYP716A12 (C-28 oxidase) 
results in the production of 11-oxo-oleanolic acid (45) (section 4.3.2.3), which 
features both the C-11 ketone and the C-28 carboxylic acid (Figure 5-4). This 
compound is not commercially available, but had been purified from N. benthamiana 
as part of work for Chapter 4.  A positional isomer of 11-oxo-oleanolic acid can be 
purchased in the form of glycyrrhetinic acid (63). Glycyrrhetinic acid is one of the 
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active constituents of liquorice [47] and features the carboxylic acid at the C-30 
position instead (Figure 5-4). Hence glycyrrhetinic acid was also tested in parallel 
(Table 5-1). 
 
Figure 5-4: Additional products tested for antiproliferative activity. These compounds are the 
result of the action of two P450s (blue) on β-amyrin. The numbering of the compounds 
corresponds to the numbering scheme used in Chapter 4. Compounds 45 and 37 were 
produced in N. benthamiana in Chapter 4. * compound 63 was commercially purchased, but 
is known to be synthesised by the consecutive action of CYP88D6 and CYP72A154 [100]. 
Abbreviations: βA – β-amyrin. Species abbreviations are as listed in Figure 5-1. 
 
Both 11-oxo-oleanolic acid and glycyrrhetinic acid showed activity across each of 
the four cell lines. However, in most cases the IC50 values for these compounds 
were slightly lower than any of the four active compounds tested initially (Table 5-3). 
These tests were conducted at a similar time to the previous tests and are therefore 
expected to be directly comparable. Between the two, 11-oxo-oleanolic acid was 
less active than glycyrrhetinic acid in the four cell lines (Table 5-3). As above, IC50 
values were generally lower in HL60 cells versus the other three lines. This could be 
evidence of selectivity towards these cells, however given that this trend was 
consistent for most compounds; it may simply reflect a higher sensitivity of these 
cells. This is consistent with previous observations in the O’Connell lab. 
In Chapter 4, combinatorial biosynthesis in N. benthamiana also afforded the 
isolation of a second 11-oxo-β-amyrin derivative in the form of 11-oxo-24-hydroxy-β-
amyrin (37) (See Figure 5-4 and Table 5-1). This compound was therefore also 
tested against the HL60 cell lines as before. No antiproliferative activity was 
detected for this compound over the 72 incubation period (Table 5-3). Together, this 
suggests that while the presence of the ketone at C-11 can influence 
antiproliferative activity over β-amyrin alone, this is apparently dramatically 
influenced by the type and position of other modifications to the scaffold. 
 
3745 63
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  M202 MCF-7 MIA PaCa-2 HL60 
11-oxo- 
oleanolic acid (45) 
85.4 ± 13.3 154.4 ± 41.6 103.2 ± 16.3 30.6 ± 4.2 
18 β- 
glycyrrhetinic acid (63) 
59.2 ± 10.3 99.6 ± 21.3 75.0 ± 18.8 25.7 ± 2.9 
11-oxo,24-hydroxy- 
β-amyrin (37) 
NT NT NT >200 
 
Table 5-3: Antiproliferative activity of oxidised triterpenes. IC50 values (μM) ± standard 
deviation for additional test compounds (Figure 5-4). Results are average of at least three 
biological and technical replicates in each of the cell lines. NT = Not tested.  
 
Glycyrrhetinic acid (63) has previously been reported to have an IC50 of 38μM and 
25µM in HL60s after over 24 and 48 hours, incubation respectively [207] which 
compares well to the current values. It has also been reported to have an IC50 of 
32.4μM in MCF-7 cells after 48 hours, which is lower than observed here [208]. 
However other studies have reported an IC50 activity of 84.7µM in MCF-7 cells using 
a sulphorodamine B cytotoxicity assay after 96 hours in MCF-7 cells (and similar 
values in 14 other lines) [209]. Although this assay differs from the formazan-based 
assay as used here, these techniques are generally comparable when used as an 
end-point assay [210]. 
There appear to be few studies that have investigated the anti-proliferative activity 
of 11-oxo-oleanolic acid (45). Assefa et al noted that both 11-oxo-oleanolic acid (45) 
and oleanolic acid (5) had comparable IC50 values towards human melanoma SK-
MEL cells (average 131µM and 112µM, respectively) [211]. In the present study, the 
activity of 11-oxo-oleanolic acid (45) was comparable to oleanolic acid only for the 
HL60 line. In the other cell lines, 11-oxo-oleanolic acid (45) tended to be much 
weaker than oleanolic acid (5) in all cell lines including the M202 melanoma cell line.  
5.3.4 – Investigating the anti-inflammatory effects of oxidised β-amyrin 
compounds. 
The above investigation showed that simple modifications to the β-amyrin scaffold 
could have profound influences on the anti-proliferative activity of the molecules. A 
number of naturally occurring and synthetic β-amyrin derivatives have been 
demonstrated to have anti-inflammatory activity. Therefore this prompted an 
investigation of the potential anti-inflammatory properties of these compounds.  
Inflammation is triggered in response both to tissue damage and to the presence of 
foreign particles or organisms, including ‘pathogen-associated molecular patterns’ 
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(PAMPS) such as the bacterial endotoxin lipopolysaccharide (LPS) [190]. 
Monocytes serve a key role in detecting pathogens and coordinating the 
inflammatory response. LPS triggers a pro-inflammatory intracellular signalling 
cascade that culminates in release of pro-inflammatory cytokines, such as tumour 
necrosis factor alpha (TNFα). These cytokines are responsible for local recruitment 
and activation of macrophages and neutrophils to combat the immediate threat, as 
well as exerting systemic effects [190]. Thus one method of gauging the anti-
inflammatory potential of a test compound is to assess its ability to attenuate 
cytokine production in response to a pro-inflammatory stimulus. To this end, an 
enzyme-linked immunosorbent assay (ELISA) was used to measure the production 
of TNFα by THP-1 cells (methods 5.5.5.1). THP-1 cells are a human monocytic cell 
line that serve as a useful in vitro model system for this purpose as they have 
comparable behaviour to primary monocytes and rapidly respond to LPS stimulation 
[212].  
The compounds that had been tested for anti-proliferative activity in sections 5.3.2 
and 5.3.3 were then evaluated using the TNFα ELISA assay in order to ascertain 
their ability to suppress TNFα secretion in LPS-stimulated THP-1 cells. The cells 
were pre-incubated in the presence of 100 μM of each compound (or 100-200 nM 
bardoxolone methyl) for 30 minutes prior to treatment with LPS, and then incubated 
for a further three hours. The supernatants were frozen and analysed for TNFα by 
ELISA (methods 5.5.5). 
The compounds that were found to be inactive in the anti-proliferative assays 
(1,2,6,12,17,53) similarly showed little or no anti-inflammatory activity, with levels of 
TNFα production comparable to vehicle-only treated controls (Supplementary 
Figure 27). Amongst the compounds that had previously shown anti-proliferative 
activity, 11-oxo-β-amyrin (13), protopanaxadiol (61) and glycyrrhetinic acid (63) 
dramatically alleviated TNFα production at 100μM. 11-oxo-oleanolic acid also 
produced a consistent reduction in TNFα relative to the vehicle-only control, but was 
less effective than the other compounds. In contrast, erythrodiol did not appear to 
attenuate TNFα production (Figure 5-5). None of the compounds tested here 
appeared to be pro-inflammatory at 100μM, since TNFα was not detected in non-
LPS-treated samples (data not shown). 
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Figure 5-5:  TNFα production in LPS-stimulated THP-1 cells incubated with triterpenes. 
Cells were pre-incubated with 100 µM of each of the test compounds prior to LPS 
stimulation. Bardoxolone methyl was used at concentrations of 100 or 200 nM as indicated. 
TNFα production was quantified by ELISA after 3 hours and is shown relative to DMSO 
(vehicle)-treated control cells. Values are means of three biological replicates except 
oleanolic acid (5) and 11-oxo,24-hydroxy-β-amyrin (37), which due to time constraints show 
three technical replicates. Error bars show standard deviation. * denotes significant 
difference compared to the control group (p<0.05); ns, not significant.  
 
Work is currently ongoing to establish the dose-dependent anti-inflammatory 
response of the active triterpenes shown here. This will allow the relative potency of 
the anti-inflammatory compounds to be tested. Initial tests using protopanaxadiol 
(61) and glycyrrhetinic acid (63) have suggested that the concentration needed to 
alleviate the TNFα production by 50% is 47.6μM and 55.5µM respectively (Figure 
5-6). As demonstrated here, bardoxolone methyl is clearly inhibitory at 200nM, 
which demonstrates as expected that these simple triterpenes are significantly less 
potent than bardoxolone-methyl. However this analysis provides a useful 
benchmark with which to compare further compounds. 
T
N
F
α
p
ro
d
u
c
ti
o
n
(P
e
rc
e
n
ta
g
e
 o
f 
c
o
n
tr
o
l)
50
100
150
0
ns
ns
*
*
*
* * * *
Chapter 5 – Investigating structural features underlying triterpene bioactivity 
133 
 
 
Figure 5-6: Dose-dependent TNFα production following incubation with different triterpene 
concentrations. THP-1 cells following LPS treatment. Cells were preincubated with 
concentrations of Protopanaxadiol and glycyrrhetinic acid from 1-100µM as indicated. TNFα 
production was quantified after 3 hours and is shown relative to the DMSO (vehicle)-treated 
control cells. These data were used to calculate IC50 values.  
 
5.3.5 – Results summary: insights into structural features underlying activity  
When considering anti-proliferative activity, the results of the present study indicate 
that modifications at the C-28 position are important for activity, since both alcohol 
and acid functionalities at this position result in anti-proliferative activity. 
Modifications to the C-11 position also emerge as potentially important; while 11-
oxo-β-amyrin (13) showed anti-proliferative activity, 11α-hydroxy-β-amyrin (12) 
(Figure 5-2) was inactive, suggesting that hydroxylation at this position is less 
favourable than the ketone group. Triterpenes with hydroxyl groups at the C-16β 
(53), C-24 (6) or C-30 (17) positions of β-amyrin were also inactive. Combinatorial 
products containing the C-11 ketone with either a C-30 (glycyrrhetinic acid) or C-28 
carboxylic acid group were also anti-proliferative, although their activity appeared to 
be generally lower than the parent compounds in most cell lines. 
The general importance of the ketone moiety at the C-11 position in pentacyclic 
triterpenes has not yet been resolved. Goncalvez et al tested the cytotoxicity of 
various derivatives of asiatic acid (an α-amyrin scaffold containing a C-28 acid) 
towards HeLa cells [213]. The cytotoxicity of certain compounds was increased 
upon incorporation of this functionality, but for others, a decrease in activity was 
observed compared to the parent scaffold [213]. In another study, a series of 
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oleanolic acid-derived triterpenoids isolated from the Southeast Asian tree Styrax 
tonkinensis were tested in HL60s. Of these, oleanolic acid (5) was found to be the 
most potent antiproliferative compound (IC50~8.9µM). The presence of an additional 
C-6β hydroxyl group led to a moderate drop in activity (3-fold) while further 
presence of the C-11 ketone decreased antiproliferative activity more than 30-fold 
compared to oleanolic acid [214]. The C-11 ketone is present in glycyrrhetinic acid 
and has been suggested to be important for inducing oxidative stress in 
mitochondria resulting in membrane permeability transition and apoptosis [215]. 
Interestingly, 11-oxo-oleanolic acid (45)  has been found to induce apoptosis, while 
oleanolic acid (5) did not [211]. Equally however, the select removal of this group 
from glycyrrhetinic acid (63) had little effect on the overall antiproliferative activity 
across 13 cell lines compared to the parent compound and resulted in comparable 
levels of apoptosis [216]. Hence ascertaining the cellular or molecular mechanisms 
underlying the antiproliferative activity of these compounds will be an important 
future task to further qualify the mechanisms behind structural modifications. 
From an investigation of the anti-inflammatory activity, similar to the anti-proliferative 
assay, it was found that a β-amyrin scaffold featuring a C-11 ketone appears to be 
important. This was evident by the fact that three molecules tested here with this 
feature (11-oxo-β-amyrin (13), 11-oxo-oleanolic acid (45) and glycyrrhetinic acid 
(63)) all show some degree of anti-inflammatory activity. Glycyrrhetinic acid (63) is a 
well-known anti-inflammatory agent and a synthetic derivative has been marketed 
as carbenoxolone for the treatment of peptic ulcers. The biological activity of 63 is 
attributed to its ability to inhibit the activity of the 11β-hydroxy-steroid 
dehydrogenase 2 (11βHSD2) [47]. This enzyme is responsible for the inactivation of 
the steroidal hormone cortisol by conversion to cortisone, hence leading to higher 
levels of cortisol (Figure 5-7). Although this mechanism may be less relevant for in 
vitro cell cultures, glycyrrhetinic acid is also capable of binding directly to the 
mineralocorticoid receptor [47]. Accordingly, glycyrrhetinic acid was shown to inhibit 
LPS-induced production of TNFα in mouse RAW264.7 macrophages via the 
glucocorticoid receptor between 1-5µM [217]. Glucocorticoid signalling plays 
important physiological roles in reducing inflammation [218]. Hence it may be that 
the anti-inflammatory effects attributed to 13 and 45 likewise reflect an interaction 
with this signalling mechanism.  
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Figure 5-7: Mechanisms of glycyrrhetinic acid anti-inflammatory activity. Glycyrrhetinic acid 
(63) can inhibit the 11β-hydroxy steroid dehydrogenase 2 enzyme (11β-HSD) which is 
responsible for inactivation of cortisol. In addition, like cortisol it can also bind directly to the 
glucocorticoid receptor. 
Other mechanisms are also plausible for the anti-inflammatory activity of these 
compounds. For example, the α,β-unsaturated ketone (enone) present in the C-ring 
might allow conjugate addition to thiols in cysteine residues within proteins (Figure 
5-8). Several proteins use this as a redox-scavenging mechanism and amongst 
these is the Kelch-like ECH-associated protein 1 (Keap1). Keap1 is a negative 
regulator of the Nrf2 transcription factor, which is responsible for activating a 
number of ‘phase 2 response’ genes with antioxidant and detoxification functions 
[219]. Moreover, activation of Nrf2 also represses the activity of pro-inflammatory 
targets such as NFκB [219]. The Keap1-Nrf2 pathway has been heavily implicated 
in the function of bardoxolone-methyl with a critical role for enone functionalities [57, 
196]. In future, the relevance of the conjugate addition mechanism could be 
investigated by incubation with glutathione [220].  
 
 
Figure 5-8: Conjugate addition of C-ring enone triterpenes. Derivatives of β-amyrin with an 
α,β-unsaturated ketone at C-11 may react with thiols present in cysteines as may be found 
in proteins or glutathione (indicated as R-group). Interaction with such groups on the surface 
of redox-sensitive proteins (such as Keap-1) may underlie the anti-inflammatory activity of 
these molecules by activating cellular detoxification mechanisms. 
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5.4 – Conclusions and perspectives 
Understanding triterpene structure-activity relationships has been confounded by 
the huge structural diversity and complexity of triterpenoids isolated from natural 
sources. An alternative approach is the systematic modification of simple triterpenes 
using enzymes, allowing the importance of individual modifications to be tested 
directly.   
To demonstrate this latter approach, here N. benthamiana was used to express 
triterpene oxidases in order to generate a series of structural analogues of oxidised 
forms of β-amyrin. These were screened for anti-proliferative and anti-inflammatory 
activity to gain insight into the structural features that are important for these 
processes. Two modifications emerged as potentially important – the presence of a 
ketone at the C-11 position, and a carboxylic acid at C-28. Forms of β-amyrin 
containing these modifications inhibited proliferation of a range of cells and showed 
the ability to alleviate TNFα production in THP-1 cells.  
Combinatorial biosynthesis also allowed the effects of combining these 
modifications to be examined. Derivatives of 11-oxo-β-amyrin (13) containing 
carboxylic acids at C-28 (45), C-30 (63) or an alcohol at C-24 (37) were also 
examined. Derivatives of 11-oxo-β-amyrin with C-28 (45) or C-30 (63) carboxylic 
acids were also active in both proliferation and anti-inflammatory assays. However 
surprisingly incorporation of a C-24 hydroxyl group (37) appeared to completely 
abolish the antiproliferative activity observed for 11-oxo-β-amyrin, and similarly 
attenuated the anti-inflammatory response. 
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Figure 5-9: Possible future test molecules based on the results of this study. A) Compounds 
identified through combinatorial biosynthesis (Chapter 4) which are predicted to contain 
either the C-11 oxo or C-28 carboxylic acid functionalities. The P450s which resulted in 
these compounds are shown in blue. Numbering of compounds is as indicated in Chapter 4. 
B) Positions around the β-amyrin for which other oxidases (indicated in blue) are known. 
Enzymes indicated in magenta are those which do act directly on β-amyrin but require an 
oxidised form. CYP72A475 and CYP94D65 are detailed in Chapter 6. Further information on 
the other enzymes is detailed in Table 1-1. 
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It will be particularly interesting to investigate the activity of other products 
containing the C-11 or C-28 functionalities. Several such products emerged from the 
combinatorial biosynthesis work described in Chapter 4 (Figure 5-9A). Likewise, 
continued investigation into the effects of oxidation at other positions around the β-
amyrin scaffold is an obvious next step. Within the enzymes investigated in Chapter 
4, it was shown that oleanolic acid can be further oxidised with hydroxyls at the C-
2β and C23 positions (Supplementary Figure 18-19). Similarly, in the following 
chapter, an investigation into avenacin biosynthesis in A. strigosa highlights 
additional P450s with putative C-21, C-23 and C-30 oxidase activity. Other 
characterised enzymes which were not tested here should also allow other positions 
to be investigated (Figure 5-9B). As more β-amyrin oxidases continue to be 
characterised from other species, extensive targeted oxidation of this backbone will 
be possible.  
Furthermore, a number of β-amyrin oxidases have previously been shown to be 
active on other triterpene backbones [95, 97, 108]. Hence this opens the opportunity 
to extend this approach to other scaffolds. Indeed here protopanaxadiol was shown 
to be one of the most active molecules in both the anti-proliferative and anti-
inflammatory assays. Therefore the importance of the type of triterpene scaffold 
should be further investigated. 
N. benthamiana has proven to be an excellent system for the generation of 
triterpene analogues. As the molecular pathways underlying triterpene biosynthesis 
in the plant kingdom continue to be uncovered, an exciting array of previously-
inaccessible triterpenoids can be realised in this system. This approach holds the 
potential to greatly improve our understanding of structure-function relationships 
underlying triterpene bioactivity and to direct biosynthesis for production of drugs 
and other useful compounds.  
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5.5 – Materials and Methods for Chapter 5 
5.5.1 – Production and purifications of compounds from N. benthamiana. 
For all compounds, plants were infiltrated by hand (section 2.1.3.3) with strains of 
A. tumefaciens carrying tHMGR, AsbAS1 and p450s as detailed in section 2.1.3.2. 
The A. tumefaciens strains carried the relevant genes within the pEAQ-HT-DEST1 
expression vector as detailed in section 4.5.1 with the exception of strains carrying 
CYP88D6 and CYP93E1. Further information on these strains is given in section 
5.5.1.1. The infiltrated solution had a total OD600 of 0.6, giving an OD600 of 0.2 per 
strain. After 5 days, infiltrated leaves were harvested, processed and crude extracts 
were made as per section 2.1.4. The extracts were dissolved in toluene and loaded 
onto the specified column and run according to programs indicated in the relevant 
sections below. Where further techniques were performed such as decolourisation 
and/or recrystallization, these are detailed in sections 2.1.4.4 and 2.1.4.4. 
5.5.1.1 – Golden Gate vectors carrying CYP88D6 and CYP93E1 
The strains carrying the CYP88D6 and CYP93E1 vectors were created prior to and 
later replaced by those detailed in section 4.5.1.1. These constructs were created 
using a Golden Gate cloning strategy by Dr Aymeric Leveau according to Weber et 
al [135]. Briefly, the CYP88D6 and CYP93E1 genes were synthesised by the 
Engineering Nitrogen Symbiosis for Africa (ENSA) project (https://www.ensa.ac.uk/) 
with silent mutations introduced into the coding sequence to remove type II 
restriction enzyme sites [135]. Vectors were based on the Golden Gate level 2 
pAGM4723 backbone [135], and were constructed from Golden Gate level 1 vectors 
containing cassettes for a) the P450 flanked by CPMV-HT 5’ and 3’ UTRs under 
control of the 35S promoter and terminator and b) the P19 R43W mutant gene (for 
regenerating transgenic plants if necessary [221]) also under the control of the 35S 
promoter and terminator. A schematic of the T-DNA for these vectors is given in 
Figure 5-10. Vector sequences have been deposited with ENSA 
(https://www.ensa.ac.uk/) under the numbers EC81392 (CYP88D6) and EC81537 
(CYP93E1). 
 
Figure 5-10: Schematic of the T-DNA portion of pAGM4723 containing either CYP88D6 or 
CYP93E1 (represented by the blue GOI arrow).  
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5.5.1.2 – 30-hydroxy-β-amyrin 
30 plants expressing tHMGR/AsbAS1/CYP72A65 yielded 19g dry leaf material. 
Flash chromatography of the extract was performed using a SNAP KP-Sil 25g 
column (Biotage) according to program P-9 (Table 2-4). Fractions containing 30-
hydroxy-β-amyrin (as identified by TLC and GC-MS) were pooled and dried by 
rotary evaporation. This was resuspended in toluene and subjected to further flash 
chromatography using a SNAP ultra 10g column (Biotage) (program P-10) (Table 
2-4). This yielded 8.9mg of an orange solid. The orange impurity was removed by 
trituration in methanol (room temperature) to give a total of 6.5mg of a white 
amorphous solid. 
5.5.1.3 – 11-hydroxy- and 11-oxo- β-amyrin 
23 plants expressing tHMGR/AsbAS1/CYP88D6 yielded 10.4g dry leaf material. 
Flash chromatography of the leaf extracts was performed using a SNAP KP-Sil 25g 
column (Biotage) as according to program P-9 (Table 2-4). Fractions were analysed 
by GC-MS and TLC. Those containing 11-oxo-β-amyrin were pooled and likewise 
for 11-hydroxy-β-amyrin. The two semi-purified extracts each underwent further 
flash chromatography with a SNAP ultra 10g column (Biotage) according to program 
P-11 (Table 2-4) (performed twice for each). The fractions containing the respective 
metabolites were isolated and dried. This gave 7mg of off-white crystals of 11-
hydroxy-β-amyrin and approximately 20mg of a yellow solid containing 11-oxo-β-
amyrin. The 11-oxo-β-amyrin was further purified by recrystallization in hot ethanol 
to yield 10.4mg of white crystals with a further 9mg of yellow solid remaining. 
5.5.1.4 – 24-hydroxy-β-amyrin 
17 plants expressing tHMGR/AsbAS1/CYP93E1 yielded 3g dry leaf material. Flash 
chromatography of the extract was performed using a SNAP ultra 10g column 
(Biotage) according to program P-9 (Table 2-4). This was repeated twice and the 
fractions containing 24-hydroxy-β-amyrin (monitored by TLC/GC-MS), were pooled 
and dried, then dissolved in toluene. A second flash column was performed (SNAP 
ultra 10g column (Biotage)) by program P-11 (Table 2-4). The purest fractions 
containing 24-hydroxy-β-amyrin were pooled and dried to give 4.7mg of a white 
crystalline solid.  
5.5.1.5 – 16β-hydroxy-β-amyrin 
45 plants expressing tHMGR/AsbAS1/CYP51H10-A354L yielded 17.9g dry leaf 
material. Flash chromatography of the extract was performed using a SNAP ultra 
50g column (Biotage) according to program P-9 (Table 2-4). Fractions were 
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monitored by TLC and GC-MS and those containing the 16β-hydroxy-β-amyrin 
product were pooled and dried. These were dissolved in toluene and loaded onto a 
SNAP Ultra 10g cartridge (Biotage). Separation was achieved with a gradient 
according to program P-12 (Table 2-4). This gave an orange solid of which 
approximately 20mg was decolourised using activated charcoal (Sigma) and then 
recrystallized using hot ethanol to give 14mg of white crystals.  
5.5.1.6 – 12,13β-epoxy,16β-hydroxy-β-amyrin  
Please see section 3.4.8. 
5.5.1.7 – Protopanaxadiol 
Protopanaxadiol (PPD) was kindly supplied by Dr Michael Stephenson and Dr 
Ramesha Thimmappa. PPD was produced in N. benthamiana by the coexpression 
of tHMGR, AsbAS1, AsbAS1-S728F and CYP716A47. Approximately 90 plants 
were infiltrated by vacuum infiltration which gave 31g of leaf material after 
harvesting and freeze drying. The extract was saponified and extracted with ethyl 
acetate before drying. The extract was adsorbed onto silica gel and loaded onto a 
SNAP ultra 10g column (Biotage) and run manually under isocratic 25:75 ethyl 
acetate:hexane conditions to remove impurities. The mobile phase was then 
increased to 100% ethyl acetate over 3 column volumes and further run at 100% 
ethyl acetate to elute the product. Extracts were analysed by GC-MS and TLC to 
isolate fractions containing PPD. These were pooled and adsorbed onto silica gel 
and loaded onto a second SNAP ultra 10g column (Biotage). A gradient was 
performed according to program P-13 (Table 2-4). Recovered fractions were 
analysed by TLC to isolate those containing PPD. These were pooled and 
decolourised with activated charcoal followed by recrystallization with hot ethanol as 
in section 2.1.4.4. A single round of recrystallization resulted in 18mg of pure PPD 
with 119mg remaining of the semi-pure extract. 
5.5.2 – Preparation of compounds for assays 
Stock solutions of each of the compounds were made in sterile DMSO. Where 
possible, these were made to 20mM, though some were used at 10mM due to poor 
solubility. Stock solutions were vortexed vigorously and heated at 60°C for 10 mins 
to ensure solubility prior to the dilutions. A series of eight different stocks were made 
for each compound by two-fold dilutions in DMSO to give a stock concentrations 
ranging from 0.156mM to 20mM or 0.078mM to 10mM depending on solubility of the 
compounds in DMSO. These stock solutions were added as detailed below in the 
relevant assays. 
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Compound Name Formula Mass Stock Supplier 
Oleanolic acid C30H48O3 456.71 20mM Extrasynthese 
Erythrodiol C30H50O2 442.73 20mM Extrasynthese 
Protopanaxadiol C30H52O3 460.74 20mM - 
11-oxo-β-amyrin C30H48O2 440.71 20mM - 
11α-hydroxy-β-amyrin C30H50O2 442.73 20mM - 
30-hydroxy-β-amyrin C30H50O2 442.73 20mM - 
24-hydroxy-β-amyrin C30H50O2 442.73 10mM - 
16β-hydroxy-β-amyrin C30H50O2 442.73 10mM - 
EpHβA C30H50O3 458.73 10mM - 
β-amyrin C30H50O 426.73 10mM Extrasynthese 
11-oxo-oleanolic acid C30H46O4 470.69 20mM - 
Glycyrrhetinic acid C30H46O4 470.69 20mM Extrasynthese 
11-oxo,24-hydroxy-β-amyrin C30H48O3 456.74 20mM - 
 
Table 5-4: Compounds used for the MTS assays and ELISAs. Suppliers of compounds are 
detailed. Where suppliers are not given, the compound was purified from N. benthamiana as 
detailed in 5.5.1, except EpHβA (section 3.4.8), 11-oxo,24-hydroxy-β-amyrin (section 4.5.6) 
and 11-oxo-oleanolic acid (section 4.5.7). 
 
5.5.3 – Culture of human cell lines 
All cell lines were obtained from the European Collection of Authenticated Cell 
Cultures (ECACC). THP-1, HL-60 and M202 cells were cultured in RPMI 1640 
media (Hyclone), while MCF-7 and MIA PaCa-2 cells were cultured in DMEM media 
(Hyclone). All media was supplemented with 10% heat-inactivated bovine foetal calf 
serum (FCS - Hyclone), L-glutamine (2mM) and antibiotics (penicillin (100U/mL) and 
streptomycin (100µg/mL)) (Gibco). All cell cultures were maintained at 37°C in a 
humidified atmosphere with 5% CO2 and passaged every 3.5 days.  
5.5.3.1– Cell density measurements 
Cell density was measured using a Malassez haemocytometer. A 50µL solution of 
0.4% trypan blue was mixed with the cells in an equal ratio. 15µL of this was added 
to the haemocytometer for counting under a light microscope.  
For the adherent Mia PaCa-2, M202 and MCF-7 lines, cells first underwent 
trypsinisation. The media was removed and cells were washed in prewarmed 
Dulbecco’s phosphate-buffered saline (PBS, Gibco) for 10 seconds. Cells were then 
treated with a 0.25% trypsin/EDTA solution (Sigma) and incubated at 37°C for 2-5 
minutes before addition of 10mL fresh media. Following measurements of cell 
density as above, M202 and MCF-7 cells were diluted to 8x104/mL in RPMI 1640 
and DMEM media, respectively. MIA PaCa-2 cells were diluted to 5x104/mL in 
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DMEM media. All media contained Fetal Bovine Serum (FBS - Hyclone) plus 
glutamine and antibiotics as above. Cells were aliquoted into 96 well plates using 
100µL of cells in each well. Cells were further incubated overnight to allow for 
adherence.  
For suspension cell lines THP-1 and HL-60, cells were measured as above and 
adjusted to a final density of 3x105 cells/mL on the day of the assay by dilution in 
RPMI 1640 media as detailed in section 5.5.3. Cells were aliquoted into 96 well 
plates at 100µL per well to give a total of 3x104 cells per well. 
5.5.4 – MTS antiproliferation assay 
MTS assays were performed in 96-well plates under sterile conditions. The 
outermost wells contained 250µL water in order to maintain humidity and minimise 
media evaporation. For each plate, two compounds were assayed in triplicate 
across eight concentrations. 1µL of the appropriate stock concentration was added 
per 100µL well to give a 100-fold dilution from the original stock. Untreated and 
vehicle (DMSO)-treated controls were also included for reference. Finally, three 
wells containing media only were included in order to subtract media absorbance 
during measurement. 
After addition of the compounds, cells were incubated for 72 hours at 37°C (5% 
CO2). Following this period, the MTS reagent (Cell Titer 96 Aqueous non-radioactive 
assay, Promega) was prepared and 10µL was added to all wells (excluding 
outermost wells). Cells were returned to the incubator for 2.5-4 hours depending on 
the individual cell line. Finally, absorbance at 492nm was measured and the 
averaged media-only reading was subtracted from all wells. 
Data analysis was performed using GraphPad Prism software (version 5). IC50 
values were generated by using non-linear regression (log of treatment 
concentration versus response, variable slope, least squares method).  
5.5.5 – Anti-inflammatory assay 
THP-1 cells were grown as detailed in section 5.5.3. Cell density was measured 
and the cells were pelleted by centrifugation (1200 rpm, 7 min). Cells were 
resuspended in an appropriate volume of medium to give a final density of 1x106 
cells/mL. Cells were aliquoted into 24 well plates at 500µL per well to give 5x105 
cells per well. 2.5µL of the test compounds in DMSO were added to the wells (1 in 
200 dilution, giving 100µM final concentration in most cases) and incubated for 30 
mins at 37°C (5% CO2). After this time, to stimulate TNFα production, 1µL LPS 
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(0.5mg/mL stock in RPMI media) was added to the appropriate wells (1µg/mL LPS 
final). Cells were incubated as above for a further three hours. Finally supernatants 
were harvested by transferring cells to microcentrifuge tubes and centrifuging at 
2000rpm for 5 mins. Supernatants were transferred to fresh microcentrifuge tubes 
on ice and stored at -80°C until needed. 
5.5.5.1 – ELISA setup 
Solutions of the following reagents were prepared for the ELISA assay: 
Phosphate Buffered Saline (PBS) solution 
Per litre (pH 7.0): 
8g NaCl 
1.17g Na2HPO4 
0.2g KH2PO4 
0.2g KCl 
 
Coating buffer 
Per litre (pH 6.5): 
16.1g NaH2PO4 
11.8g Na2HPO4 
 
Wash buffer 
1L PBS (as above) 
50µL Tween-20 
 
Assay diluent 
90% Phosphate buffered saline solution 
10% Foetal bovine serum 
pH to 7.0 
 
Stop solution 
2N H2SO4 
 
5.5.5.2 – TNFα ELISA 
Determination of TNFα production was carried out in 96 well plates using a Human 
TNF ELISA kit (BD biosciences). Plates were coated in 100µL of human TNF 
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capture antibody diluted in coating buffer, sealed and stored overnight at 4°C. Cells 
were aspirated three times with wash buffer, blocked with >200µL assay diluent and 
incubated at room temperature for 1 hour. Cells were washed again three times in 
wash buffer before addition of samples. 100µL of supernatants from THP-1 cells 
were added (section 5.5.5) to the plate. Supernatants derived from LPS-treated 
cells were first diluted in assay diluent four-fold in media in order to bring these 
samples to within the range of the standard curve. A TNFα standard (BD 
Biosciences) was included across a two-fold serial dilution range from 500pg/mL to 
7.8pg/mL (diluted in PBS). This was used to generate the standard curve for each 
assay for determination of TNFα production. A pre-prepared 100pg/mL TNF 
standard was also included across all plates to ensure consistency of the assay 
between replicates. Plates were incubated at room temperature for 2 hours and 
then washed 5 times in wash buffer. 100µL of the detection antibody was added 
before sealing and incubating the plate at RT for 1 hour. After this period, the plate 
was washed again seven times with wash buffer, leaving the wash buffer in the 
wells for at least 30 seconds each time. 100µL of substrate solution (TMB substrate 
reagent kit, BD Biosciences) was added to each well and left in the dark for 30 
minutes before addition of 50µL stop solution. Plates were measured by absorption 
at both 450nm and 570nm and the value for 570nm was subtracted from the value 
for 450nm. 
Data analysis was performed using GraphPad Prism software (version 5). A linear 
regression analysis was performed on the TNFα standard and this was used to 
convert the absorbance values of test samples to pg/mL. The values were divided 
by the value for the DMSO + LPS-treated control to show relative TNFα production. 
These were averaged from three biological replicates. For statistical analysis, a one 
way ANOVA was performed with post-hoc analysis performed by Tukey’s multiple 
comparison test. 
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6.1 – Introduction 
6.1.1 – Saponins in Avena species 
The saponins are a structurally diverse group of triterpene and steroidal glycosides 
that serve as a major class of defensive agents in plants [33, 34, 39]. Saponins are 
distributed throughout the angiosperms, but are rarer in monocotyledonous species 
[37, 72] and largely absent from Graminaceous species, including most cultivated 
cereals [222]. Oats (Avena spp) are a notable exception due to their ability to 
produce antimicrobial triterpene saponins (avenacins). The avenacins confer 
defence against soil-borne pathogens such as Gaeumannomyces graminis var. 
tritici, the causative agent of ‘take-all’ disease. Indeed, oats are frequently used as a 
‘break crop’ to manage take-all and other diseases. An understanding of the 
biosynthesis of avenacins in oat offers the potential to engineer production of 
avenacins and other structurally related antimicrobial triterpenes into other important 
crops such as wheat for disease control. 
6.1.2 – Structure and biosynthesis of avenacins 
Four structurally related avenacins are present in oat, named A-1, B-1, A-2 and B-2 
(Figure 6-1A).  There are three major structural features common to all four 
avenacins, including a core oxidised β-amyrin skeleton, a C-3 branched 
trisaccharide and a C-21 acyl group (Figure 6-1A).  Other modifications to the β-
amyrin scaffold that are present in all four avenacins include several oxidations – 
namely, a β-hydroxyl group at C-16, an aldehyde at C-30, and a β-epoxide bridging 
C-12 and C-13. The four avenacins also all have the same trisaccharide moiety 
attached at the C-3 position, which consists of an α-L-arabinose linked at the 2 and 
4 positions to two β-D-glucose molecules [182]. Avenacins A-1 and A-2 differ from 
B-1 and B-2 in that they contain a hydroxyl moiety at the C-23 position. A second 
distinction is the type of acyl ester at the C-21 position, which may be either an N-
methyl-anthraniloyl group (A1 and B1) or a benzoyl group (A2 and B2) (Figure 
6-1A). Avenacin A-1 and B-1 are strongly UV fluorescent due to the presence of the 
N-methyl anthranilate group, while avenacins A-2 and B-2 are not (Figure 6-1B).  
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Figure 6-1: Avenacins in oat A) Structures of the oat avenacins. The four structural variants 
are distinguished by modifications at two positions, including the presence or absence of 
hydroxylation at C-23 and the type of acyl group present at C-21; N-methyl-anthranilate or 
benzoate B) Oat roots exhibit bright blue fluorescence under UV light due to the presence of 
the major avenacin, A-1. This fluorescence is restricted to the root tips (left) and lateral roots 
(middle) . Scale bars = 200µm. A root cross section shows that the fluorescence associated 
with avenacin A-1 is located in the epidermal cells (right). Scale bar = 50µm. Adapted from 
[29] and [223]. 
 
Avenacin A-1 is the major avenacin produced in oats [224]. The biosynthesis of 
avenacin A-1 depends on two converging pathways, one that synthesises the fully 
formed triterpene glycoside lacking the acyl group [des-acyl avenacin (DAA)], and 
the other that generates the N-methyl anthraniloyl-O-glucose acyl donor for addition 
at the C-21 position (Figure 6-2A). The first of these pathways is carried out 
between the endoplasmic reticulum (ER) and the cytosol. The second involves 
methylation and glycosylation of anthranilate to form the N-methyl anthraniloyl-O-
glucose acyl donor. These two pathways converge in the vacuole, where the N-
methyl anthranilate is conjugated to DAA at the C-21β position [225, 226].  At the 
start of this project five genes required for avenacin biosynthesis had been cloned 
and the encoded enzymes characterised. These include the β-amyrin synthase 
AsbAS1 (Sad1), which forms the triterpene scaffold, and the AsCYP51H10 β-amyrin 
A) 
B) 
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oxidase (Sad2),  responsible for initial oxidation of β-amyrin (Figure 6-2A) [85, 86, 
225-228]. Two additional genes include AsMT1 (Sad9) and AsUGT74H5 (Sad10) 
which encode a methyltransferase and glycosyltransferase, respectively, that make 
N-methyl-anthraniloyl glucoside from anthranilate [225, 228] (Figure 6-2A). Finally, 
AsSCPL1 (Sad7) encodes the serine carboxypeptidase-like acyltransferase that 
conjugates the acyl group to the triterpene scaffold [226] (Figure 6-2A). The 
enzymes responsible for oxidation at the C-21, C-23 and C-30 positions and for 
addition of the sugar chain at the C-3 position were unknown. 
6.1.3 – Approaches for discovering new Sad gene candidates. 
Elucidation of the avenacin pathway thus far has been facilitated by the 
establishment of a collection of avenacin-deficient mutants of A. strigosa following 
sodium azide mutagenesis, using a screen for loss of root fluorescence [38]. This 
work resulted in the identification of 8 independent saponin deficient (Sad) loci [38, 
227].  Four of these loci (Sad1, Sad2, Sad7 and Sad9) have been cloned and 
characterized and shown to encode AsbAS1, AsCYP51H10, AsSCPL1 and AsMT1, 
as described above [86, 225-228]. The remaining loci defined by genetic analysis 
had not yet been uncharacterized at the start of this project.  
Intriguingly, the loci for avenacin biosynthesis are genetically linked and form a 
biosynthetic gene cluster [94]. This cluster is the result of the independent 
recruitment of a number of unrelated genes from other parts of the genome during 
oat evolution and is not present in other related cereal species [92, 229, 230]. The 
first pathway gene to be cloned was AsbAS1. Establishment of a bacterial artificial 
chromosome (BAC) library for A. strigosa then facilitated identification of the four 
other characterized genes within the avenacin cluster by assembly and sequencing 
of a BAC contig  [86, 225, 226, 228]. These genes lie within a 200 kb region with no 
other obvious intervening genes [225] (Figure 6-2B). Further loci are known to be 
genetically linked to the cluster, but have not yet been characterised. Extension of 
the sequences flanking the cloned avenacin biosynthetic genes is therefore 
expected to reveal other candidate pathway genes. 
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Figure 6-2: Biosynthesis of avenacins in oat A) Proposed pathway for biosynthesis of 
avenacin A-1 in A. strigosa. Synthesis and oxidation of β-amyrin is believed to occur on the 
cytosolic face of the endoplasmic reticulum (ER). The oxidised scaffold is expected to be 
glycosylated prior to transport to the vacuole, where it is then conjugated to the shikimate 
pathway-derived N-methyl anthranilate group by the acyltransferase AsSCPL1. Enzymatic 
steps are indicated by red arrows, and transport by black arrows. B) The avenacin gene 
cluster. The five genes that have so far been shown to be involved in avenacin biosynthesis 
lie within a 200kb region of the oat genome. Additional biosynthetic loci defined by 
mutagenesis are also known to be linked to the cluster.  
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6.1.4 – Aims 
Acylation of the avenacins is an important modification required for antifungal 
activity. Conjugation of the acyl group requires functionalisation of the triterpene 
scaffold at the C-21β position, likely by P450-mediated hydroxylation. At present 
however, no C-21β oxidase has been identified in oat or any other species. 
Additionally, the enzymes responsible for oxidation of the triterpene scaffold at the 
C-23 and C-30 positions are unknown. Oxidation at these and other positions may 
also be important for antifungal activity [85, 224]. In this chapter, three A. strigosa 
P450s are implicated in avenacin biosynthesis. These findings represent an 
important advance in understanding biosynthesis of antimicrobial triterpenes in oat 
and will facilitate metabolic engineering of other crop plants for enhanced disease 
resistance.  Furthermore, these newly characterized triterpene oxidases offer an 
important addition to the suite of enzymes available for generating triterpenes in 
other species. This will be important for investigating structure-function relationships 
and creating novel antifungal saponins. 
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6.2 – Results and discussion 
6.2.1 – Identification of new avenacin P450 candidates  
All currently known β-amyrin oxidases are members of the cytochrome P450 
superfamily [171]. Thus a P450 was expected to be the most likely candidate for a 
C-21 hydroxylase in oat. The Osbourn lab has generated an oat root tip 454 
transcriptomic database [29] within which all of the known avenacin biosynthetic 
genes are represented. Thus this database was expected to contain the additional 
P450s required for avenacin biosynthesis. However the database contains a total of 
168 P450 sequences (Dr Jenni Rant, personal communication) which makes 
screening such a large number of candidates difficult. 
Recently, next-generation sequencing-based mapping of recombinant inbred lines 
(RILs) derived from crosses of Avena atlantica and A.strigosa was performed by Dr 
Tim Langdon (Aberystwyth University, Wales). This has allowed mapping of A. 
atlantica genomic sequence data to ‘bins’ which correspond to relatively large 
genomic segments. In collaboration with Dr Langdon, these bins were mined for 
known Sad genes. This gave a series of genomic contigs that could potentially 
harbour physically linked genes participating in avenacin biosynthesis. 
Identification of oat P450s which are both linked to known Sad loci and expressed in 
root tips allows the number of candidates to be considerably narrowed. Therefore, 
the A. atlantica genomic sequence contigs were used as search queries against the 
A. strigosa root tip 454 transcriptomic database [29] (methods 6.4.1). Eight P450 
sequences were identified in the A. strigosa root tip database using this approach, 
including the previously characterised CYP51H10 (Sad2) gene. The A. strigosa 
P450 sequences were submitted to the P450 nomenclature committee for 
assignment [82] and are listed in Table 6-1.  
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Name Clan 454 number Length (bp) 
CYP51H10/Sad2 CYP51 17168 1473 
CYP71E22  CYP71 23466/23468 1518 
CYP72A475 CYP72 18622/00941/00942 1608 
CYP72A476  CYP72 09269 1548 
CYP88A75  CYP85 13408/06752 1482 
CYP89N1  CYP71 18440 1485 
CYP706C45  CYP71 19837 1764 
CYP711A54  CYP711 06108/19967 1605 
    
Table 6-1: P450s identified in this study. The corresponding 454 contig numbers and 
predicted lengths of the protein coding regions are given.  
 
Avenacin biosynthesis is confined to the epidermal cells of oat root tips (Figure 
6-1B), and in accordance with this the five previously characterized Sad genes are 
expressed specifically in the root tips and not in other tissues [29, 86, 225-228]. 
Therefore, RT-PCR was used to investigate the expression profiles of the new 
candidate genes in root and shoot tissues of A. strigosa seedlings (methods 6.4.8). 
The AsbAS1 (Sad1) and CYP51H10 (Sad2) genes were included for comparison, 
along with the housekeeping gene glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH). 
The majority of the candidate genes could be successfully amplified by PCR in 
cDNA preparations from A. strigosa root tips, in accordance with their 
representation in the 454 database. However of the seven candidates, only two 
(CYP72A475 and CYP72A476) showed a Sad gene-like expression pattern, with 
strongest expression in the root tips and little or no expression in the elongation 
zone or shoots (Figure 6-3). Three of the other candidates (CYP71E22, CYP88A75 
and CYP711A54) were expressed at very low levels in the root tips. CYP706C45, 
CYP71E22, CYP89N1 and CYP88A75 also showed expression in the elongation 
zone and/or shoot (Figure 6-3). Thus, based on gene expression profiling, 
CYP72A475 and CYP72A476 are the most promising candidates for missing steps 
in avenacin biosynthesis.  
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6.2.2 – Expression of P450 candidates in N. benthamiana 
As previously mentioned, the A. strigosa CYP51H10 (Sad2) gene encodes the 
second enzyme in the avenacin biosynthetic pathway and converts β-amyrin to 
12,13β-epoxy, 16β-hydroxy-β-amyrin (EpHβA) [85]. To establish whether any of the 
seven new oat P450s were able to modify β-amyrin or EpHβA, the predicted full-
length coding sequences of the candidate genes were amplified from oat root tip 
cDNA for transient expression in N. benthamiana (performed by Dr Aymeric 
Leveau). This was successful for five out of seven candidates; however it was not 
possible to obtain full length products for CYP88A75 or CYP71E22, which is broadly 
in accordance with their poor amplification from root tip cDNA during the previous 
RT-PCR analysis (Figure 6-3). The five full length coding sequences were cloned 
into the pEAQ-HT-DEST1 vector and used to transform A. tumefaciens (methods 
6.4.4). Each candidate was then coexpressed either with AsbAS1 alone, or with 
AsbAS1 and CYP51H10. Additionally, tHMGR was included in all combinations to 
enhance the levels of the substrate and allow better identification of novel 
metabolites (Chapter 3).  
 
 
Figure 6-3: Analysis of the expression profiles of candidate P450 genes.  (Left) Avenacin 
production is restricted to the root tips (blue glow) and lateral roots (not shown). (Right) RT-
PCR expression profiling of candidate genes. The profiles of the previously characterized 
AsbAS1 (Sad1) and AsCYP51H10 (Sad2) genes were included as positive controls 
(indicated in blue), along with that of the housekeeping gene GAPDH (shown in green). RNA 
was extracted from 4 day old oat seedlings. Abbreviations: RT = root tip, WR = whole root, 
EZ = elongation zone, S = shoot. 
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Five days after infiltration with A. tumefaciens, N. benthamiana leaves were 
harvested and extracts analysed by GC-MS. Of the five candidates tested, none 
showed any activity on β-amyrin when coexpressed with tHMGR/AsbAS1 (data not 
shown). Similarly, CYP706C45, CYP89N1 or CYP711A54 showed no activity on 
EpHβA when coexpressed with tHMGR/AsbAS1/CYP51H10 (data not shown). This 
could be due to problems with expression of these enzymes in N. benthamiana.  
However, new products could be detected upon coexpression of either CYP72A475 
(15.5 mins) or CYP72A476 (15.0 mins) with tHMGR/AsbAS1/CYP51H10, 
suggesting that these enzymes had activity on EpHβA (Figure 6-4A). Furthermore, 
the new peak in the tHMGR/AsbAS1/CYP51H10/CYP72A475 sample was 
accompanied by a large decrease in the EpHβA peak compared to controls, 
suggesting that much of the EpHβA had been converted (Figure 6-4A). In contrast, 
EpHβA remained the major product in the tHMGR/AsbAs1/ CYP51H10/CYP72A476 
extract (Figure 6-4A). Analysis of the electron-impact (EI) mass spectra revealed 
that each of the new peaks had a nominal parent mass of m/z 690 corresponding to 
a hydroxylated form of EpHβA (Figure 6-4A). The difference in retention times 
indicated that each of the new products represents different hydroxylated forms of 
the EpHβA product. 
The avenacins are oxidised at up to five positions across the β-amyrin scaffold 
including a C-ring epoxide (C-12-C-13) and a D-ring hydroxyl (C-16), both of which 
are present in the EpHβA substrate. The remaining positions include E-ring 
aldehyde (C-30) and hydroxyl (C-21) groups, and an optional A-ring C-23 hydroxyl 
(present only in avenacins A-1 and A-2) (Section 6.1.2/Figure 6-1). Thus the C-21, 
C-23 and C-30 are the obvious candidate positions for oxidation. To investigate 
which modifications were likely to be present in the new products, the mass spectra 
were further analysed. The EI fragmentation of β-amyrin and related products is 
described in detail in section 4.1.2. Briefly, EI fragmentation of β-amyrin proceeds 
via a retro-Diels-Alder (rDA) mechanism, giving a characteristic ion at m/z 218 
(representing the C*DE rings) (Supplementary Figure 17) [173, 174]. An 
alternative fragmentation route results in a minor ion at m/z 279 and corresponds to 
the ABC* rings (with silylated C-3 hydroxyl) [162, 174]. The EpHβA mass spectrum 
also shows a prominent m/z 279 ion (ABC* rings) while the m/z 218 ion in β-amyrin 
(C*DE rings) shifts to m/z 322 due to the gain of the C-ring epoxide and the 
(silylated) C-16 hydroxyl group (Figure 6-4A and Supplementary Figure 17). 
Changes to these ions can thus inform the location of new modifications on the 
scaffold. 
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Figure 6-4: Analysis of N. benthamiana leaf extracts by GC-MS. A) Total ion 
chromatograms (TIC) of extracts from leaves expressing tHMGR/AsbAS1/ CYP51H10 
versus those expressing tHMGR/AsbAS1/CYP51H10/ CYP72A475 and  
tHMGR/AsbAS1/CYP51H10/CYP72A476. The EI mass spectra for the novel peaks in each 
sample are given to the right. Below are shown the putative structures of the new products. 
B) The novel product in tHMGR/AsbAS1/CYP51H10/CYP72A476 samples has a matching 
mass spectrum to a peak in tHMGR/AsbAS1/CYP51H10/CYP72A65 samples (Chapter 4, 
compound 36, Figure 4-8). This suggests the product may be a C-30 hydroxylated form of 
EpHβA. 
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Analysis of the novel peaks showed that both contain the m/z 279 ion but have lost 
the m/z 322 ion, together suggesting that neither enzyme oxidises the A-ring-
localised C-23 position (Figure 6-4A). A distinction between the remaining possible 
oxidations (C-21 and C-30) can be made due to the fact that hydroxyl groups 
located on methyl groups (as for C-30) are usually lost as TMSiOCH2• (loss of m/z 
103) whereas ring hydroxyls are lost as TMSiOH• (loss of m/z 90) [173]. 
Accordingly, the fragmentation of the peak at 15 min in the tHMGR/AsbAS1/ 
CYP51H10/CYP72A476 sample showed ions indicating the presence of a methyl-
localised hydroxyl group (Figure 6-4A). These ions were not present in the 
tHMGR/AsbAs1/CYP51H10/CYP72A475 sample, which instead showed losses 
consistent with ring-localised hydroxyl groups (Figure 6-4A). Together these 
observations suggest that the CYP72A475 may be a C-21 oxidase and the 
CYP72A476 is a C-30 oxidase, catalysing production of 12,13-epoxy,16,21-
dihydroxy-β-amyrin and 12,13-epoxy,16,30-dihydroxy-β-amyrin, respectively. 
In work described in Chapter 4, combinatorial biosynthesis of β-amyrin oxidases in 
N. benthamiana allowed for production of novel oxidised forms of EpHβA. In 
particular, coexpression of tHMGR, AsbAS1 and CYP51H10 with the M. truncatula 
C-30 oxidase CYP72A65 resulted in a novel peak putatively identified as 12,13-
epoxy, 16,30-dihydroxy-β-amyrin (section 4.3.2). Comparison of the mass spectra 
of this product with the novel product from tHMGR/AsbAS1/CYP51H10/ 
CYP72A476 revealed that the two mass spectra are very similar (Figure 6-4B). This 
offers further evidence that CYP72A476 is a C-30 oxidase.  
The apparent specificity of CYP72A475 and CYP72A476 for EpHβA over β-amyrin 
is evidence for their involvement in avenacin biosynthesis. However while 
CYP72A475 demonstrates almost total conversion of the EpHβA substrate, 
CYP72A476 converted only minor amounts. This could indicate that EpHβA is not 
the preferred substrate for the enzyme. Further coexpression of both P450s 
together with tHMGR, AsbAS1 and CYP51H10 was conducted, but new products 
were not detected (data not shown). This may suggest that CYP72A476 is poorly 
active in N. benthamiana or that none of the molecules synthesised here are good 
substrates for this enzyme. Other CYP72A enzymes (CYP72A224 and CYP72A1) 
have been shown to utilise glycosylated substrates [122, 231]. Identification of other 
enzymes in the avenacin biosynthetic pathway may allow the order of modifications 
to be better understood. 
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It is interesting to note that CYP72A476 apparently catalyses oxidation to a C-30 
alcohol, but not the aldehyde present in the four avenacins. P450-mediated 
formation of aldehydes occurs via the 2-step oxidation of methyl groups via an 
alcohol intermediate [232]. Sequential oxidation at a single position is often 
catalysed by a single P450, but it is equally possible that other unknown enzymes 
are required [233]. It is also possible that the aldehyde constituent is formed but 
subsequently reduced back to an alcohol by endogenous reductases in N. 
benthamiana. Similar activity has been noted previously; production of aldehyde-
containing precursors of artemisinin are converted to their respective alcohols when 
expressed transiently in N. benthamiana [234] or when fed exogenously to the 
closely related Nicotiana tabacum [235]. As such, it may be worth testing this 
enzyme in other systems such as yeast to see if additional metabolites can be 
detected.  
6.2.3 – CYP72A475 is synonymous with the Sad6 locus 
The above results suggested that CYP72A475 may be a C-21β oxidase. Absence 
of the C-21β hydroxyl group would prevent acylation at this position and cause a 
loss-of-fluorescence phenotype as used in the original mutagenesis screen [38]. 
Two of the avenacin-deficient mutants within the Osbourn group collection (#825 
and #1243) have recently been profiled by LC-MS by Dr Sam Mugford (John Innes 
Centre) and shown to accumulate a compound that is not present in the wild type 
S75 A. strigosa line (Figure 6-5). Genetic complementation analyses indicates that 
mutant lines #825 and #1243 are allelic, and are herein referred to as sad6 mutants 
(Prof A. Osbourn, personal communication).  
The compound accumulating in the sad6 mutants has a mass spectrum similar to 
that of des-acyl avenacin B, which accumulates in sad7 mutants (Figure 6-6, left) 
[226]. This suggests that this compound lacks the acyl group at C-21 and is missing 
an oxygen atom at one position. Further examination of the mass spectra revealed 
the presence of a group of four ions at m/z 435, 453, 471 and 489 (Figure 6-6, 
right). These have consistent mass differences of 18, likely representing the 
aglycone (m/z 489) and fragmentation products that have undergone sequential 
loss of hydroxyl groups as water (at C-3, C-16, C-21 and C-23, highlighted in red in 
Figure 6-6). This pattern can be seen in the product from the sad6 mutants as well 
as des-acyl avenacin B (sad7) (Figure 6-6, right). Des-acyl avenacin A by contrast 
contains five ions at m/z 433, 451, 469, 487 and 505 due to the presence of the 
additional C-23 hydroxyl group (Figure 6-6, right). Therefore the product in sad6 
mutant root extracts is expected to contain four hydroxyl groups. These should 
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include the C-3 and C-16 hydroxyl groups as the sad6 mutation affects a step 
downstream of EpHβA production. The C-23 is also likely to be present, owing to 
the difference in retention time between these products and des-acyl avenacin B 
(Figure 6-5). Therefore absence of the C-21 hydroxyl group is the most likely 
interpretation. This new compound is hereby named des-acyl, des-21-hydroxy-
avenacin A (Figure 6-5). 
 
  
Figure 6-5: LC-MS analysis of oat roots. Extracts of the wild type A. strigosa line S75,  a 
sad7 mutant, and the two sad6 (#825 and #1243) mutants are shown. The mutant numbers 
are as in Papadopoulou et al [38]. The numbers above the peaks are the retention times 
(minutes). The compound detected at 8.3 mins in mutants #825 and #1243 is likely to be 
des-acyl, des-21-hydroxy avenacin A based on the mass fragmentation pattern. Supporting 
mass spectra are given for these assignments in Figure 6-6. Data kindly provided by Dr 
Sam Mugford. 
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Figure 6-6: ESI mass spectra for compounds in root extracts of A. strigosa sad mutants. 
Left: sad6 mutants (#825 and #1243) accumulate a compound with similar mass spectrum 
to des-acyl avenacin B, (which accumulates in sad7 mutant roots), but different retention 
times (8.3 minutes vs 5.9 minutes respectively). Right: In-chamber fragmentation of the 
compounds can be observed, which results in loss of the trisaccharide at C-3. The aglycone 
can undergo further fragmentation with characteristic losses of m/z 18 (loss of the hydroxyl 
groups as water). The compound in #825 and #1243 plants is therefore expected to have 3 
hydroxyl groups. The lack of the acyl group implicates the C-21 hydroxyl group as being 
absent in the compound at 8.3 minutes. Data kindly provided by Dr Sam Mugford. 
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To genotype the two mutant lines, attempts were made to clone CYP72A475 from 
cDNA derived from root tissues of #825 and #1243 seedlings (methods 6.4.5.1). A 
PCR product of the correct size was amplified from the #1243 cDNA template, but 
not the #825 template. The product from the #1243 line was cloned and sequenced. 
This revealed a guanine-to-adenine substitution at position 1068 in mutant that is 
predicted to result in conversion of Trp356 to a premature stop codon (TGG  
TGA) (Figure 6-7A). The same mutation has also been identified from genomic 
sequencing of this line (Dr Aymeric Leveau, personal communication).  
To eliminate the possibility that sample preparation errors were responsible for the 
failure to amplify a product in #825, qPCR expression analysis of AsbAS1 and 
CYP72A475 was performed in wild type and the two mutant lines (methods 6.4.9). 
This revealed that CYP72A475 transcript levels were markedly reduced in #1243 
mutants compared to the wild type, which may be due to nonsense-mediated RNA 
decay [236] (Figure 6-7B). Again, no amplification product was detected for mutant 
#825, despite clear amplification of the AsbAS1 transcript. This is further evidence 
that the CYP72A475 is disrupted in these two mutant lines. Further recent analysis 
suggests that mutant #825 has undergone a deletion event in the region of the 
CYP72A475 gene (Dr Aymeric Leveau, personal communication). 
Taken together, these results suggest that the allelic sad6 mutants #825 and #1243 
both fail to hydroxylate the β-amyrin backbone at C-21, and that this is due to 
absence of a functional CYP72A475 gene. Oxidation of the C-21β position is a pre-
requisite for addition of the acyl group, which in turn is important for anti-fungal 
activity [225]. Accordingly, lines #825 and #1243 both show increased susceptibility 
to infection by the take-all fungus  Gaeumannomyces graminis var. tritici, 
highlighting the importance of this modification for disease resistance [38]. 
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Figure 6-7: Analysis of CYP72A475 in oat mutants #825 and #1243 A) Sequencing of the 
CYP72A475 transcript in the wild type (S75) and in mutant line #1243. The #1243 line 
carries a nonsense point mutation at position +1068 (GA). Sequence data for the wild type 
(S75) transcript was kindly provided by Dr Aymeric Leveau B) qPCR analysis of transcript 
levels of AsbAS1 and CYP72A475 in the wild type (S75) and the two sad6 mutants #825 
and #1243. The CYP72A475 transcript is abolished in #825 and dramatically reduced in 
#1243, while the AsbAS1 transcript can be readily detected in all lines. Expression levels are 
shown relative to #1243 AsbAS1 transcript and normalised to transcript levels for the oat 
elongation factor1-α (EF1-α) using the ΔΔCq method.  
 
6.2.4 – A CYP94D family member lies next to CYP72A475 
Genome sequencing of A. strigosa S75 is currently underway in collaboration 
between the Osbourn lab and the group of Professor Bin Han, (China).  Recent 
progress in this area has resulted in sequence data providing 89.4% coverage of 
the genome. This provided the opportunity to further explore the sequence 
surrounding the P450s characterised in this study.  
BLAST searches of this database were used to identify A. strigosa genomic 
scaffolds containing CYP72A475 and CYP72A476 (methods 6.4.10). In the A. 
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on a single scaffold 5947bp apart. However they were not represented on a single 
scaffold in the A. strigosa genome (v0.6) because of a gap in the assembly (Figure 
6-8A). Nevertheless, the two scaffolds that were retrieved extended the regions 
flanking the two P450s and were therefore searched for the presence of additional 
genes using GENSCAN [237]. This revealed two additional neighbouring genes. 
The first was identified as the UGT74H5/Sad10 homologue, UGT74H7. UGT74H7 
sits 17.6kb upstream of CYP72A476 (Figure 6-8A) and is also known to be 
expressed in root tips [228]. The second was a predicted P450 gene (assigned as 
CYP94D65) that was located 73.4 kb from the CYP72A475 gene (Figure 6-8A). 
CYP94D65 transcripts were also represented within the 454 transcriptomic 
database (contig 20449), indicating that this gene is likely to be expressed in A. 
strigosa root tips. qPCR profiling revealed that the expression profile of the 
CYP94D65 was similar to those of other Sad genes although expression levels in 
whole roots was somewhat higher  (Figure 6-8B). The similarity in expression 
pattern suggested that this gene may also have a role in avenacin biosynthesis. 
 
Figure 6-8: Clustering and coexpression of novel avenacin biosynthetic genes A) Schematic 
of the three oat P450s characterised in this study by analysis of genome sequence data. 
The red line between CYP72A475 and CYP72A476 represents the adjoining ends of the two 
A. strigosa scaffolds which are expected to be linked based on the sequence data from A. 
atlantica. These genes are expected to be located adjacent to the other known Sad genes 
based on genetic analysis (indicated in Figure 6-2B), but the intervening region has not yet 
been resolved. B) qPCR analysis of CYP72A476, CYP72A475  and CYP94D65  expression 
in wild-type (S75) A. strigosa seedlings. AsbAS1 and CYP51H10 are included as positive 
controls. Expression levels are shown relative to root tips and normalised using the ΔΔCq 
method to the oat elongation factor1-α (EF1-α). 
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6.2.5 – Product profiling of CYP94D65 
To determine a possible role in avenacin biosynthesis, the CYP94D65 gene was 
cloned from root cDNA into the pEAQ-HT-DEST1 vector and transformed into A. 
tumefaciens for transient expression in N. benthamiana (methods 6.4.4). As before, 
CYP94D65 was coexpressed with tHMGR/AsbAS1 and tHMGR/AsbAS1/ 
CYP51H10. In contrast to CYP72A475 and CYP72A476 which were inactive on β-
amyrin, GC-MS analysis of the tHMGR/AsbAS1/CYP94D65 sample revealed a new 
peak at 11.7 min. This was not present in a tHMGR/CYP94D65 control (Figure 6-9). 
Analysis of the mass spectra revealed a putative parent mass ion of m/z 586 
consistent with a hydroxylated β-amyrin. Furthermore, the most abundant ion was 
found to be m/z 218, which is also present in β-amyrin and represents the 
unmodified C*DE rings following rDA fragmentation [173]. Together, these 
observations indicate a derivative of β-amyrin hydroxylated within the ABC* rings 
(see section 6.2.2). Given that avenacins A-1 and A-2 contain a hydroxyl group at 
C-23, it is possible that CYP94D65 is a β-amyrin C-23 oxidase. This is also 
supported by the fact that A. strigosa sad2 mutants (lacking functional CYP51H10) 
have been reported to accumulate a mixture of β-amyrin and 23-hydroxy-β-amyrin 
and indicates that the C-23 hydroxylase can utilise β-amyrin as a substrate [238]. 
Comparison of sad2 mutant root extracts with the tHMGR/AsbAS1/CYP94D65 
sample showed that a peak within this sample had a mass spectrum identical to the 
putative 23-hydroxy-β-amyrin which could not be found in wild type controls 
(Supplementary Figure 28). This further supports the idea that CYP94D65 is a β-
amyrin C-23 hydroxylase.  
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Figure 6-9: Activity of CYP94D65 towards β-amyrin. GC-MS analysis of N. benthamiana 
leaves expressing tHMGR/AsbAS1/CYP94D65 are shown above. The total ion 
chromatograms (TIC) are displayed on the left, with EI mass spectra of labelled peaks to the 
right and below relevant chromatograms. The peak at 11.7 mins closely matches a peak in 
sad2 mutants (Supplementary Figure 28) which is believed to be 23-hydroxy-β-amyrin. 
Minor peaks at 12.1 and 12.7 minutes could also be observed which had putative parent 
ions at m/z 556. As described previously (section 4.3.2.2), these are likely artefacts of the 
extraction method resulting from transesterification of the product at 11.7 min. 
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For the sample containing tHMGR/AsbAS1/CYP51H10/CYP94D65, several new 
peaks could be seen relative to the control. The first of these coeluted with the 
EpHβA product at 12.9 mins, but had a clearly distinct mass spectrum, including a 
parent mass at m/z 690 suggesting a hydroxylated form of EpHβA (Figure 6-10). 
This spectrum was clearly distinct from either of the previous products of 
CYP72A475 and CYP72A476 and shared an ion at m/z 322 with EpHβA which (as 
described in Section 6.2.2) is suggested to be the C*DE rings. This product was 
therefore assigned putatively as 12,13β-epoxy, 16β, 23-dihydroxy-β-amyrin. The 
identity of the other peaks was less apparent. Two had likely parent masses of m/z 
660 (13.4 and 14.5 min), while a third had a mass of m/z 704 (14.3 min) (Figure 
6-10). The products with m/z 660 are likely to be the C-23-acetylated form of the 
EpHβA. The peak with m/z 704 is 14 mass units above the putative 23-hydroxy-
EpHβA and suggests that an additional carbonyl group may be present. However 
the overall resemblance of the spectrum to that of 23-hydroxy-EpHβA indicates that 
the additional group was likely to be in proximity to the 23-hydroxyl group. One 
possibility is that this compound is a C-23 carboxylic acid (Figure 6-10), however 
avenacins carrying this functional group do not appear to have been reported 
previously. Isolation of this product will be necessary to confirm its identity. 
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Figure 6-10: Formation of putative C-23 oxidised EpHβA in N. benthamiana. GC-MS total 
ion chromatograms (TIC) from leaf extract expressing tHMGR/AsbAS1/CYP51H10/ 
CYP94D65 are shown on the left side, with the mass spectra for indicated peaks to the right 
or below chromatograms. Predicted structures are given inset above the mass spectra. 
 
Finally, given that both CYP72A475 and CYP94D65 showed substantial oxidative 
capacity towards the EpHβA product, the compatibility of these enzymes was 
investigated. Analysis of extracts of N. benthamiana leaves coexpressing 
tHMGR/AsbAS1/CYP51H10/CYP72A475/CYP94D65 showed a peak at 15.6 min 
which coeluted with a similar peak in the tHMGR/AsbAS1/CYP51H10/CYP72A475 
control but had a unique mass spectrum (Figure 6-11). This product had a putative 
parent ion at m/z 778, which is in accordance with EpHβA plus 2 derivatised 
hydroxyl groups. Based on these results, it is suggested that that the new product 
may be 12,13-epoxy, 16,21,23-trihydroxy-β-amyrin. 
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Figure 6-11: Formation of novel products through transient expression of CYP94D65 with 
CYP51H10 and CYP72A475 in N. benthamiana. The total ion chromatograms are shown on 
the left side, with the mass spectra for indicated peaks to the right or below chromatograms. 
The major peak in the tHMGR/AsbAS1/CYP51H10/ CYP72A475/CYP94D65 sample 
coeluted with a peak in the control (15.6 mins). Predicted structures are inset above the 
mass spectra. 
 
In the last five years, members of the CYP94B and CYP94C families have been 
established as key players in jasmonate homeostasis [239]. Jasmonates are 
important plant hormones mediating responses to various environmental stresses 
such as wounding and pathogen infection. The C-12 oxidation of jasmonates by 
CYP94B3, CYP94C-1 and (to a lesser extent) CYP94B1 in A. thaliana has been 
shown to be an important mechanism for attenuating the jasmonate signalling 
response [233, 240-242]. It is likely that at least some of the same subfamily 
members are relevant to jasmonate inactivation in monocots [243]. The CYP94D 
family sits in a separate clade to the CYP94A, CYP94B and CYP94C families and 
its members are functionally uncharacterised [244]. The discovery here of 
CYP94D65 as an enzyme capable of oxidising β-amyrin suggests that (at least in 
oat), the CYP94D family may function in specialised metabolism. A fifth subfamily, 
CYP94E, is closely related to the CYP94D subfamily and is present exclusively in 
monocots [244]. Future characterisation of further monocot and dicot CYP94D 
members will be of interest to understand the functional evolution of this group. 
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6.3 – Conclusions and perspectives 
6.3.1 – P450s involved in avenacin biosynthesis. 
With the exception of CYP51H10, all of the currently known triterpene-oxidising 
cytochrome P450s are from dicot species (see Table 1-1). Here, three new 
triterpene-oxidising P450s were identified from oat and implicated in avenacin 
biosynthesis. CYP72A475 was found to be synonymous with the Sad6 gene 
(Section 6.2.3). It is expected that this P450 catalyses oxidation of the C-21β 
position of the triterpene scaffold allowing for acylation. At the time of writing, no 
other C-21β oxidase has yet been described. A second closely-related P450, 
CYP72A476, is expected to be a C-30 triterpene oxidase (Section 6.2.2). No A. 
strigosa mutants have yet been identified as deficient in this function, although they 
may be present amongst the uncharacterised sad mutants. Identification of such 
mutants may help to shed light on the importance of this functionality for antifungal 
activity. 
The third P450, CYP94D65 is likely to be the avenacin C-23 oxidase. One other 
P450 has previously been characterised as an oleanolic acid C-23 oxidase 
(CYP72A68v2). The CYP72 and CYP94 families are part of the CYP72 and CYP86 
P450 clans, respectively, and thus these enzymes have likely evolved their C-23-
oxidising activity independently (Figure 6-12). Interestingly, CYP94D65 appears to 
be the first triterpene oxidase identified within the CYP86 clan (Figure 6-12). This 
therefore raises questions about whether members of this clan may have wider 
significance in triterpene biosynthesis in monocots. 
Although the genome of A. strigosa has not yet been finalised, the three P450s 
investigated in this study are thought to be located across a 100kb region with no 
obvious intervening genes (Figure 6-8A). The CYP72A475/Sad6 gene is also 
known to be closely linked to the cluster [94]. The discovery of putative C-23 and C-
30 hydroxylases within the vicinity suggests the cluster encompasses at least two 
additional genes. Therefore at least eight unique genes are likely to be present 
within the avenacin cluster. 
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Figure 6-12: Phylogenetic tree of cytochrome P450s implicated in triterpenoid biosynthesis. 
The three oat P450s characterised in this study are highlighted in green. CYP72A475 and 
CYP72A476 cluster with other CYP72A subfamily members as expected. CYP94D65 
occupies a separate clade to the other characterised P450s including another C-23 oxidase 
(CYP72A68v2) and the two are found within different P450 clans. The tree was constructed 
using the Neighbour-joining method with 10,000 bootstrap replicates (bootstrap support 
shown as percentages). Gaps were eliminated from the data set. 
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These P450s offer an exciting opportunity to understand the intricate structure-
function relationships underlying the bioactivity of these molecules. A combinatorial 
approach may be used to generate avenacin analogues lacking one or more 
functional groups (Figure 6-13). This may also be facilitated by the recently-
generated mutant variants of CYP51H10 capable of producing either the C-12-13 
epoxide or C-16-hydroxyl group (see section 4.3.3). Furthermore, as demonstrated 
in section 4.3.2, P450s from other species may be used to extend the modifications 
beyond those found naturally in the avenacins. Such studies will be particularly 
informative for engineering antifungal saponin biosynthesis in vulnerable crop 
species.  
 
  
Figure 6-13: Combinations of oat P450s expressed in this study and the predicted products. 
Clockwise from top: EpHβA; 23-hydroxy-β-amyrin; 12,13β-epoxy,16β,23-dihydroxy-β-
amyrin; 12,13β-epoxy,16β,30-dihydroxy-β-amyrin; 12,13β-epoxy,16β,21β-dihydroxy-β-
amyrin;  12,13β-epoxy,16β,21β,23-trihydroxy-β-amyrin 
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6.4 – Materials and Methods for Chapter 6 
6.4.1 – Identification of P450 candidates 
Genomic sequence data from A. atlantica were kindly provided by Dr Tim Langdon. 
The entire genomic scaffold sequences (approximately 5-50kb each) were used as 
queries to search (by BLASTn) against the A. strigosa 454 root tip transcriptomic 
database. This allowed identification of orthologous A. strigosa genes which were 
expressed in the root tips. The A. strigosa contigs with the lowest e-values were 
selected (typically e = zero). These were in turn used as BLAST queries against the 
Genbank database to ascertain the relevant enzyme families. Non-P450 enzymes 
were subsequently eliminated from the list of candidates. Sequences from the oat 
454 database were translated in all 6 reading frames to identify the expected coding 
sequence (http://web.expasy.org/translate/). 
6.4.2 – Growth and harvesting of A. strigosa seedlings 
Seeds of A. strigosa were dehusked by hand and sterilised using a 5% sodium 
hypochlorite solution for 5 minutes. The following steps were performed in a sterile 
laminar flow hood. The seeds were washed multiple times using sterile water and 
air dried on sterile filter paper. Seeds were transferred to distilled water agar 
medium in 10cm petri dishes with the radicle facing towards the bottom of the plate. 
Plates were stored at 4°C in the dark for 24 hours before transfer to a growth 
cabinet (22°C constant, 16 hour lighting). Seedlings were incubated for 4-7 days 
depending on rate of growth.  
For harvesting different tissues for expression profiling of the A. strigosa S75 
accession (qPCR or RT-PCR), a set of the seedlings were divided into whole roots 
and shoots, with another set having their roots further divided into the terminal 2-
3mm ‘tips’ and the elongation zone (~5mm) immediately above the tips. These 
steps were performed on a glass plate placed on dry ice and the harvested tissues 
were transferred immediately to microcentrifuge tubes placed in dry ice. Harvested 
samples were stored at -80°C until needed. 
6.4.3 – RNA extraction from oat seedlings and cDNA synthesis 
For extraction of RNA from oat tissues, tissues were taken from the -80°C freezer 
and transferred to liquid nitrogen. Using a micropestle, the tissues were ground to a 
fine powder. RNA extraction was performed using a RNeasy Plant Mini kit (Qiagen) 
according to the manufacturer’s instructions with minor changes noted here. Briefly, 
following transfer of the samples to the RNeasy Mini Spin Column, an on-column 
Chapter 6 – Identification of P450s required for avenacin biosynthesis in oat 
173 
 
DNase digestion was performed (Promega RQ1 DNase). The columns were 
washed with 350μl buffer RW1 and centrifuged. 80μl DNase (prepared according to 
manufacturer’s instructions) was transferred to the column membrane and 
incubated for 1 hour at room temperature. Columns were washed a second time 
with 350μl buffer RW1 and the rest of the protocol was followed as normal. RNA 
concentration was checked using a Thermo Nanodrop 2000 and the integrity of 
RNA was confirmed by running 5μl of the samples on a 1% agarose gel (plus 
ethidium bromide) run at 100V for 15 minutes. cDNA synthesis was performed using 
the Superscript-II First Strand Synthesis System (Invitrogen) with the supplied 
OligodT primers. For all samples, 1μg total RNA was used per synthesis reaction to 
give approximately equal template concentrations for downstream applications. 
6.4.4 – Cloning of candidate A. strigosa P450s 
Cloning was performed by Dr Aymeric Leveau from A. strigosa S75 root tip cDNA, 
using primers as detailed in Table 6-2. Amplified products were cloned into 
pDONR207 for sequencing before transfer to pEAQ-HT-DEST1. The constructs 
were transformed into A. tumefaciens LBA4404 as detailed in section 2.1.2.3 
6.4.5 – Cloning Primers 
Name 
Adapter/ 
5'sequence Gene-specific sequence 
CYP71E22-GW-F attB1F-3 ATGGTGATCCTGCACCCCTCGC 
CYP71E22-GW-R attB2R-3 CTAGGCGCGCGGCGGCACGTATAG 
CYP72A475 attB1Fs-2 ATGGCACTGCTTGTAGAGTTGTTC 
CYP72A475 attB2Rs-2 TCATATAGCCTTGAGCTTAATATG 
CYP72A476-GW-F attB1F-3 ATGAGTAGTTTTGAGATGGAATTC 
CYP72A476-GW-R attB2R-3 TCMGATGGCCTTGAGAGTAATCTGAGC 
CYP88A75-GW-F attB1F-3 ATGTGGTGGCCGTGGTGGGCGG 
CYP88A75-GW-R attB2R-3 TCAGTGTCCACCGGAGCCGGAGG 
CYP89N1-GW-F attB1F-3 ATGGAGGGGCTCACCATCCTCTTG 
CYP89N1-GW-R attB2R-3 TCMCTGCTTCATGTCCCTTGGGATGATG 
CYP94D65 attB1Fs-2 ATGGAGCCGGCGCCCTTGAGCTC 
CYP94D65 attB2Rs-2 TTAGTACTGATTTCTAGGTGC 
CYP706C45-GW-F attB1F-3 ATGCCACATACGTTAACGTTTTCC 
CYP706C45-GW-R attB2R-3 TTACTCAGACGAATAATAGAGTTC 
CYP711A54-GW-F attB1F-3 ATGGGCCGCCTGGCAGAAGCACTG 
CYP711A54-GW-R attB2R-3 TCATATGTTCCGCTCGATGACTTGGAG 
 
Table 6-2: Primers used to clone candidate P450s from A. strigosa. Gene-specific 
sequences are given on the right, with 5’ adapters for Gateway cloning indicated in the 
middle column and detailed in Table 2-1 
6.4.5.1 – Cloning and sequencing CYP72A465 from #1243 
Seedlings from lines #825 and #1243 were grown as in section 6.4.2. Roots were 
harvested and used to synthesise cDNA (section 6.4.3). A PCR was performed 
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using Phusion polymerase (NEB) for cDNA from each line. A strong band of the 
correct size was formed in the #1243 cDNA template. Two very weak bands were 
formed in the #825 sample (~1.5 and 2.5kb). Gel purification of the bands was 
performed (QIAquick gel extraction kit, Qiagen) and cloned into pDONR207 before 
transforming E. coli DH5α. Colonies were recovered on all plates and two from each 
were sent for sequencing with attL1-F/2-R primers (Table 2-1). The #1243 mutant 
full-length CYP72A465 transcript was found to contain a G1068A point mutation. 
None of the clones from #825 contained the CYP72A465 gene. 
6.4.6 – Infiltration, extraction and analysis of N. benthamiana leaves 
Infiltration was performed by Dr Aymeric Leveau and James Reed according to the 
protocol in section 2.1.3.3. Extraction of the leaves was performed according to 
section 4.5.5. For GC-MS analysis, ethyl acetate leaf extracts of N. benthamiana 
plants were dried under nitrogen before adding 50μl Tri-Sil Z reagent (Sigma). 
Samples were heated at 70°C for 30 minutes before loading onto the GC-MS. 
Samples were analysed according to section 2.1.5.2. 
6.4.7 – LC-MS analysis of oat mutants 
LC-MS analysis of oat mutants was performed by Dr Sam Mugford as previously 
described [226]. 
6.4.8 – RT-PCR profiling 
Primers for RT-PCR were designed using Primer3 [245]. The following parameters 
were specified: 18-23nt, Tm = 57-62°C, GC % = 30-70% and product size = 270bp. 
For most candidates, primers were designed towards the 3’ end of the cDNA. For 
GAPDH, primers were designed to span predicted intron sequences to identify the 
presence of contaminating genomic DNA by the product size (gDNA = 427bp, cDNA 
= 246bp). 25µL PCR was carried out using GoTaq Green polymerase (Promega) 
with primers listed in (Table 6-4) and thermal cycle detailed in Table 6-3. cDNA 
templates were from different tissues of 4-day old S75 seedlings (detailed in 
section 6.4.2). PCR products were analysed using a 2% agarose gel. 
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Step Temp (°C) Time 
 
Denaturation 98 30 sec 
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Denaturation 98 10 sec 
Annealing 55 10 sec 
Extension 72 60 sec 
 
Extension 72 3 min 
 
Table 6-3: RT-PCR thermal cycle parameters   
  Name Sequence 
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GAPDH-RT-PCR-F GGTGGTCATTTCAGCCCCTA 
GAPDH-RT-PCR-R CTCCCACCTCTCCAGTCCTT 
AsbAS1-RT-PCR-F AACTACGCCAACTACCGCAA 
AsbAS1-RT-PCR-R ACGATTAAACCGCGGGACTT 
CYP51H10-RT-PCR-F ACACACTTACAAGGACCCCG 
CYP51H10-RT-PCR-R CGCACACAAAGATACATCCGT 
CYP72A475-RT-PCR-F CCGAGGCCTCAAAGAATCCA 
CYP72A475-RT-PCR-R TGACCCATTATTACACTGTTGCA 
CYP72A476-RT-PCR-F TTCCAAGGCGCATATCTCCC 
CYP72A476-RT-PCR-R TCAGATCCCGATTCATCCGC 
CYP706C45-RT-PCR-F CTCGAGTTCAACCCGGAGAG 
CYP706C45-RT-PCR-R AATTCAAGTTCATGCCGCCT 
CYP71E22-RT-PCR-F GGTCAATGGCGCTGATGAAC 
CYP71E22-RT-PCR-R TTTATTTGGGAACGACGGGC 
CYP89N1-RT-PCR-F CACACTGCATGCCGAGTACT 
CYP89N1-RT-PCR-R TGAATTAAGAGGACCGGGCC 
CYP88A75-RT-PCR-F GACATGATGGACCGGCTGAT 
CYP88A75-RT-PCR-R AAAGTGTCTCGAGTCGCCTG 
CYP711A54-RT-PCR-F GCGATACGGGCCAATCTACA 
CYP711A54-RT-PCR-R CGGCCCTGTTGATGTAAGGT 
 
Table 6-4: Primers used for RT-PCR expression profiling of P450s A. strigosa.  
 
6.4.9 – qPCR analysis 
Primers for EF1-α, AsbAS1 and CYP51H10 were the same as described previously 
[29]. For CYP72A475, CYP72A476 and CYP94D65, primers were designed using 
primer 3 [245] to give similar amplicons and annealing temperatures. One primer in 
each pair was designed to span a predicted exon-exon boundary by comparison of 
the cDNA sequence with the A. strigosa genomic sequence. Primers for 
CYP72A475 were designed to anneal upstream of the mutation identified in line 
#1243. Primer sequences are listed in Table 6-5. 
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For expression profiling of AsbAS1, CYP51H10, CYP72A475, CYP72A476 and 
CYP94D5 in wild-type plants, cDNA templates were synthesised from root and 
shoot tissues as described in sections 6.4.2 and 6.4.3. For CYP72A475 expression 
profiling in S75, and #825 and #1245 mutants, cDNA templates were synthesised 
from whole roots from 5-7 day-old seedlings. 
Samples were set up in triplicate in white 96 well plates (4titude) using the 
DYNAMO Flash SYBR Green kit (Thermo) according to the manufacturer’s 
instructions. qPCR profiling was conducted using a BIO-RAD CFX96 Touch Real-
Time PCR Detection system. All targets were measured using the ΔΔCq method 
relative to the A. strigosa housekeeping gene EF1-α (elongation factor 1-α).  
Name Sequence 
EF1-α-qPCR-F TCCCCATCTCTGGATTTGAG 
EF1-α-qPCR-R TCTCTTGGGCTCGTTGATCT 
AsbAS1-qPCR-F TGCGGAATTCACAAAGAACA 
AsbAS1-qPCR-R GCTTGGCTTCTGTCGGAATA 
CYP51H10-qPCR-F TCGACAGGAAGTGGAGGAGT 
CYP51H10-qPCR-R ATCTCGGACCTCACTTCCAA 
CYP72A475-qPCR-F GGAAGCTGCTAGGTAATGG  
CYP72A475-qPCR-R CCGACAACTTGAGCTTGA 
CYP72A476-qPCR-F GCATTCAACGAGATGCTC 
CYP72A476-qPCR-R AAATTGTTCTTGATGGCCTG 
CYP94D65-qPCR-F GTCATTACCAGGTTCGTGT 
CYP94D65-qPCR-R GATGATGTTGTCGGCGTA 
 
Table 6-5: Primers used for q-PCR expression profiling of A. strigosa P450s. 
 
6.4.10 – BLAST searches of the A. strigosa genome 
Searches were performed by Dr Aymeric Leveau. Briefly, genomic sequence 
scaffolds from version 0.6 of the A. strigosa genome were kindly supplied by Prof 
Bin Han (National Centre for Gene Research, China). A database of the sequences 
was compiled using CLC (Qiagen) and BLAST searches were conducted using the 
A. strigosa 454 coding sequences for CYP72A475 and CYP72A476 to identify 
scaffolds containing the genomic sequences. 
6.4.11 – Extraction and GC-MS analysis of oat roots 
For growing seedlings, ten seeds for each of three A. strigosa lines were used 
(S75/sad1 line #109/sad2 line #1027) [38]. Seeds were sterilised and grown as in 
section 6.4.2 and harvested after 5 days. The whole roots were cut away from the 
rest of the seedling using a razor blade and stored at -80°C. The roots were 
Chapter 6 – Identification of P450s required for avenacin biosynthesis in oat 
177 
 
lyophilised overnight and weighed the following day. The roots were then saponified 
and extracted as in section 3.4.7. GC-MS analysis was performed according to 
section 2.1.5.1. 
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7.1 – Introduction 
The abundance and diversity of the triterpenes is testament to their importance 
throughout the plant kingdom. Naturally, these molecules have also found a wide 
range of applications throughout human history with uses ranging from traditional 
medicines to cleaning agents. Triterpenes still have huge potential for development 
in the commercial, agrochemical and pharmaceutical sectors, however much of this 
potential remains unrealised due to the difficulties in sourcing and selective 
modification of these compounds. Recent understanding of the biosynthetic 
pathways of these molecules in a range of plant species now provides for the first 
time an opportunity to use heterologous host production platforms to access and 
exploit the full potential of the triterpenes. In the present work, transient expression 
in N. benthamiana was developed as a powerful and rapid strategy for functional 
analysis of triterpene biosynthetic enzymes and for triterpene engineering. The 
value of this expression platform for combinatorial triterpene biosynthesis is 
demonstrated.  This system is also used to generate suites of analogues of known 
and new-to-nature triterpenes in milligram quantities and the biological activities of 
these derivatives is investigated.   
7.2 – N. benthamiana as a platform for triterpene production 
At present, yeast has been the major organism of choice for functional 
characterisation of triterpene biosynthetic enzymes. Efforts have also been made to 
optimise production in this host [108, 147, 148]. Nevertheless, N. benthamiana was 
considered to have promise because it is a plant-based system and might have 
certain advantages over yeast (e.g. availability of precursors, coenzymes and 
appropriate subcellular compartmentalisation mechanisms). Prior to the start of this 
project, there were few reported cases of triterpenes being successfully produced in 
N. benthamiana [85, 93]. Therefore a major aim of the present PhD thesis was to 
determine the suitability of N. benthamiana as a production platform for a range of 
different triterpenes. To this end, a triterpene ‘toolkit’ was established, consisting of 
a collection of genes encoding characterised triterpene biosynthetic enzymes.  
These genes were each cloned into expression constructs and introduced into A. 
tumefaciens strains.  Each A. tumefaciens strain carried a single gene encoding an 
OSC or P450, allowing the strains to be used in a modular fashion, enabling rapid 
assembly and validation of new combinations. 
Agroinfiltration of the OSC-carrying strains in N. benthamiana confirmed that a 
diverse range of triterpene scaffolds could be produced in this system (Chapter 4). 
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Further experiments demonstrated that several triterpenes including β-amyrin and 
dammarenediol-II could be further oxidised in planta by coexpression of previously 
characterised P450s with the relevant scaffold-generating OSC. In each case, the 
major product observed upon GC-MS analysis conformed to the expected product. 
This is particularly encouraging as perhaps one of the factors presently limiting 
more widespread use of N. benthamiana is the frequency with which unintended 
modifications to the produced compound are observed [140]. For example, certain 
diterpenes have been reported to be modified by endogenous oxidases [128]. 
Although unknown peaks were found in some of the chromatograms in the present 
study, in many cases these could be resolved as extraction or analytical artefacts 
(section 4.3). Glycosylation has also been reported upon production of simple and 
oxidised monoterpenes and sesquiterpenes [122, 127, 132, 234]. While production 
of triterpene monoglucosides in N. benthamiana has also been reported to elicit 
further glycosylation, this did not appear to occur for triterpene aglycones [105]. As 
GC-MS was the major analytical tool employed throughout this study, it is possible 
that some conversion of simple triterpenes occurred in N. benthamiana which were 
not detected. Nevertheless, the abundance of the triterpene products as assessed 
by GC-MS suggested that substantial quantities are present in the expected form. 
Ultimately in the present study it was possible to use this system to produce and 
purify a number of oxidised triterpenes in milligram quantities. These results indicate 
that N. benthamiana is a very good system for the production and oxidation of a 
diverse range of triterpenes. 
7.3 – Further enhancing triterpene production in N. benthamiana 
Optimising triterpene production in N. benthamiana is desirable for increasing the 
levels of product, facilitating purification, structural analysis and use for downstream 
applications.  Metabolic engineering of the host species is one way in which the 
production capacity of the host system can be improved. However metabolic 
engineering in N. benthamiana, (and indeed plants in general) is in its infancy 
compared to microbial systems such as yeast, for which an array of molecular tools 
are available [246]. Nevertheless, there is clear promise for metabolic engineering 
of N. benthamiana by transient expression. Strategies investigated include alternate 
cellular compartmentalisation [127, 132, 133] and use of rate-limiting enzymes [127, 
128, 132]. However such strategies had not been demonstrated for triterpenes. 
Therefore, Chapter 3 investigated strategies for improving triterpene production in 
N. benthamiana. To this end, potential rate-limiting steps within the native 
triterpene-producing MVA pathway were considered.  Coexpression of a truncated, 
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feedback-insensitive form of 3-hydroxy,3-methylglutaryl-CoA reductase (tHMGR) 
increased the yields of β-amyrin by approximately 4-fold when compared to plants 
expressing β-amyrin synthase (AsbAS1) alone (section 3.2.2).  Inclusion of tHMGR 
also enhanced production of oxidised forms of β-amyrin, including 12,13β-
epoxy,16β-hydroxy-β-amyrin (EpHβA), when AsbAS1 was co-expressed with 
P450s. To test how the use of tHMGR would impact isolated yields, this product 
was scaled up and purified, resulting in a total of 79 mg of pure EpHβA, equivalent 
to 4mg/g dw (section 3.2.5). This is almost four-fold higher than previous reports 
[85]. 
That such a yield should be obtained with relatively little engineering is very 
encouraging for future development. Thus further investigation of other candidate 
rate-limiting enzymes within the plant cell should be considered for future work. 
Although tHMGR gave the largest increase in β-amyrin, squalene synthase (SQS) 
was also found to improve β-amyrin production. Further increases in β-amyrin were 
consequently observed when both tHMGR and SQS were expressed together with 
AsbAS1 (section 3.2.3). This demonstrates that additional yield increases may be 
obtained by co-expressing addition upstream precursor pathway genes. In a recent 
example, overexpression of every gene in the MVA pathway in A. thaliana illustrated 
that several of the genes resulted in enhanced sterol accumulation [169]. Thus, one 
strategy to improve yields might simply be the overexpression of every gene in the 
MVA pathway, a strategy that has been successfully used to improve sesquiterpene  
production in yeast [247]. Rather than coinfiltrating several A. tumefaciens strains 
carrying single MVA genes, a more efficient method would be to integrate multiple 
genes into a single vector. Golden Gate cloning [135] is one such approach which 
facilitates integration of multiple genes into a single binary vector for expression in 
N. benthamiana. This system is currently being utilised in the Osbourn lab. 
Alternatively, several genes might be fused into a single open reading frame 
separated by sequence encoding a ‘self-cleaving’ peptide. A viral 2A peptide has 
been successfully applied for transient expression in N. benthamiana to fuse an 
amorphadiene synthase, FPS and tHMGR enzymes [132]. 
In conjunction with overexpressing rate-limiting enzymes, other strategies may also 
have merit for further boosting triterpene yields. For example, the loss of metabolic 
intermediates might also be prevented by using transient expression to silence 
endogenous N. benthamiana enzymes which compete with triterpene biosynthesis 
(such as cycloartenol synthase). This has been shown to be a viable strategy for 
improving sesquiterpene content in N. benthamiana transient expression studies 
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[131]. Spatial control of key enzymes in the pathway might also be used to channel 
metabolism towards triterpene biosynthesis. This could be achieved through fusion 
of key enzymes into a single polypeptide [248] or alternatively through tethering 
multiple enzymes to protein scaffolds [249]. 
The relative abundance of individual proteins might be ‘tuned’ to overcome 
metabolic bottlenecks and optimise product yield. The pEAQ vectors used in the 
present study have significant potential for such an approach. For example, control 
over individual proteins might be achieved through use of both wild type and HT 
CPMV 5’ UTRs. In this way the stoichiometry of Bluetongue virus proteins could be 
optimised allowing for the enhanced formation of virus-like particles [250]. 
Modifications to the 3’ UTR also have similar potential for altering protein levels 
[251]. It should be noted that significant variation in relative expression of individual 
proteins may be observed between plant cells when the respective T-DNA encoding 
these proteins are derived from separate strains of A. tumefaciens [252]. Therefore, 
efforts to explore the above approaches would be best served through integration of 
several genes into a common vector as described above. 
7.4 – Expanding triterpene diversity 
Triterpenes are amongst the most chemically diverse terpenes and the 
overwhelming majority of these products are oxygenated [73]. Oxidation provides 
the functional handles for further modification by tailoring enzymes such as 
glycosyltransferases and hence serves a key role in generating triterpene structural 
diversity. As described above, a core aim of this PhD was to assemble a collection 
of known oxidases for engineering triterpenes in N. benthamiana. In addition, this 
collection was also expanded through functional characterisation of putative C-21, 
C-23 and C-30 P450s from oat with a role in avenacin biosynthesis (Chapter 6). 
Avenacins are triterpene glycosides (saponins) with strong antifungal activity, thus 
these enzymes represent important advances in our understanding of this pathway. 
The ability to produce triterpene saponins is very rare amongst cereals. Thus 
understanding avenacin biosynthesis provides an opportunity for engineering 
avenacin production into crop species which are susceptible to fungal pathogens 
such as take-all disease, a major pathogen of wheat.  
In addition to recreating known triterpenoids in heterologous hosts, an important 
application for the collection of triterpene biosynthetic enzymes is engineering the 
production of new triterpenes through combination of enzymes from different 
species. To demonstrate this principle, a core set of the β-amyrin oxidases from the 
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triterpene toolkit were systematically combined in Chapter 4. This approach showed 
that almost all of the pairwise combinations resulted in the formation of new 
products. Two such hybrid compounds, 11-oxo,24-hydroxy-β-amyrin and 11-oxo-
oleanolic acid were subsequently purified and the identity of the compounds was 
verified by NMR. Work is currently ongoing to verify the identity of the other 
compounds, but the expected products do not appear to have been previously 
isolated. This clearly demonstrates the utility of this approach for accessing novel 
structural diversity. 
7.4.1 – Engineering triterpene glycosides 
Triterpene glycosides (saponins) found within the plant kingdom frequently feature 
an array of diverse sugars including glucose, arabinose, rhamnose, xylose and 
galactose [72]. Most of the necessary sugar donors required for their synthesis are 
not present in microbial systems. Therefore an important test of the potential of N. 
benthamiana as a production host will be the capacity to produce a range of diverse 
triterpene glycosides. In the present work, it was demonstrated that high levels of 
the ginsenoside scaffolds protopanaxadiol and protopanaxatriol could be produced 
through coexpression of a mutant form of AsbAS1 with P450s from Panax ginseng. 
These scaffolds are present in over 90% of ginsenosides [44] and are normally 
present as glycosides. Recent progress in elucidating UDP-dependent 
glycosyltransferases (UGTs) from P. ginseng [253] has allowed for the reproduction 
of a number of key ginsenosides in N. benthamiana. (Dr Thomas Louveau and 
Charlie Owen, Osbourn lab). Furthermore, a combinatorial approach using UDP-
dependent glycosyltransferases (UGTs) in the Osbourn lab has revealed that a 
range of triterpene glycosides can be produced in N. benthamiana upon 
coexpression of triterpene-modifying UGTs from various plant species. This 
includes the ability to glycosylate the scaffold with non-glucose sugars. 
Furthermore, glycosides of several P450 combinatorial products described within 
this thesis have also been produced (Dr Thomas Louveau, personal 
communication). This further demonstrates that N. benthamiana may be an 
excellent system for generating structurally diverse triterpenoids and saponins. 
An obvious question to consider is the extent to which combinatorial biosynthesis 
can be applied for a multi-step pathway. For example, while some of the pairwise 
P450 combinations used herein were highly active (such as CYP88D6 and 
CYP93E1), others gave relatively poor accumulation of new products (such as 
CYP51H10 and CYP716A12). Such bottlenecks will be detrimental to further 
elaboration of the scaffold. Protein engineering approaches might therefore be 
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applied to enhance the activity of individual P450s [110]. Alternatively, functionally 
conserved orthologues of individual enzymes have been shown to have differences 
in their catalytic efficiency towards a common substrate [99]. By extension, similar 
differences might be observed in efficiency towards novel substrates. In the present 
thesis, two C-30 oxidases (CYP72A63 and CYP72A65) were investigated using the 
combinatorial biosynthesis approach. Of these, CYP72A65 was found to be a better 
candidate for use in combinatorial biosynthesis (Chapter 4). Therefore this stresses 
the importance of fully exploiting the available sequence data to not only to identify 
enzymes with novel functionalities, but also functionally ‘redundant’ enzymes which 
may be better suited for individual applications.  
7.4.2 – Expanding the enzyme collection further 
The number of characterised genes in triterpene biosynthesis has increased 
significantly in recent years. However there are still relatively few species for which 
multi-step triterpene biosynthesis pathways have been defined. Rapid decreases in 
sequencing costs mean that the available plant sequence data is likely to increase 
hugely over the coming years. Data from projects such as the 1000 plants initiative 
(1KP - www.onekp.com) offer access to transcriptomic data from a diverse variety of 
plant species [254]. These may be mined for new OSCs or common triterpene 
oxidase families. Additionally, the growing number of sequenced plant genomes 
provides an opportunity to use computational methods to search for clustered 
triterpene biosynthetic genes [255].  
Ultimately, as the number of available triterpene biosynthetic genes increases, the 
opportunity for combinatorial biosynthesis will increase exponentially. Hence high-
throughput combinatorial screening approaches should be considered. A recent 
approach developed by Dr T. Rademacher (Fraunhofer IME, Aachen, Germany) 
allows generation of a 3-D cell ‘pack’ from plant cell cultures which can be 
transformed by A. tumefaciens. This approach is suited to a 96-well format and 
might be applied to high-throughput screening of triterpene combinatorial libraries 
while maintaining the benefits of the plant-based expression and modular A. 
tumefaciens toolkit approach. 
7.5 – Understanding structural features behind biological activity 
The number of possible chemical structures (chemical space) is vast; small organic 
molecules of 30 atoms or less have been estimated to number more than 1060 
compounds [256]. However within this vast space, it is now recognised that a much 
smaller subset of these molecules occupy ‘biologically relevant’ chemical space 
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[257]. Natural products inherently occupy this area and consequently have been 
hugely important for the discovery and development of therapeutics [186]. 
Triterpenes, like most natural products, have a high number of chiral centres and 
display structural rigidity, properties which may be important mediators of biological 
activity, such as their ability to bind protein targets [258]. Equally, their similarity to 
other biological products such as sterols may enhance their bioavailability, such as 
through interaction with cellular transporters. Therefore triterpenes can be 
considered excellent bioactive leads from which explore further structural variants. 
Much of the vast structural variation present within the triterpenes has not yet been 
accessed. The current understanding of triterpene structure-activity relationships is 
very limited, and has been restricted to synthetic derivatives of a small number of 
readily available scaffolds. The use of P450s to selectively functionalise the β-
amyrin scaffold provided a unique opportunity for systematic investigation into the 
types and positions of oxidation which contribute to activity. As a proof-of-concept a 
series of oxidised forms of β-amyrin was generated and these analogues 
investigated for their antiproliferative and anti-inflammatory activity in human cells 
(Chapter 5). Clear differences could be observed between the different oxidised 
compounds, suggesting that the type and position of the modification plays an 
important role in determining their activity. This was attributed to the presence of a 
ketone at C-11 and modifications to the C-28 position. Further combinatorial 
biosynthesis allowed structural variants of 11-oxo-β-amyrin to be assessed, and the 
resulting compounds again showed clear differences in their activity. Hence there is 
significant value in extending this approach to other positions around the β-amyrin 
scaffold to gain further insight into structure-activity relationships. Other triterpene 
scaffolds also have great potential for exploring bioactivity. In the present work, the 
dammarenediol-II-based triterpene protopanaxadiol was also active in both the 
antiproliferative and anti-inflammatory assays. The cucurbitacins are another class 
of structurally diverse cytotoxic triterpenes which have considerable potential as 
cancer therapeutics [91]. The biosynthesis of these molecules is beginning to be 
elucidated in species such as cucumber [89]. Equally, as described above (section 
7.4.2), genome mining efforts will undoubtedly lead to novel scaffold-generating 
OSCs and associated tailoring enzymes, providing access to a rich diversity of 
previously-uncharacterised triterpenes which can be tested for activity. 
Moving forward in our understanding of triterpene structure-function relationships 
will require further qualification of mechanisms by which these compounds exert 
their effect. This ‘target deconvolution’ step can be approached at the level of 
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functional genetics to identify individual protein targets, or alternatively, considered 
in the context of their cellular response such as through transcriptomic profiling 
[259]. Identification of the relevant cellular targets will allow for hypothesis-driven 
testing of the features contributing to bioactivity.  
Bridging the gap between discovery of a lead molecule and its deployment as an 
effective therapeutic agent often requires the use of synthetic chemistry. Synthetic 
modifications of natural products are frequently deployed to improve the therapeutic 
profile of the molecule, increasing potency, reducing toxicity and increasing 
solubility or chemical stability [260]. Presently most chemical syntheses require 
access to relatively pure starting material. In future it could be possible to move 
towards both biosynthesis of triterpenes and subsequent chemical modification in 
planta. Such ‘one-pot’ reactions would reduce both the time and cost required to 
purify compounds prior to synthetic modification. At the same time, this approach 
could itself facilitate purification of products which prove hard to separate from 
endogenous N. benthamiana metabolites by altering polarity or adding chromo- or 
fluorophores which aid detection.  
Ultimately, biological components may be seen as another tool for synthetic 
chemistry. As described above, the ability of enzymes such as P450s to carry out 
regio- and stereoselective scaffold oxidation can provide the necessary functional 
handles allowing modification of otherwise synthetically intractable C-H bonds. 
Equally, other classes of enzyme may also find use in the synthetic chemical toolkit. 
For example, chemical moieties such as acetyl groups are frequently used as 
protecting agents to prevent unwanted chemical modification of specific functional 
groups. Hence regiospecific acylation of triterpenes could be achieved by use of 
acyltransferases, further reducing the number of downstream synthetic steps 
needed. Although relatively few triterpene acyltransferases are currently known, 
there is significant evidence to suggest that triterpene acyltransferases may be 
found clustered with OSCs [89, 225]. Therefore the number of characterised 
acyltransferases can be expected to increase significantly over the coming years. 
The therapeutic potential of plants has been known since ancient times [1]. Even 
today plants continue to be a source of important therapeutics, highlighted by the 
recent 2015 Nobel Prize in Physiology or Medicine being awarded to Prof Youyou 
Tu for the discovery of artemisinin. Triterpenes show clear potential for application 
in a range of areas from cancer and inflammation [48, 50, 57] to vaccine adjuvants 
[53, 56] and obesity treatment [49]. Nevertheless the difficulty in isolating many of 
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these compounds coupled with the need for accessing new, biologically relevant, 
chemical diversity underscores the need for development of biological platforms to 
engineer their production. The rapidly accumulating sequence data from across the 
plant kingdom coupled with advances in gene synthesis and assembly methods 
present for the first time exciting opportunities to assemble and engineer production 
of diverse new triterpenes, enabling the full potential of these very important 
molecules to be exploited. 
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Supplementary Figures 
  
Supplementary Figure 1: Amino acid sequence alignment of the three A. strigosa isoforms 
of HMGR as identified in the root tip 454 transcriptomic database. Sequence conservation is 
indicated by colour. Yellow indicates absolute conservation of residues between the three 
sequences while blue indicates conservation in two sequences only. Only a partial sequence 
was available for AsContig20171. Green indicates different but chemically similar amino 
acids. 
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Supplementary Figure 2: Amino acid sequence alignment between the A. thaliana and A. 
strigosa FPS proteins. The mitochondrially-targeted A. thaliana FPS (AT5G47770) and the 
putative A. strigosa FPS (AsContig17290) used in this study were aligned using vector NTI. 
Yellow highlighting indicates absolute sequence conservation between the two proteins, 
while green indicates different but chemically similar residues. 
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Supplementary Figure 3: Mass spectra for products not shown in Figure 4-4 from leaves 
expressing tHMGR/AsbAS1/CYP93E1. Peak 11 is expected to be the C-24 acetylated form 
of 24-hydroxy-β-amyrin. 
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Supplementary Figure 4: Additional products observed upon GC-MS analysis of 11-oxo-β-
amyrin. A) Mass spectra for products not shown in Figure 4-5. The product at 22.4 minutes 
is likely to be a tautomerised and silylated form of 11-oxo-β-amyrin resulting from the basic 
environment of the pyridine solvent present in the derivitising reagent. (see scheme below) 
B) GC-MS analysis of underivitised N. benthamiana leaf extracts expressing 
tHMGR/AsbAS1/CYP88D6. In contrast to the derivitised samples, one major peak was 
dominant in the sample. This had the expected mass of non-silylated 11-oxo-β-amyrin (MW 
= 440). 
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Supplementary Figure 5: EI fragmentation of 11-oxo-β-amyrin. A) The presence of a C-11 
carbonyl group in β-amyrin derivatives allows γ- (McLafferty) rearrangement during 
fragmentation. For 11-oxo-β-amyrin this gives rise to a characteristic ion at m/z 273. This 
mass shifts accordingly with the presence of functionalities in the C,D or E rings. B) 11-oxo-
β-amyrin can also undergo retro Diels-Alder fragmentation as with β-amyrin. 
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Supplementary Figure 6: Combinatorial biosynthesis with CYP72A63. These combinations 
resulted in much poorer accumulation of the products versus the equivalent combination 
expressing CYP72A65. A) Combinations of CYP72A63 with either CYP716A12 (left) or 
CYP51H10 (right) failed to reveal any novel products. Black chromatograms represent the 
combinatorial samples containing CYP72A63, and blue chromatograms represent the 
equivalent sample with CYP72A65. The combinatorial products found in the CYP72A65 
samples are labelled. B) Combinations of tHMGR/AsbAS1/CYP88D6/CYP72A63 and C) 
tHMGR/AsbAS1/CYP93E1/CYP72A63 resulted in trace amounts of products which matched 
those shown in Supplementary Figure 8. Mass spectra from the CYP72A63 sample are 
shown.  
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Supplementary Figure 7: Combinatorial biosynthesis of compounds which could be verified 
against previously-published data. Total ion chromatograms (TIC) of N. benthamiana leaves 
expressing tHMGR, AsbAS1 and A) CYP93E1 and CYP716A12, B) CYP72A65 and 
CYP716A12, Chromatograms are shown on the left side, with the black chromatograms 
representing the combinatorial sample, and single-P450 controls in orange and blue.  In 
each case the EI mass spectrum for the major combinatorial product is given on the right 
and below. IS – Internal standard (Coprostanol).  
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Supplementary Figure 8: Combinatorial biosynthesis of compounds which could be verified 
against previously-published data. Total ion chromatograms (TIC) of N. benthamiana leaves 
expressing tHMGR, AsbAS1 and A) CYP72A65 and CYP88D6 and B) CYP72A65 and 
CYP93E1. Chromatograms are shown on the left side, with the black chromatograms 
representing the combinatorial sample, and single-P450 controls in orange and blue.  In 
each case the EI mass spectrum for the major combinatorial product is given on the right 
and below. IS – Internal standard (Coprostanol). 
 
 
 
(29.5 min)
306
73 201148
95 541369278 486
100 200 300 400 500
(28.9 min)
276
73 147
391330 541
100 200 300 400 500
2625
(27.4 min)
306
73
148201
103 278
368 571481
100 200 300 400 500
tHMGR/AsbAS1/CYP72A65/CYP93E1
19 20 21 22 23 24 25 26 27 28 29 30
IS
Time (min)
T
IC
24
25
26
24
tHMGR/AsbAS1/CYP72A65/CYP88D6
20 21 22 23 24 25 26 27 28 29
IS
(28.5 min)
73 361135
175 271 600471
510
100 200 300 400 500 600
A)
B)
T
IC
22
23
23
(28.0 min)
497
73 202 307 600
271 387
100 200 300 400 500 600
22
Mass-to-charge ratio (m/z)Mass-to-charge ratio (m/z)
Supplementary Figures 
213 
 
 
Supplementary Figure 9:  GC-MS analysis of N. benthamiana leaf extracts expressing 
tHMGR/AsbAS1/CYP51H10/CYP93E1. The total ion chromatogram (TIC) is shown on the 
upper left. Black chromatograms represent the combinatorial sample, with single-P450 
controls in orange and blue. The EI mass spectra for predicted combinatorial products is 
given to the right and below the chromatogram. IS – Internal standard (Coprostanol). 
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Supplementary Figure 10: NMR spectra for β-amyrin. Upper panel: Proton (
1
H) NMR of β-
amyrin in CDCl3. Lower panel: DEPT-edited HSQC.  
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Supplementary Figure 11: NMR spectra for 11-oxo, 24-hydroxy-β-amyrin (37). Upper 
panel: Proton (
1
H) NMR of β-amyrin in CDCl3. Important resonances described in the main 
text are annotated. The singlet marked * overlapped with a contaminating impurity. Lower 
panel: DEPT-edited HSQC. A full assignment of this compound (in deuterated pyridine) is 
provided in Table 4-5. 
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Supplementary Figure 12: GC-MS analysis of N. benthamiana leaf extracts expressing 
tHMGR/AsbAS1 with CYP72A65 and CYP51H10. The total ion chromatograms (TIC) is 
shown on the left side with the black chromatogram representing the combinatorial sample 
and single-P450 controls in orange and blue. The EI mass spectra for peak 36 is given to 
the right of the chromatogram. IS – Internal standard (Coprostanol). 
 
 
Supplementary Figure 13: Mass spectra for peaks not shown in the main text  A) Peaks 
38-41 not shown in Figure 4-9A. B) Peak 43 not shown in Figure 4-11A 
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Supplementary Figure 14: GC-MS analysis of N. benthamiana leaves expressing tHMGR 
and AsbAS1 with A) CYP51H10 and CYP88D6 and B) CYP51H10 and CYP716A12. Total 
ion chromatograms (TIC) are given in the upper left of each section with the combinatorial 
sample in black and control samples in orange and blue. Mass spectral data for the major 
products to the right and/or below. Putative product structures are given in grey.  
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Supplementary Figure 15: Combinatorial biosynthesis utilising CYP51H10-A354L. N. 
benthamiana leaves expressing A) tHMGR/AsbAS1/CYP51H10-A354L/CYP88D6  B) 
tHMGR/AsbAS1/ CYP51H10-A354L/CYP93E1  C) tHMGR/AsbAS1/CYP51H10-
A354L/CYP72A65.  GC-MS total ion chromatograms (TIC) are given on the left with the 
combinatorial sample (black) overlaid with single-P450 controls (orange and blue). Mass 
spectra for the major products and predicted structures are given on the right and below. For 
C) tHMGR/AsbAS1/CYP51H10/CYP72A65 leaves accumulate a product (56) which has a 
similar retention time and mass spectrum to a peak observed in the control sample (57). The 
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presence of unique ions (bold) in each sample suggest that these are two different 
compounds. 
 
Supplementary Figure 16 Combinatorial biosynthesis utilising CYP51H10-I471M. GC-MS 
analysis of N. benthamiana leaves expressing A) tHMGR/AsbAS1/CYP51H10-
I471M/CYP716A12 and B) tHMGR/AsbAS1/CYP51H10-I471M/CYP72A65. Total ion 
chromatograms (TIC) are displayed on the left side with combinatorial sample 
chromatograms given in black and controls in blue and orange. Mass spectra and putative 
structures for the major products given to the right and below. 
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Supplementary Figure 17: EI fragmentation of EpHβA and CYP51H10 mutants. A) 
Proposed fragmentation for the wild-type CYP51H10 product (12,13β-epoxy,16β-hydroxy-β-
amyrin) leading to the formation of the ion 322. B) retro Diels-Alder (rDA) fragmentation of 
16β-hydroxy-β-amyrin, the product of CYP51H10-A354L. C) Proposed fragmentation of the 
CYP51H10-I471M product 12,13β-epoxy-β-amyrin. The mechanism is likely to be similar to 
that in A), leading to the ion at m/z 234. 
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Supplementary Figure 18: Production of 2β-hydroxy-oleanolic acid in N. benthamiana  by 
coexpression of tHMGR/AsbAS1/CYP716A12/CYP72A67. A) Schematic for C-2 oxidation of 
oleanolic acid to 2β-hydroxy-oleanolic acid. B) GC-MS analysis of leaf extracts from 
coexpression of tHMGR/AsbAS1/CYP716A12/CYP72A67 in N. benthamiana. 
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Supplementary Figure 19: Production of hederagenin in N. benthamiana  by coexpression 
of tHMGR, AsbAS1, CYP716A12 and CYP72A68v2. A) Schematic for the step C-23 
oxidation of oleanolic acid to gypsogenic acid.  B) GC-MS data from N. benthamiana leaves 
expressing tHMGR/AsbAS1/ CYP716A12/CYP72A68v2 plus control extracts. Gypsogenin 
and gypsogenic acid were not detected using the present method. 
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Supplementary Figure 20: Production and oxidation of thalianol  in N. benthamiana. GC-
MS total ion chromatograms (TIC) are shown on the left from analysis of extracts of leaves 
expressing tHMGR with the Arabidopsis thaliana thalianol synthase (THAS). Oxidation of 
this scaffold was further achieved by coexpression of the thalianol oxidases CYP708A2 
(middle) and CYP705A5 (bottom). Details of these genes are given in Supplementary 
Table 5. 
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Supplementary Figure 21: Mass spectra for peaks detailed in Figure 4-15. Each of the 
standards for Dammarenediol-II, Protopanaxadiol and Protopanaxatriol result in two peaks 
by GC-MS. 
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Supplementary Figure 22: GC-MS analysis of the purified EpHβA product. Total ion 
chromatograms (TIC) for N. benthamiana leaves expressing tHMGR/AsbAS1/CYP51H10 
(middle left). Control tHMGR/AsbAS1/GFP leaves are shown at the top. GC-MS analysis of 
the purified EpHβA product is shown to the bottom left. EpHβA can degrade under the 
conditions of the GC-MS to form multiple peaks. The mass spectrum for the major peaks in 
the samples is shown to the right of the chromatogram. 
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Supplementary Figure 23: GC-MS analysis of the purified 11-α-hydroxy-β-amyrin and 11-
oxo-β-amyrin. Total ion chromatograms (TIC) for control N. benthamiana leaves expressing 
tHMGR/AsbAS1 are shown at the top left. Leaves expressing tHMGR/AsbAS1/CYP88D6 
are shown below. GC-MS analyses of the purified products are shown to the bottom left. 
Product 16 in the 11-oxo-β-amyrin sample is believed to be an artefact of the derivatisation 
process. The mass spectrum for the indicated peaks in the samples is shown to the right of 
the chromatograms. 
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Supplementary Figure 24: GC-MS of the purified 24-hydroxy-β-amyrin. Total ion 
chromatograms (TIC) for control N. benthamiana leaves expressing tHMGR/AsbAS1/GFP 
are shown at the top left. Leaves expressing tHMGR/AsbAS1/CYP93E1 are shown middle-
left. The TIC chromatogram for the purified 24-hydroxy-β-amyrin is shown to the bottom left. 
Mass spectra are shown on the right of the chromatograms. 
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Supplementary Figure 25: GC-MS of the purified 16β-hydroxy-β-amyrin. Total ion 
chromatograms (TIC) of control N. benthamiana leaves expressing tHMGR/AsbAS1/GFP 
are shown at the top left. Leaves expressing tHMGR/AsbAS1/CYP51H10-A354L are shown 
middle-left. The TIC chromatogram for the purified 16β-hydroxy-β-amyrin is shown to the 
bottom left. Mass spectra are shown on the right of the chromatograms. 
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Supplementary Figure 26: GC-MS of the purified 30-hydroxy-β-amyrin. Total ion 
chromatograms (TIC) of control N. benthamiana leaves expressing tHMGR/AsbAS1/GFP 
are shown at the top left. Leaves expressing tHMGR/AsbAS1/CYP72A65 are shown middle-
left. The TIC chromatogram for the purified 30-hydroxy-β-amyrin is shown to the bottom left. 
Mass spectra are shown on the right of the chromatograms. 
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Supplementary Figure 27: ELISA measurements of TNFα in LPS-stimulated THP-1 cells 
treated with inactive compounds. The compounds indicated were inactive in the MTS assay. 
Cells were preincubated with 100µM of the test compounds indicated prior to LPS 
stimulation. Bardoxolone-methyl (Bdox) was used at 200nM as indicated. TNFα production 
was quantified after 3 hours and is shown relative to the DMSO (vehicle)-treated control 
cells. Only a single test was conducted. 
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Supplementary Figure 28: GC-MS comparison of oat roots. The A. strigosa sad2 mutants 
accumulate β-amyrin (βA) as previously reported [238]. A second peak can also be seen at 
23.8 minutes with a mass spectrum consistent with the product found in N. benthamiana 
leaves expressing tHMGR/AsbAS1/CYP94D65. The two chromatograms cannot be 
compared directly due to differences in the GC program.  
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Supplementary Tables 
 
Enzyme 
name EC number 
A. thaliana 
homologue 
A. thaliana 
short name 
Oat 454 
Contig 
e value        
(TBLASTN) 
HMGR 1.1.1.34 AT1G76490 AtHMGR1 01257     6.90E-208 
    
17852    1.30E-206 
    
20171    4.70E-40 
  
AT2G17370 AtHMGR2 01257     1.90E-189 
    
17852    4.30E-185 
    
20171    2.40E-35 
FPS 2.5.1.10 AT5G47770 AtFPS1 17290      5.30E-138 
  
AT4G17190 AtFPS2 17290      8.00E-135 
SQS 2.5.1.21 AT4G34640 AtSQS1 17273    8.30E-150 
  
AT4G34650 AtSQS2 17273    1.30E-137 
SQE 1.14.99.7 AT1G58440 AtSQE1 01780    2.80E-212 
  
AT2G22830 AtSQE2 01780    1.60E-200 
  
AT4G37760 AtSQE3 01780    3.30E-209 
  
AT5G24140 AtSQE4 01780    4.30E-120 
  
AT5G24150 AtSQE5 01780    5.20E-131 
  
AT5G24160 AtSQE6 01780    4.80E-128 
  
AT5G24155 AtSQE7 01780    9.20E-17 
      
      
Supplementary Table 1: Searching an oat root tip transcriptomic database for MVA 
pathway genes. Protein sequences for the known A. thaliana genes were used as search 
queries in a translated A. strigosa 454 database (TBLASTN cutoff value e-10). Oat 454 
contig numbers and e-values are given in the right-most columns. A comparison of the three 
forms of oat HMGR are given in Supplementary Figure 1. The AtFPS1 gene (AT5G47770) 
encodes both long- and short protein variants which localise to either the mitochondria or 
cytosol respectively depending on the presence or absence of 41 amino acids at the N-
terminus of the protein[41]. Analysis of the oat FPS contig 17290 did not identify any obvious 
targeting sequences. Furthermore, amino acid sequence alignment with the mitochondrial-
targeted form of A. thaliana AtFPS1 revealed that the oat FPS is shorter and does not align 
within the N-terminal mitochondrial peptide (Supplementary Figure 2). 
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Fragment loss 
None (M+) 
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CH
3
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TMSiOH 
 
408 496 510 496 510 422 496 424 496 512 
TMSiOCH
2
 
 
- 
 
- 483 - - 483 - - - 
TMSiOOCH 
 
- - 482 - 
 
- - - - - 
ABC* rings 
 
218 306 320 218 218 232 306 234 306 322 
C*DE rings 
 
279 279 279 368 382 - 279 279 279 279 
ABC rings 
(McLafferty) 
 
- - - - - 273 - - - - 
ABC* + 
TMSiOH 
 
- 216 - - - - - - 216 232 
ABC* + 
TMSiOCH
2
 
 
- - - - - - 203 - - - 
ABC* + 
TMSiCOOH - - 203 - - - - - - - 
C*DE + 
TMSiOH  
189 189 189 278 292 189 189 189 189 189 
            
Supplementary Table 2: Summary of ions observed by from EI fragmentation of oxidised 
forms of β-amyrin. The column on the left describes the likely fragment which is lost to give 
the observed ion. Where ABC* rings is indicated, this generally refers to retro-Diels Alder 
fragmentation, with the exception of molecules containing the C-12,13 epoxide as shown in 
Supplementary Figure 17. Loss of the ABC rings by McLafferty rearrangement is also 
observed only in compounds containing the C-11 carbonyl group (11-oxo-β-amyrin) [100, 
174, 261] (A scheme for this rearrangement is shown in Supplementary Figure 5). 
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Fragment loss 
     None (M+) 
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Supplementary Table 3: Summary of ions observed by EI fragmentation of previously 
described combinatorial compounds. The fragment loss is as described in Supplementary 
Table 2. Ions labelled in red were not observed in the present study likely due to low 
abundance of the compound. Ions labelled in grey were minor constituents of the mass 
spectra and could not be clearly defined as a characteristic fragment. 
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Fragment loss 
 
    
 
   
None (M+) 
 
602 690 690 600 614 600 674 602 
CH3 
 
587 675 675 585 599 585 659 587 
TMSiOH 
 
512 600 600 510 524 510 584 512 
TMSiOCH2 
 
499 587 587 497 - - 571 499 
TMSiOOCH 
 
- - - - 496 - - - 
ABC* rings 
 
234 322 410 232 334 320 306 322 
C*DE rings 
 
367 368 279 - - - 367 279 
AB rings (McLafferty) 
 
- - - 273 375 361 - - 
ABC* + TMSiOH 
 
- 232 320 - - 230 216 232 
ABC* + TMSiOCH2 
 
- - 307 - - - - 219 
ABC* + TMSiCOOH 
 
- - - - 216 - - - 
C*DE + TMSiOH 
 
277 277 189 277 289 189 278 189 
 
Supplementary Table 4: Ions observed upon EI fragmentation of combinatorial products for 
which reference spectra were not available. The fragment loss scheme is as described in 
Supplementary Table 2. With the exception of 11-oxo-oleanolic acid and 11-oxo,24-
hydroxy-β-amyrin, product identities are putatively inferred from GC-MS data. Not shown are 
the putative 11-oxo,12,13-epoxy,16β-hydroxy-β-amyrin, 11,16β-dihydroxy,12,13-epoxy-β-
amyrin and 12,13β-epoxy-oleanolic acid as their fragmentations differed significantly from 
the usual fragmentation pattern.  
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Name Substrate Product Accession Ref 
CYP72A67 Oleanolic acid  2β-hydroxy-
Oleanolic acid  
AB558149 [102] 
CYP72A68v2 Oleanolic acid  Gypsogenic  acid  AB558150  [101] 
CYP716A47 Dammarenediol-II Protopanaxadiol JN604536 [103] 
CYP716A53v2 Protopanaxadiol Protopanaxatriol JX036031 [88] 
CYP708A2 Thalianol 7β-hydroxy- 
thalianol 
NM_180822 [32, 
74] 
CYP705A5 Thalianol Desaturated 
thalianol 
NM_124173 [32] 
     
Name Substrate Product Accession Ref 
MdOSC1 Oxidosqualene α-amyrin FJ032006 [262] 
LjOSC3 Oxidosqualene Lupeol AB181245 [263] 
CsCPQ Oxidosqualene Cucurbitadienol NP_ 
001292630 
[89] 
AsbAS1-
S728F 
Oxidosqualene Dammarenediol-II ABG88962 
(w/t) 
[137] 
THAS Oxidosqualene Thalianol NM_124175 [264] 
 
Supplementary Table 5: Additional P450s and OSCs expressed as part of the triterpene 
toolkit. 
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